<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Clin Diabetes Healthc</journal-id><journal-id journal-id-type="iso-abbrev">Front Clin Diabetes Healthc</journal-id><journal-id journal-id-type="pmc-domain-id">4398</journal-id><journal-id journal-id-type="pmc-domain">fcdh</journal-id><journal-id journal-id-type="publisher-id">Front. Clin. Diabetes Healthc.</journal-id><journal-title-group><journal-title>Frontiers in Clinical Diabetes and Healthcare</journal-title></journal-title-group><issn pub-type="epub">2673-6616</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10012165</article-id><article-id pub-id-type="pmcid-ver">PMC10012165.1</article-id><article-id pub-id-type="pmcaid">10012165</article-id><article-id pub-id-type="pmcaiid">10012165</article-id><article-id pub-id-type="pmid">36992740</article-id><article-id pub-id-type="doi">10.3389/fcdhc.2022.812134</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Clinical Diabetes and Healthcare</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course&#8212;A Narrative Review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Tzeravini</surname><given-names initials="E">Evangelia</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/939622"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stratigakos</surname><given-names initials="E">Eleftherios</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Siafarikas</surname><given-names initials="C">Chris</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tentolouris</surname><given-names initials="A">Anastasios</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/956946"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tentolouris</surname><given-names initials="N">Nikolaos</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/969664"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital</institution>, <addr-line>Athens</addr-line>, <country>Greece</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Gastroenterogy Department, Athens General Hospital &#8220;G Gennimatas&#8221;</institution>, <addr-line>Athens</addr-line>, <country>Greece</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Dimitrios Tsilingiris, Heidelberg University Hospital, Germany</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ibrahim Demirci, Gulhane Training and Research Hospital, Turkey; Luca D&#8217;Onofrio, Sapienza University of Rome, Italy</p></fn><corresp id="fn001">*Correspondence: Evangelia Tzeravini, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:evatz90@gmail.com">evatz90@gmail.com</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Diabetes Clinical Epidemiology, a section of the journal Frontiers in Clinical Diabetes and Healthcare</p></fn></author-notes><pub-date pub-type="epub"><day>10</day><month>3</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>3</volume><issue-id pub-id-type="pmc-issue-id">431209</issue-id><elocation-id>812134</elocation-id><history><date date-type="received"><day>09</day><month>11</month><year>2021</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>03</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>28</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-28 16:25:29.650"><day>28</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2022 Tzeravini, Stratigakos, Siafarikas, Tentolouris and Tentolouris</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Tzeravini, Stratigakos, Siafarikas, Tentolouris and Tentolouris</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fcdhc-03-812134.pdf"/><abstract><p>It was previously reported that subjects with diabetes mellitus (DM) are more vulnerable to several bacterial or viral infections. In the era of coronavirus disease 2019 (COVID-19) pandemic, it is reasonable to wonder whether DM is a risk factor for COVID-19 infection, too. It is not yet clear whether DM increases the risk for contracting COVID-19 infection or not. However, patients with DM when infected are more likely to develop severe or even fatal COVID-19 disease course than patients without DM. Certain characteristics of DM patients may also deteriorate prognosis. On the other hand, hyperglycemia per se is related to unfavorable outcomes, and the risk may be higher for COVID-19 subjects without pre-existing DM. In addition, individuals with DM may experience prolonged symptoms, need readmission, or develop complications such as mucormycosis long after recovery from COVID-19; close follow-up is hence necessary in some selected cases. We here present a narrative review of the literature in order to set light into the relationship between COVID-19 infection and DM/hyperglycemia.</p></abstract><kwd-group><kwd>diabetes mellitus</kwd><kwd>hyperglycemia</kwd><kwd>COVID-19</kwd><kwd>outcome</kwd><kwd>post-discharge</kwd></kwd-group><counts><fig-count count="1"/><table-count count="2"/><equation-count count="0"/><ref-count count="216"/><page-count count="20"/><word-count count="10820"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>1 Introduction</title><p>The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a world pandemic with almost 5 million deaths so far (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). On the other hand, diabetes mellitus (DM) is also a global burden; the International Diabetes Federation estimated that in 2019, one in 11 adults had DM, which is translated to 463 million people worldwide (<xref rid="B3" ref-type="bibr">3</xref>). We could therefore say that DM is a pandemic itself. Previously, DM was also identified as an independent risk factor for severe disease from two other members of the coronavirus family, SARS and Middle East Respiratory Syndrome (MERS) (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). It is hence reasonable to assume that DM may affect the COVID-19 infection course.</p><p>Investigation of the way SARS-CoV-2 affects host cells may enlighten the reasons for increased vulnerability of patients with DM to COVID-19 infection. After inhalation, the first step for SARS-CoV-2 invention into host cells is binding to angiotensin-converting enzyme 2 (ACE-2) receptor on cell membrane (<xref rid="B6" ref-type="bibr">6</xref>). Receptors of ACE-2 are found on epithelial cells of the lungs but are also expressed on several other tissues, such as the heart, vessels, pancreas, and kidneys (<xref rid="B7" ref-type="bibr">7</xref>). Infection by SARS-CoV-2 can therefore damage several organs beyond the lungs (<xref rid="B7" ref-type="bibr">7</xref>). Some studies support that lungs of patients with DM overexpress ACE-2 receptors (<xref rid="B8" ref-type="bibr">8</xref>), either due to DM alone or as a result of pharmacological treatment (<xref rid="B9" ref-type="bibr">9</xref>); patients with DM could therefore be more vulnerable to SARS-CoV-2 entry into the host cells. Regardless the ACE-2 receptor expression, hyperglycemia may also increase SARS-CoV-2 cell entry through glycosylation of ACE-2 receptors (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>).</p><p>Moreover, COVID-19 infection is linked to a profound inflammation and release of cytokines such as intereukin-6 (IL-6) and tumor necrosis factor-a (TNF-a), which can lead to the so-called cytokine storm and severe disease (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Diabetes mellitus is also characterized by a chronic, pro-inflammatory state, so patients with DM are more likely to develop a catastrophic inflammatory response to COVID-19 infection (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). Excess cytokine circulation in turn increases insulin resistance (<xref rid="B15" ref-type="bibr">15</xref>). On the other hand, b-cell also expresses ACE-2 receptors and can be infected by SARS-CoV-2, with b-cell damage and apoptosis as a consequence (<xref rid="B16" ref-type="bibr">16</xref>). The reduction in insulin production can then accelerate pre-existing DM and induce hyperglycemia or even new onset diabetes in previously normoglycemic subjects (<xref rid="B16" ref-type="bibr">16</xref>). Hence, a vicious cycle between COVID-19 and hyperglycemia may evolve.</p><p>In addition, another mediator between COVID-19 infection and hyperglycemia/DM might be oxidative stress; excess free radicals seem to promote viral entry into the cells and severe tissue damage (<xref rid="B17" ref-type="bibr">17</xref>). Hyperglycemic states, in turn, enhance oxidative stress (<xref rid="B18" ref-type="bibr">18</xref>), and they can consequently increase the risk for severe COVID-19 infection. Finally, hyperglycemia directly and indirectly through inflammation and oxidative stress promotes endothelial damage and hypercoagulation, two key mechanisms in COVID-19 infection course (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B19" ref-type="bibr">19</xref>).</p><p>The relationship between COVID-19 and DM may therefore be bidirectional; the presence of DM enhances SARS-CoV-2 catastrophic action, and SARS-CoV-2 in turn induces hyperglycemia and insulin resistance.</p><p>We here conducted a review of the literature in order to (1) investigate the role of DM on COVID-19 disease progression, (2) explore the importance of hyperglycemia for COVID-19 infection prognosis, (3) address patients characteristics that may increase the risk of unfavorable outcomes, and (4) highlight possible post-discharge implications.</p><p>For the purpose of this review, we researched PubMed database using keywords &#8220;diabetes mellitus and COVID-19&#8221;, &#8220;hyperglycemia and COVID-19&#8221;, and &#8220;glucose and COVID-19&#8221;. We included articles that were published until September 15, 2021, all in the English language. We excluded articles that seemed irrelevant based on their title, or abstract, or after reading the main body of the text. We also searched reference lists of the included articles. We then composed a narrative review of the gathered literature.</p></sec><sec id="s2"><title>2 DM as a Risk Factor for COVID-19 Infection</title><p>Patients with DM seem to be more prone to several bacterial and viral infections than the general population (<xref rid="B20" ref-type="bibr">20</xref>). However, it is not yet clear whether the presence of DM increases the risk for contracting COVID-19 infection. In a large web-based survey with 780,961 participants, DM was an independent risk factor for COVID-19 infection, with an odds ratio (OR) of 1.46 [95% confidence interval (CI), 1.23&#8211;1.74] (<xref rid="B21" ref-type="bibr">21</xref>). Likewise, among 219,729 individuals that were examined by Park et&#160;al., patients with DM experienced a higher risk for COVID-19-positive test than subjects without DM (OR, 1.15; 95% CI, 1.07&#8211;1.24) (<xref rid="B22" ref-type="bibr">22</xref>). Crouse et&#160;al. also reported a twofold risk of contracting COVID-19 infection for DM subjects (OR, 2.11; 95% CI, 1.78&#8211;2.48) (<xref rid="B23" ref-type="bibr">23</xref>). In addition, Gutierrez et&#160;al. observed that the prevalence of DM was higher among individuals who tested positive for COVID-19 than those with a negative result (16.2% versus 10.1%, respectively) (<xref rid="B24" ref-type="bibr">24</xref>). Comparable were the findings of another large study with about half a million participants, which recorded DM in 16.6% of COVID-19-positive and only in 9.5% of COVID-19-negative individuals (<xref rid="B25" ref-type="bibr">25</xref>). Three research groups from Mexico also reported DM prevalence from 16.1% to 18.4% among COVID-19-positive inpatients and outpatients (<xref rid="B26" ref-type="bibr">26</xref>&#8211;<xref rid="B29" ref-type="bibr">29</xref>); this was higher than the prevalence of DM in the general population of Mexico, which, in 2016, was estimated at 9.4% (<xref rid="B30" ref-type="bibr">30</xref>). Likewise, in a large study from the USA, DM was the second most frequent comorbidity, corresponding to 15% of COVID-19-infected individuals, while the prevalence of DM in the same region was 9.7% (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>On the other hand, in a study of 10,069 COVID-19-infected patients and 50,587 matched controls, patients with DM tented to be more susceptible to COVID-19 infection, but the risk was not statistically significant (OR, 1.06; 95% CI; 0.97&#8211;1.16) (<xref rid="B32" ref-type="bibr">32</xref>). In the subgroup analysis, however, DM patients on insulin use, and especially men and those aged 40-59 years old, were more likely to be infected than participants without DM (<xref rid="B32" ref-type="bibr">32</xref>). On the contrary, in a meta-analysis of 41 studies from China, the pooled prevalence of DM was lower among COVID-19-positive individuals compared with the general population (9% versus 10.9%, respectively, p &lt; 0.0001) (<xref rid="B33" ref-type="bibr">33</xref>). Another group of investigators also observed that DM patients corresponded to 8.8% of COVID-19-positive individuals (<xref rid="B34" ref-type="bibr">34</xref>). Similarly, a meta-analysis of 212 studies from 11 countries reported a DM prevalence of 10.2% among COVID-19 positive subjects (<xref rid="B35" ref-type="bibr">35</xref>), comparable with the worldwide prevalence of DM (<xref rid="B36" ref-type="bibr">36</xref>).</p><p>Based on the above findings, the relationship between DM and the risk for COVID-19 infection is not well documented. The heterogeneity in the design of the aforementioned studies, and differences in local policy for COVID-19 spread prevention, may be responsible for the lack of consensus.</p></sec><sec id="s3"><title>3 DM and COVID-19 Infection Outcomes</title><sec id="s3_1"><title>3.1 DM as a Risk Factor for Hospitalization From COVID-19 Infection</title><p>The presence of DM seems to increase the risk for hospitalization among COVID-19 infected individuals (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B37" ref-type="bibr">37</xref>). In a study based on 211,003 medical records of COVID-19 infected subjects, patients with DM had an almost twofold greater risk for hospital admission (<xref rid="B38" ref-type="bibr">38</xref>). Similar were the findings of Gottlieb et&#160;al. and Martos-Benirez et&#160;al. (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>). In a large cross-sectional study from Mexico as well, COVID-19-positive patients with self-reported DM had 38.4% (95% CI, 37.6&#8211;39.2) predicted probability for hospitalization; the estimated probability was higher when one or more comorbidities were added to DM (<xref rid="B28" ref-type="bibr">28</xref>). Halalu et&#160;al., on the other hand, in a small multicenter study, reported a significantly increased hospitalization rate not only for DM but also for prediabetes (<xref rid="B41" ref-type="bibr">41</xref>). In addition, according to a study from the USA with almost a million participants, 20.5% of COVID-19 hospitalizations were attributable to DM; investigators also estimated that a 10% reduction in DM prevalence could reduce hospital admissions for COVID-19 infection by 2.7% (<xref rid="B42" ref-type="bibr">42</xref>). From another point of view, the prevalence of DM among COVID-19-positive hospitalized patients ranged from 19.4% to 33.8% (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>), which was much higher than the prevalence of DM in the corresponding general populations (9.7% and 8.9% for USA and Europe respectively) (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B31" ref-type="bibr">31</xref>). On the contrary, according to another study, DM was not an independent risk factor for hospitalization (<xref rid="B45" ref-type="bibr">45</xref>). Certain characteristics of DM patients may increase the risk of hospitalization after COVID-19 infection; COVID-19-positive patients with DM and one or more comorbidities, such as obesity, hypertension, chronic kidney disease, or chronic obstructive pulmonary disease were more likely to need hospital admission than COVID-19-infected subjects with DM alone in several studies (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Of note, however, Maddaloni et&#160;al. reported that cardiovascular disease was not an independent risk factor for hospitalization among patients with DM, perhaps due to overlap in pathophysiology of the two diseases (<xref rid="B46" ref-type="bibr">46</xref>). Apart from comorbidities, older age, male sex, delayed search of medical help, and exact time point during the pandemic increased the risk of hospitalization among individuals with DM (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B37" ref-type="bibr">37</xref>). In addition, socioeconomic factors such as living in a community with meager health resources or social isolation, indigenous language speaking, and the type of health care provider also influenced the chance of admission for COVID-19-infected patients with DM (<xref rid="B28" ref-type="bibr">28</xref>). Nevertheless, some of the above factors may truly increase vulnerability of individuals with DM to severe COVID-19 infection requiring hospital admission, while others are rather linked to doctors&#8217; perception and influence their decisions.</p></sec><sec id="s3_2"><title>3.2 DM as a Risk Factor for Severe COVID-19 Disease</title><sec id="s3_2_1"><title>3.2.1 DM as a Risk Factor for ICU Admission</title><p>Several data highlight DM as a risk factor for severe COVID-19 infection. The presence of DM increased the risk for intensive care unit (ICU) admission in a small study by Abohamr et&#160;al. (<xref rid="B47" ref-type="bibr">47</xref>). According to another study from Mexico, DM independently increased the risk for severe COVID-19 infection on admission, defined as pneumonia or organ failure that requires treatment in the ICU (<xref rid="B48" ref-type="bibr">48</xref>). Similar were the results from a large study based on over 200,000 medical records of COVID-19-infected subjects, with a 66% higher risk for ICU admission among DM patients (<xref rid="B38" ref-type="bibr">38</xref>). Data from 1,157 patients hospitalized in two London hospitals also supported that DM is a risk factor for critical care requirement (<xref rid="B49" ref-type="bibr">49</xref>); the combined outcome of critical care or death did not, however, reach statistical significance (<xref rid="B49" ref-type="bibr">49</xref>).</p></sec><sec id="s3_2_2"><title>3.2.2 DM as a Risk Factor for Mechanical Ventilation</title><p>In addition, the need for mechanical ventilation was reported to be higher among DM patients with COVID-19 infection compared with those without DM (<xref rid="B50" ref-type="bibr">50</xref>). The presence of DM increased the risk of intubation in COVID-19-infected patients with a slightly higher OR when obesity or obesity and hypertension accompanied DM (<xref rid="B24" ref-type="bibr">24</xref>). In the study by Hernandez-Galdamez et&#160;al. as well, DM was an independent risk factor for endotracheal intubation (<xref rid="B38" ref-type="bibr">38</xref>). Similar were the results reported by Moon et&#160;al.; DM was independently associated with the need for supplemented oxygen or ventilator support, even after adjustment for age, sex, and comorbidities (<xref rid="B45" ref-type="bibr">45</xref>).</p></sec><sec id="s3_2_3"><title>3.2.3 DM as a Risk Factor for Complicated Disease Course</title><p>Moreover, in a study based on national electronic health records, DM increased the risk for COVID-19 pneumonia, ICU admission, and intubation in the multivariable analysis compared with individuals without DM (<xref rid="B40" ref-type="bibr">40</xref>). Jakob et&#160;al. also observed that DM was an independent risk factor for a complicated clinical picture on the day of COVID-19 infection diagnosis (<xref rid="B51" ref-type="bibr">51</xref>). Likewise, Huang et&#160;al. suggested that patients with DM were more likely to have severe (defined as respiratory rate &gt;30 breaths/min, blood oxygen saturation &#8804;93%, oxygenation, index &#8804;300 mmHg, and/or lung infiltrates increased &gt;50% within 24&#8211;48 h) or critical (defined as respiratory failure, septic shock, and/or multiple organ dysfunction/failure) COVID-19 infection than patients without DM (<xref rid="B52" ref-type="bibr">52</xref>). According to another study with 5,685 COVID-19 patients, DM also increased the risk for severe disease course (<xref rid="B53" ref-type="bibr">53</xref>), with severity being defined using World Health Organization criteria (<xref rid="B54" ref-type="bibr">54</xref>). In addition, results from a Spanish cohort highlighted DM as a risk factor for acute respiratory distress syndrome (ARDS) among COVID-19-infected patients (<xref rid="B55" ref-type="bibr">55</xref>). Based on data from Wuhan, patients with DM were also more likely to develop complications such as ARDS, acute kidney injury (AKI), acute cardiac injury (ACI), septic shock, or secondary infections and need ICU admission or non-invasive mechanical ventilation; however, the risk of death and the need of mechanical ventilation were not significantly higher among DM patients in this cohort (<xref rid="B56" ref-type="bibr">56</xref>).</p><p>Chen et&#160;al. examined patients with type 2 DM (T2DM) and observed significantly more complications from COVID-19 infection, namely, ARDS, AKI, ACI, coagulopathy, and hypoproteinemia, compared with patients without DM (<xref rid="B57" ref-type="bibr">57</xref>). Type 2 DM was also reported as an independent risk factor for ICU admission, after adjustment for age, sex, comorbidities, and insurance status (<xref rid="B58" ref-type="bibr">58</xref>). Moreover, in a large cohort of COVID-19 hospitalized participants, patients with T2DM had higher rates of ICU admission and intubation, and longer hospital stay compared with patients without DM (<xref rid="B59" ref-type="bibr">59</xref>). Similar were the results reported by Sun et&#160;al.; T2DM was independently associated with the risk for ADRS and severe disease (defined as respiration rate &#8805;30 times/min, blood oxygen saturation &#8804;93%, oxygenation index &#8804;300 mmHg, organ failure that requires ICU or shock) (<xref rid="B60" ref-type="bibr">60</xref>).</p><p>The results of the aforementioned studies are presented in summary in <xref rid="T1" ref-type="table">
<bold>Table&#160;1</bold>
</xref>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table&#160;1</label><caption><p>Studies that highlight diabetes mellitus as a risk factor for mortality and/or complications from COVID-19 disease.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">First Author(ref)</th><th valign="top" align="center" rowspan="1" colspan="1">Study population</th><th valign="top" align="center" rowspan="1" colspan="1">Health structure</th><th valign="top" align="center" rowspan="1" colspan="1">Region</th><th valign="top" align="center" rowspan="1" colspan="1">N</th><th valign="top" colspan="2" align="center" rowspan="1">OR HR [95% CI]**</th><th valign="top" align="center" rowspan="1" colspan="1">p</th><th valign="top" align="center" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td valign="top" rowspan="2" align="left" colspan="1">Abohamr et&#160;al. (<xref rid="B47" ref-type="bibr">47</xref>)</td><td valign="top" rowspan="2" align="left" colspan="1">Record-based case-series study</td><td valign="top" rowspan="2" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="2" align="left" colspan="1">Saudi Arabia</td><td valign="top" rowspan="2" align="center" colspan="1">768</td><td valign="top" colspan="2" align="left" rowspan="1">OR 2.29<break/>[1.70&#8211;3.06]</td><td valign="top" rowspan="2" align="center" colspan="1">0.001</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">OR 3.01,<break/>[1.87&#8211;4.84]</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Denova-Gutierrez et&#160;al. (<xref rid="B48" ref-type="bibr">48</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Cross-sectional, electronic record nationwide study*</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Mexico</td><td valign="top" align="center" rowspan="1" colspan="1">23,593</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.87,<break/>[1.41&#8211;4.26]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" rowspan="4" align="left" colspan="1">Hernandez-Galdamez<break/> (<xref rid="B38" ref-type="bibr">38</xref>)</td><td valign="top" rowspan="4" align="left" colspan="1">Cross-sectional, electronic record nationwide study</td><td valign="top" rowspan="4" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="4" align="left" colspan="1">Mexico</td><td valign="top" rowspan="4" align="center" colspan="1">212,802</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.98,<break/>[1.93&#8211;2.03]</td><td valign="top" rowspan="4" align="center" colspan="1">&lt; 0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Hospitalization</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.66,<break/>[1.56&#8211;1.77]</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.68,<break/>[1.58&#8211;1.78]</td><td valign="top" align="left" rowspan="1" colspan="1">Intubation</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR1.69,<break/>[1.63&#8211;1.74]</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="3" align="left" colspan="1">Galloway et&#160;al. (<xref rid="B49" ref-type="bibr">49</xref>)</td><td valign="top" rowspan="3" align="left" colspan="1">Two center observational study</td><td valign="top" rowspan="3" align="left" colspan="1">Inpatients</td><td valign="top" rowspan="3" align="left" colspan="1">England</td><td valign="top" rowspan="3" align="center" colspan="1">1,157</td><td valign="top" colspan="2" align="left" rowspan="1">HR 1.42,<break/>[1.04&#8211;1.95]</td><td valign="top" align="center" rowspan="1" colspan="1">0.029</td><td valign="top" align="left" rowspan="1" colspan="1">Critical Care</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">HR 1.24,<break/>[0.95&#8211;1.60]</td><td valign="top" align="center" rowspan="1" colspan="1">0.109</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">HR 1.20,<break/>[0.97, 1.48]</td><td valign="top" align="center" rowspan="1" colspan="1">0.092</td><td valign="top" align="left" rowspan="1" colspan="1">Death or Critical Care</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Capak et&#160;al. (<xref rid="B50" ref-type="bibr">50</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Cross-sectional, electronic record nationwide study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Croatia</td><td valign="top" align="center" rowspan="1" colspan="1">2,249</td><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Mechanical Ventilation</td></tr><tr><td valign="top" rowspan="3" align="left" colspan="1">Gutierrez and Bertozzi (<xref rid="B24" ref-type="bibr">24</xref>)</td><td valign="top" rowspan="3" align="left" colspan="1">Cross-sectional, electronic record nationwide study*</td><td valign="top" rowspan="3" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="3" align="left" colspan="1">Mexico</td><td valign="top" rowspan="3" align="center" colspan="1">1,378,002</td><td valign="top" colspan="2" align="left" rowspan="1">OR 2.28,<break/>[2.22&#8211;2.34]</td><td valign="top" rowspan="3" align="center" colspan="1">&lt; 0.01</td><td valign="top" align="left" rowspan="1" colspan="1">Hospitalization</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">OR 1.10<break/>[1.05&#8211;1.15]</td><td valign="top" align="left" rowspan="1" colspan="1">Intubation</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">OR 1.82,<break/>[1.76&#8211;1.88]</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="3" align="left" colspan="1">Moon et&#160;al. (<xref rid="B45" ref-type="bibr">45</xref>)</td><td valign="top" rowspan="3" align="left" colspan="1">Nationwide population-based cohort study</td><td valign="top" rowspan="3" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="3" align="left" colspan="1">South Korea</td><td valign="top" rowspan="3" align="center" colspan="1">5,307</td><td valign="top" colspan="2" align="left" rowspan="1">aOR1.07,<break/>[0.72&#8211;1.59]</td><td valign="top" align="center" rowspan="1" colspan="1">0.735</td><td valign="top" align="left" rowspan="1" colspan="1">Hospitalization</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.90,<break/>[1.28&#8211;2.92]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Ventilator Support</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR2.66,<break/>[1.90&#8211;3.73]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="4" align="left" colspan="1">Martos-Benitez et&#160;al. (<xref rid="B40" ref-type="bibr">40</xref>)</td><td valign="top" rowspan="4" align="left" colspan="1">Retrospective, electronic record nationwide study*</td><td valign="top" rowspan="4" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="4" align="left" colspan="1">Mexico</td><td valign="top" rowspan="4" align="center" colspan="1">38,324</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 2.11,<break/>[1.94&#8211;2.28]</td><td valign="top" rowspan="4" align="center" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Hospitalization</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.80,<break/>[1.66&#8211;1.95]</td><td valign="top" align="left" rowspan="1" colspan="1">Pneumonia</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.43,<break/>[1.21&#8211;1.48]</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.46,<break/>[1.25&#8211;1.72]</td><td valign="top" align="left" rowspan="1" colspan="1">Mechanical Ventilation</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Gottlieb et&#160;al. (<xref rid="B39" ref-type="bibr">39</xref>)</td><td valign="top" rowspan="2" align="left" colspan="1">Retrospective, registry-based cohort study</td><td valign="top" rowspan="2" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="2" align="left" colspan="1">USA</td><td valign="top" rowspan="2" align="center" colspan="1">8,673</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.85,<break/>[1.53&#8211;2.22]</td><td valign="top" rowspan="2" align="center" colspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">Hospitalization</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR1.21,<break/>[0.93 &#8211; 1.58]</td><td valign="top" align="left" rowspan="1" colspan="1">Critical Illness</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Jakob et&#160;al. (<xref rid="B51" ref-type="bibr">51</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Electronic record international, multicenter study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Europe</td><td valign="top" align="center" rowspan="1" colspan="1">2,155</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.33,<break/>[1.04&#8211;1.69]</td><td valign="top" align="center" rowspan="1" colspan="1">0.023</td><td valign="top" align="left" rowspan="1" colspan="1">Complicated Clinical Stage</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Al Kuwari et&#160;al. (<xref rid="B53" ref-type="bibr">53</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Case series</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Qatar</td><td valign="top" align="center" rowspan="1" colspan="1">5,685</td><td valign="top" colspan="2" align="left" rowspan="1">OR 3.17,<break/>[1.76&#8211; 5.71]</td><td valign="top" align="center" rowspan="1" colspan="1">0.0001</td><td valign="top" align="left" rowspan="1" colspan="1">Severe/<break/>Critical Disease</td></tr><tr><td valign="top" rowspan="6" align="left" colspan="1">Shi et&#160;al. (<xref rid="B56" ref-type="bibr">56</xref>)</td><td valign="top" rowspan="6" align="left" colspan="1">Two-center retrospective study</td><td valign="top" rowspan="6" align="left" colspan="1">Inpatients</td><td valign="top" rowspan="6" align="left" colspan="1">China</td><td valign="top" rowspan="6" align="center" colspan="1">1,561</td><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" rowspan="5" align="center" colspan="1">&lt;0.05</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">AKI</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">ACI</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">Shock</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aHR 1.58,<break/>[0.84&#8211;2.99]</td><td valign="top" align="center" rowspan="1" colspan="1">&gt;0.05</td><td valign="top" align="left" rowspan="1" colspan="1">In hospital mortality</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Rodriguez-Gonzalez et&#160;al. (<xref rid="B55" ref-type="bibr">55</xref>)</td><td valign="top" rowspan="2" align="left" colspan="1">Retrospective, single center study</td><td valign="top" rowspan="2" align="left" colspan="1">Inpatients</td><td valign="top" rowspan="2" align="left" colspan="1">Spain</td><td valign="top" rowspan="2" align="center" colspan="1">1,255</td><td valign="top" colspan="2" align="left" rowspan="1">aOR1.93,<break/>[1.34&#8211;2.78]</td><td valign="top" rowspan="2" align="center" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR1.45,<break/>[1.09&#8211;1.92]</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="5" align="left" colspan="1">Chen et&#160;al. (<xref rid="B57" ref-type="bibr">57</xref>)</td><td valign="top" rowspan="5" align="left" colspan="1">Retrospective, single center study</td><td valign="top" rowspan="5" align="left" colspan="1">Inpatients</td><td valign="top" rowspan="5" align="left" colspan="1">China</td><td valign="top" rowspan="5" align="center" colspan="1">1,105</td><td valign="top" colspan="2" align="left" rowspan="1">aHR 1.37,<break/>[1.03&#8211;1.81]</td><td valign="top" align="center" rowspan="1" colspan="1">0.029</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aHR1.76,<break/>[1.14&#8211;2.71]</td><td valign="top" align="center" rowspan="1" colspan="1">0.010</td><td valign="top" align="left" rowspan="1" colspan="1">AKI</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aHR 1.50,<break/>[1.05&#8211;2.15]</td><td valign="top" align="center" rowspan="1" colspan="1">0.025</td><td valign="top" align="left" rowspan="1" colspan="1">ACI</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aHR1.58,<break/>[1.03&#8211;2.44]</td><td valign="top" align="center" rowspan="1" colspan="1">0.036</td><td valign="top" align="left" rowspan="1" colspan="1">Coagulopathy</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aHR 1.47,<break/>[1.04&#8211;2.08]</td><td valign="top" align="center" rowspan="1" colspan="1">0.028</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">You et&#160;al. (<xref rid="B58" ref-type="bibr">58</xref>)</td><td valign="top" rowspan="2" align="left" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" rowspan="2" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="2" align="left" colspan="1">Korea</td><td valign="top" rowspan="2" align="center" colspan="1">5,473</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.59,<break/>[1.02&#8211;2.49]</td><td valign="top" align="center" rowspan="1" colspan="1">0.042</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR1.90,<break/>[1.13&#8211;3.21]</td><td valign="top" align="center" rowspan="1" colspan="1">0.016</td><td valign="top" align="left" rowspan="1" colspan="1">In hospital mortality</td></tr><tr><td valign="top" rowspan="3" align="left" colspan="1">Sonmez et&#160;al. (<xref rid="B59" ref-type="bibr">59</xref>)</td><td valign="top" rowspan="3" align="left" colspan="1">Retrospective, electronic record nationwide study</td><td valign="top" rowspan="3" align="left" colspan="1">Inpatients</td><td valign="top" rowspan="3" align="left" colspan="1">Turkey</td><td valign="top" rowspan="3" align="center" colspan="1">18,426</td><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" rowspan="3" align="center" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Intubation</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">HR 1.75,<break/>[1.58&#8211;1.93]</td><td valign="top" align="left" rowspan="1" colspan="1">In hospital mortality</td></tr><tr><td valign="top" rowspan="3" align="left" colspan="1">Sun et&#160;al. (<xref rid="B60" ref-type="bibr">60</xref>)</td><td valign="top" rowspan="3" align="left" colspan="1">Retrospective cohort study</td><td valign="top" rowspan="3" align="left" colspan="1">Inpatients</td><td valign="top" rowspan="3" align="left" colspan="1">China</td><td valign="top" rowspan="3" align="center" colspan="1">3,400</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 4.38,<break/>[2.41&#8211;7.95]</td><td valign="top" rowspan="3" align="center" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 2.21,<break/>[1.60, 3.06]</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">aOR 5.26,<break/>[2.39&#8211;11.58]</td><td valign="top" align="left" rowspan="1" colspan="1">In hospital mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kim et&#160;al. (<xref rid="B61" ref-type="bibr">61</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Korea</td><td valign="top" align="center" rowspan="1" colspan="1">7,590</td><td valign="top" colspan="2" align="left" rowspan="1">HR1.87,<break/>[1.41&#8211;2.48]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="top" align="left" rowspan="1" colspan="1">Mortality</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Carrilo-Vega et&#160;al. (<xref rid="B37" ref-type="bibr">37</xref>)</td><td valign="top" rowspan="2" align="left" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" rowspan="2" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="2" align="left" colspan="1">Mexico</td><td valign="top" rowspan="2" align="center" colspan="1">10,544</td><td valign="top" colspan="2" align="left" rowspan="1">OR 2.14,<break/>[1.70&#8211;2.69]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Hospitalization</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">OR 1.50,<break/>[1.13&#8211;1.98]</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td><td valign="top" align="left" rowspan="1" colspan="1">Mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Najera and Ortega-Avila (<xref rid="B62" ref-type="bibr">62</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Mexico</td><td valign="top" align="center" rowspan="1" colspan="1">515,090</td><td valign="top" colspan="2" align="left" rowspan="1">OR 1.63,<break/>[1.66&#8211;1.59]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">Mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">De Souza et&#160;al. (<xref rid="B63" ref-type="bibr">63</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Cross-sectional observational study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Brazil</td><td valign="top" align="center" rowspan="1" colspan="1">9,807</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 2.33,<break/>[1.99&#8211;2.74]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="top" align="left" rowspan="1" colspan="1">Mortality</td></tr><tr><td valign="top" rowspan="3" align="left" colspan="1">Williamson et&#160;al. (<xref rid="B64" ref-type="bibr">64</xref>)</td><td valign="top" rowspan="3" align="left" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" rowspan="3" align="left" colspan="1">Inpatients and outpatients</td><td valign="top" rowspan="3" align="left" colspan="1">England</td><td valign="top" rowspan="3" align="center" colspan="1">17,278,392</td><td valign="top" align="left" rowspan="1" colspan="1">HbA1c<break/>&lt; 58<break/>mmol/mol</td><td valign="top" align="left" rowspan="1" colspan="1">aHR<break/>1.31,<break/>[1.24&#8211;1.37]</td><td valign="top" rowspan="3" align="center" colspan="1">&#8211;</td><td valign="top" rowspan="3" align="left" colspan="1">Mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HbA1c &#8805; 58 mmol/mol</td><td valign="top" align="left" rowspan="1" colspan="1">aHR 1.95, [1.83&#8211;2.08]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">no recent HbA1c</td><td valign="top" align="left" rowspan="1" colspan="1">aHR<break/>1.90,<break/>[1.72&#8211;2.09]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Parra-Bracamonte et&#160;al. (<xref rid="B26" ref-type="bibr">26</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients and outpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Mexico</td><td valign="top" align="center" rowspan="1" colspan="1">331,298</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 1.30,<break/>[1.24&#8211;1.34]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">Mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhu et&#160;al. (<xref rid="B65" ref-type="bibr">65</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective, multi-centered study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="center" rowspan="1" colspan="1">7,337</td><td valign="top" colspan="2" align="left" rowspan="1">aHR 1.49,<break/>[1.13&#8211;1.96]</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td><td valign="top" align="left" rowspan="1" colspan="1">In-hospital mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Silva et&#160;al. (<xref rid="B66" ref-type="bibr">66</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective, multi-centered study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Brazil</td><td valign="top" align="center" rowspan="1" colspan="1">120,804</td><td valign="top" colspan="2" align="left" rowspan="1">aHR 1.14,<break/>[1.11&#8211;1.18]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="left" rowspan="1" colspan="1">In-hospital mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Shin et&#160;al. (<xref rid="B67" ref-type="bibr">67</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Nationwide case series study</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatients</td><td valign="top" align="left" rowspan="1" colspan="1">Korea</td><td valign="top" align="center" rowspan="1" colspan="1">5,771</td><td valign="top" colspan="2" align="left" rowspan="1">aOR 2.26,<break/>[1.46&#8211;3.49]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">In-hospital mortality</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Esme et&#160;al. (<xref rid="B68" ref-type="bibr">68</xref>)</td><td valign="top" rowspan="2" align="left" colspan="1">Retrospective,<break/>electronic record<break/>nationwide study</td><td valign="top" rowspan="2" align="left" colspan="1">Inpatients, Elderly</td><td valign="top" rowspan="2" align="left" colspan="1">Turkey</td><td valign="top" rowspan="2" align="center" colspan="1">16,942</td><td valign="top" align="left" rowspan="1" colspan="1">60&#8211;79<break/>years</td><td valign="top" align="left" rowspan="1" colspan="1">aOR<break/>1.18,<break/>[1.06&#8211;1.30]</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td><td valign="top" rowspan="2" align="left" colspan="1">In-hospital mortality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8805;80<break/>years</td><td valign="top" align="left" rowspan="1" colspan="1">aOR 1.26,<break/>[1.07&#8211;1.49]</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td></tr></tbody></table><table-wrap-foot><fn><p>N, number of participants; OR, odds ratio; HR, hazard ratio; 95% CI, 95% confidence interval; aOR, adjusted OR (in the multivariable analysis); aHR, adjusted HR (in the multivariable analysis); ICU, Intensive Care Unit; T2DM, type 2 diabetes mellitus; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury; ACI, acute cardiac injury; USA, United States of America; HbA1c, glycated hemoglobin.</p></fn><fn><p>*Studies that included both SARS-CoV-2-positive and SARS-CoV-2-negative individuals.</p></fn><fn><p>**Risk for SARS-CoV-2-positive patients with diabetes mellitus compared with SARS-CoV-2-positive patients without diabetes.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3_2_4"><title>3.2.4 DM as a Risk Factor for Severe COVID-19 Infection: Evidence From Meta-analysis</title><p>The results of several meta-analyses are in concordance with the aforementioned studies. In a meta-analysis of 61 studies, the presence of DM almost doubled the risk for severe COVID-19 disease, ICU admission, and invasive ventilation and tripled the risk for ARDS and progression to severe disease (<xref rid="B69" ref-type="bibr">69</xref>). Similar were the results of Huang et&#160;al., with the exception of ICU admission that did not reach statistical significance; of interest, the relative risk for severe COVID-19 infection was higher among younger patients (<xref rid="B70" ref-type="bibr">70</xref>). On the contrary, two other study groups observed a significant association between DM and ICU admission (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>). In addition, Kumar et&#160;al. estimated a triple risk for severe disease among patients with DM, after the analysis of 58 studies (<xref rid="B73" ref-type="bibr">73</xref>). Four more resent meta-analyses also reported a statistically significant risk for severe COVID-19 disease among DM patients (<xref rid="B74" ref-type="bibr">74</xref>&#8211;<xref rid="B77" ref-type="bibr">77</xref>). Moreover, Liang et&#160;al. highlighted DM as an independent predictor of disease severity (<xref rid="B78" ref-type="bibr">78</xref>).</p><p>
<xref rid="T2" ref-type="table">
<bold>Table&#160;2</bold>
</xref> summarizes the main findings of the aforementioned meta-analyses.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table&#160;2</label><caption><p>Meta-analyses that highlight diabetes mellitus as a risk factor for mortality and/or complications from COVID-19 disease.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">First Author (ref)</th><th valign="top" align="center" rowspan="1" colspan="1">N of Studies</th><th valign="top" align="center" rowspan="1" colspan="1">N of participants</th><th valign="top" align="center" rowspan="1" colspan="1">Risk, 95% CI</th><th valign="top" align="center" rowspan="1" colspan="1">p</th><th valign="top" align="center" rowspan="1" colspan="1">Heterogeneity (I2%)</th><th valign="top" align="center" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td valign="top" rowspan="6" align="left" colspan="1">Fang et&#160;al. (<xref rid="B69" ref-type="bibr">69</xref>)</td><td valign="top" rowspan="6" align="center" colspan="1">61</td><td valign="top" rowspan="6" align="center" colspan="1">~10,000</td><td valign="top" align="left" rowspan="1" colspan="1">RR 1.95,<break/>[1.60&#8211;2.36]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">42.6</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 3.30,<break/>[1.08&#8211;10.07]</td><td valign="top" align="center" rowspan="1" colspan="1">0.036</td><td valign="top" align="center" rowspan="1" colspan="1">0.0</td><td valign="top" align="left" rowspan="1" colspan="1">Progression to Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 1.88,<break/>[1.10&#8211;3.23]</td><td valign="top" align="center" rowspan="1" colspan="1">0.021</td><td valign="top" align="center" rowspan="1" colspan="1">51.4</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 3.07,<break/>[1.28&#8211;7.36]</td><td valign="top" align="center" rowspan="1" colspan="1">0.012</td><td valign="top" align="center" rowspan="1" colspan="1">62.9</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 1.85,<break/>[1.24&#8211;2.76]</td><td valign="top" align="center" rowspan="1" colspan="1">0.003</td><td valign="top" align="center" rowspan="1" colspan="1">50.8</td><td valign="top" align="left" rowspan="1" colspan="1">Invasive Ventilation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 1.75,<break/>[1.27&#8211;2.41]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">67.1</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="5" align="left" colspan="1">Huang et&#160;al. (<xref rid="B70" ref-type="bibr">70</xref>)</td><td valign="top" rowspan="5" align="center" colspan="1">30</td><td valign="top" rowspan="5" align="center" colspan="1">6,452</td><td valign="top" align="left" rowspan="1" colspan="1">RR 3.31,<break/>[1.08&#8211;10.14]</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td><td valign="top" align="center" rowspan="1" colspan="1">0.0</td><td valign="top" align="left" rowspan="1" colspan="1">Disease Progression</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 4.64,<break/>[1.86&#8211;11.58]</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td><td valign="top" align="center" rowspan="1" colspan="1">9.0</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 1.47,<break/>[0.38&#8211;5.67]</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td><td valign="top" align="center" rowspan="1" colspan="1">63.0</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 2.45<break/>[1.79&#8211;3.35]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">45.0</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RR 2.12,<break/>[1.44&#8211;3.11]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">72.0</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Hu et&#160;al. (<xref rid="B71" ref-type="bibr">71</xref>)</td><td valign="top" rowspan="2" align="center" colspan="1">30</td><td valign="top" rowspan="2" align="center" colspan="1">6,685</td><td valign="top" align="left" rowspan="1" colspan="1">Pooled OR 2.57,<break/>[1.91&#8211;3.46]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">36.1</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pooled OR 1.61,<break/>[1.04&#8211; 1.04]</td><td valign="top" align="center" rowspan="1" colspan="1">0.032</td><td valign="top" align="center" rowspan="1" colspan="1">76.8</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Hussain et&#160;al. (<xref rid="B72" ref-type="bibr">72</xref>)</td><td valign="top" rowspan="2" align="center" colspan="1">43</td><td valign="top" rowspan="2" align="center" colspan="1">23,007</td><td valign="top" align="left" rowspan="1" colspan="1">Pooled Risk Ratio 1.88,<break/>[1.20&#8211;2.93]</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td><td valign="top" align="center" rowspan="1" colspan="1">75.0</td><td valign="top" align="left" rowspan="1" colspan="1">ICU admission</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pooled Risk Ratio 1.61,<break/>[1.16&#8211;2.25]</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td><td valign="top" align="center" rowspan="1" colspan="1">93.0</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kumar et&#160;al. (<xref rid="B73" ref-type="bibr">73</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">58</td><td valign="top" align="center" rowspan="1" colspan="1">6,892</td><td valign="top" align="left" rowspan="1" colspan="1">Pooled<break/>OR 3.11,<break/>[1.99&#8211;4.88]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.05</td><td valign="top" align="center" rowspan="1" colspan="1">48.0</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Li X et&#160;al. (<xref rid="B74" ref-type="bibr">74</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">21,060</td><td valign="top" align="left" rowspan="1" colspan="1">OR 2.40,<break/>[1.98&#8211;2.91]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">55.6</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Giri et&#160;al. (<xref rid="B75" ref-type="bibr">75</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">16,495</td><td valign="top" align="left" rowspan="1" colspan="1">OR 2.04,<break/>[1.67&#8211;2.50]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="top" align="center" rowspan="1" colspan="1">55.0</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Honardoost et&#160;al. (<xref rid="B76" ref-type="bibr">76</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">6,270</td><td valign="top" align="left" rowspan="1" colspan="1">OR 2.61,<break/>[2.02&#8211;3.30]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">30.5</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nget al. (<xref rid="B77" ref-type="bibr">77</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">2464</td><td valign="top" align="left" rowspan="1" colspan="1"> HR 1.94,<break/>[1.54&#8211;2.46]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">0.0</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liang et&#160;al. (<xref rid="B78" ref-type="bibr">78</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">22,359</td><td valign="top" align="left" rowspan="1" colspan="1">aHR1.61,<break/>[1.28&#8211;2.04]<break/>&amp;<break/>aOR 1.58,<break/>[1.07&#8211;2.32]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">58.2<break/>&amp;<break/>29.2</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Li et&#160;al. (<xref rid="B35" ref-type="bibr">35</xref>)</td><td valign="top" rowspan="2" align="center" colspan="1">212</td><td valign="top" rowspan="2" align="center" colspan="1">281,461</td><td valign="top" align="left" rowspan="1" colspan="1">Coefficient 23.4,<break/>[15.0&#8211;31.7]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" rowspan="2" align="center" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coefficient<break/>8.2,<break/>[2.4&#8211;14.0]</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="5" align="left" colspan="1">Kaminska et&#160;al. (<xref rid="B79" ref-type="bibr">79</xref>)</td><td valign="top" rowspan="5" align="center" colspan="1">19</td><td valign="top" rowspan="5" align="center" colspan="1">7,327</td><td valign="top" align="left" rowspan="1" colspan="1">OR 2.38,<break/>[1.80&#8211;3.13]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">40.0</td><td valign="top" align="left" rowspan="1" colspan="1">ARDS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OR 1.97,<break/>[1.36&#8211;2.85]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">0.0</td><td valign="top" align="left" rowspan="1" colspan="1">AKI</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OR 2.59,<break/>[1.81&#8211;3.73]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">57.0</td><td valign="top" align="left" rowspan="1" colspan="1">ACI</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OR 1.43,<break/>[0.82&#8211;2.50]</td><td valign="top" align="center" rowspan="1" colspan="1">0.20</td><td valign="top" align="center" rowspan="1" colspan="1">85.0</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OR 2.39,<break/>[1.65&#8211;3.64]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">62.0</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Wu et&#160;al. (<xref rid="B80" ref-type="bibr">80</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">926</td><td valign="top" align="left" rowspan="1" colspan="1">Pooled OR 1.75,<break/>[1.31&#8211;2.36]</td><td valign="top" align="center" rowspan="1" colspan="1">0.0002</td><td valign="top" align="center" rowspan="1" colspan="1">5.0</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Varikasuvu et&#160;al. (<xref rid="B81" ref-type="bibr">81</xref>)</td><td valign="top" rowspan="2" align="center" colspan="1">47</td><td valign="top" rowspan="2" align="center" colspan="1">13,268</td><td valign="top" align="left" rowspan="1" colspan="1">OR 2.20,<break/>[1.69&#8211;2.86]</td><td valign="top" rowspan="2" align="center" colspan="1">&lt;0.00001</td><td valign="top" align="center" rowspan="1" colspan="1">58.0</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OR 2.52,<break/>[1.93&#8211;3.30]</td><td valign="top" align="center" rowspan="1" colspan="1">31.0</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Palaiodimos et&#160;al. (<xref rid="B82" ref-type="bibr">82</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">18,506</td><td valign="top" align="left" rowspan="1" colspan="1">OR 1.65,<break/>[1.35&#8211;1.96]</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">77.4</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Silverio et&#160;al. (<xref rid="B83" ref-type="bibr">83</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">45</td><td valign="top" align="center" rowspan="1" colspan="1">18,300</td><td valign="top" align="left" rowspan="1" colspan="1">Adjusted coefficient 1.02,<break/>[1.01&#8211;1.05]</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="left" rowspan="1" colspan="1">In hospital Mortality</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">Mantovani et&#160;al. (<xref rid="B84" ref-type="bibr">84</xref>)</td><td valign="top" rowspan="2" align="center" colspan="1">83</td><td valign="top" rowspan="2" align="center" colspan="1">78,874</td><td valign="top" align="left" rowspan="1" colspan="1">OR 2.10,<break/>[1.71&#8211;2.57]</td><td valign="top" rowspan="2" align="center" colspan="1">&#8211;</td><td valign="top" align="center" rowspan="1" colspan="1">41.5</td><td valign="top" align="left" rowspan="1" colspan="1">Severe Disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OR 2.68,<break/>[2.09&#8211;3.44]</td><td valign="top" align="center" rowspan="1" colspan="1">46.7</td><td valign="top" align="left" rowspan="1" colspan="1">Death</td></tr></tbody></table><table-wrap-foot><fn><p>N, number of; OR, odds ratio; HR, hazard ratio; RR, relative risk; 95% CI, 95% confidence interval; aOR, adjusted OR (in the multivariable analysis); aHR, adjusted HR (in the multivariable analysis); ICU, intensive care unit; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury; ACI, acute cardiac injury.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3_2_5"><title>3.2.5 DM as a Risk Factor for Severe Disease: Conflicting Data</title><p>There are, however, some evidence that does not support the relationship between DM and severe COVID-19 disease. In a study by Hasani et&#160;al., DM was not an independent risk factor for ICU admission or mechanical ventilation in the multivariable analysis (<xref rid="B85" ref-type="bibr">85</xref>). Kim et&#160;al. also reported DM as a risk factor for ICU admission, but not for severe disease overall [defined as non-invasive ventilation, invasive ventilation, extracorporeal membrane oxygenation (ECMO), and death] or for progression to severe disease (<xref rid="B86" ref-type="bibr">86</xref>). According to data from a large New York City cohort, DM increased the risk for critical illness (defined as a composite of ICU admission, need of mechanical ventilation, discharge to hospice, or death) among COVID-19-infected patients, but the relationship was attenuated in the fully adjusted model (<xref rid="B87" ref-type="bibr">87</xref>). Similar were the results of another study from Korea; DM was not an independent predictor of severe disease (defined according to oxygen needs, multiorgan failure/ECMO, and death) after adjustment for age, sex, and comorbidities (OR, 1.08; 0.82&#8211;1.42) (<xref rid="B67" ref-type="bibr">67</xref>). Tchang et&#160;al. also observed a higher incidence of the composite outcome (ICU admission, invasive mechanical ventilation, or in-hospital death), but the risk for ICU admission or invasive ventilation alone was not significantly higher in patients with DM (<xref rid="B88" ref-type="bibr">88</xref>). Lastly, in two meta-analysis, DM was a predictor of ICU admission, COVID-19 complications, and length of hospitalization but not of severe COVID-19 disease as a composite outcome (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B89" ref-type="bibr">89</xref>). Overall, patients with DM are more likely to face a complicated clinical course of COVID-19 infection than patients without DM. Only little evidence opposes this observation; the heterogeneity in the definition of severe COVID-19 disease in different studies, and over-adjustment for confounding factors in some others, may explain the lack of complete consensus.</p></sec></sec><sec id="s3_3"><title>3.3 DM as a Risk Factor for Mortality From COVID-19 Infection</title><sec id="s3_3_1"><title>3.3.1 DM as a Risk Factor for Overall Mortality</title><p>With regard to mortality alone, DM patients have at least a twofold greater risk of dying from COVID-19 compared with individuals without DM. Two large studies, one from Mexico and one from Korea, based on outpatients and inpatients data, observed an increased risk of death in DM COVID-19-positive patients compared with COVID-19 subjects without DM (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B61" ref-type="bibr">61</xref>). Slightly lower ORs for DM but still statistically significant were reported by Carrilo-Vega et&#160;al., Hernandez-Galdamez et&#160;al., and Najera et&#160;al. all based on both inpatients and outpatients records from national databases (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B62" ref-type="bibr">62</xref>). Another group also identified T2DM as a risk factor for death among COVID-19-positive patients; the risk was lower after adjustment for age, sex, and comorbidities, but remained significant, supporting that DM is an independent risk factor for mortality among COVID-19-infected individuals (<xref rid="B26" ref-type="bibr">26</xref>). In addition, among 44,672 COVID-19 subjects examined by Asfahan et&#160;al., older age and comorbidities increased mortality, with DM patients having a case fatality rate of 7.3% (<xref rid="B90" ref-type="bibr">90</xref>). In the OpenSAFELY, a huge population based study from England, investigators analyzed over 17 million electronic health records and reported DM as an independent risk factor for death from COVID-19 infection (<xref rid="B64" ref-type="bibr">64</xref>). Likewise, according to another population-based study focused on older adults (age &#8805;60 years old), the presence of DM significantly increased mortality from COVID-19 in the multivariable analysis (<xref rid="B63" ref-type="bibr">63</xref>).</p></sec><sec id="s3_3_2"><title>3.3.2 DM as a Risk Factor for In-Hospital Mortality</title><p>Zhu et&#160;al. reported higher in-hospital mortality for T2DM patients compared with non-DM (<xref rid="B65" ref-type="bibr">65</xref>). Additionally, in a large cohort from Brazil, hospitalized COVID-19-infected patients with DM were more likely to die than patients without DM (<xref rid="B66" ref-type="bibr">66</xref>). According to a study from Korea, DM independently associated with mortality in hospitalized patients with COVID-19 infection (<xref rid="B67" ref-type="bibr">67</xref>). Evidence from Turkey as well highlights DM as a risk factor for death in COVID-19-infected hospitalized patients in general (<xref rid="B59" ref-type="bibr">59</xref>) and in the elderly (<xref rid="B68" ref-type="bibr">68</xref>).</p><p>The main studies that examined the relationship between DM and COVID-19 mortality overall and in-hospital are shown in <xref rid="T1" ref-type="table">
<bold>Table&#160;1</bold>
</xref>.</p></sec><sec id="s3_3_3"><title>3.3.3 Age and Comorbidities as Risk Factors for Mortality Among COVID-19-Infected DM Patients</title><p>A study with ~340,000 COVID-19-positive participants also reported a reverse relationship between risk of death and age among patients with DM (<xref rid="B91" ref-type="bibr">91</xref>). Likewise, Woolcott et&#160;al. assessed over 1.5 million medical records of COVID-19-positive and COVID-19-negative inpatients and outpatients and observed a stronger association between DM and mortality among younger COVID-19-infected patients; among subjects older than 80 years, DM was no longer a significant risk factor for death from COVID-19 [adjusted hazard ratio (aHR), 1.52; 95% CI, 1.40&#8211;1.66 for patients 20&#8211;39 years; aHR, 1.03; 95% CI, 0.98&#8211;1.08 for patients over 80 years old] (<xref rid="B92" ref-type="bibr">92</xref>). In addition, among DM patients with COVID-19 infection, the risk was higher for outpatients and female patients (<xref rid="B92" ref-type="bibr">92</xref>).</p><p>In another study from Mexico, however, DM was an independent risk factor for poor outcome for both inpatients and outpatients with COVID-19 infection, but the risk was higher for those admitted to hospital (aHR, 2.09; 95% CI, 1.09&#8211;4.00 for in-patients and aHR, 1.25; 95% CI, 1.02&#8211;1.53 for outpatients) (<xref rid="B27" ref-type="bibr">27</xref>). According to findings of Pena et&#160;al., on the other hand, although DM increased in-hospital mortality [adjusted OR (aOR), 1.19; 95% CI, 1.15&#8211;1.24], it was not independently associated with the risk of death among outpatients with COVID-19 infection (aOR, 1.09; 95% CI, 0.9&#8211;1.13) (<xref rid="B34" ref-type="bibr">34</xref>). Nevertheless, the combination of DM with obesity and/or arterial hypertension deteriorated prognosis significantly for both inpatients and outpatients (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B34" ref-type="bibr">34</xref>).</p></sec><sec id="s3_3_4"><title>3.3.4 DM as a Risk Factor for Mortality: Data From Meta-analysis</title><p>The results of several meta-analyses support the above findings (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B79" ref-type="bibr">79</xref>). Wu et&#160;al. estimated a pooled OR of 1.75 for mortality among DM patients with COVID-19 (<xref rid="B80" ref-type="bibr">80</xref>). Similar were the findings of a meta-analysis by Varikasuvu et&#160;al. and by Palaiodimos et&#160;al. (<xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B93" ref-type="bibr">93</xref>). Of note, Corona et&#160;al., in a meta-analysis of 87 studies, also identified DM as the best predictor of dying from COVID-19 infection, and the association between DM and mortality was independent of sex but was weaker among older subjects (<xref rid="B93" ref-type="bibr">93</xref>). On the contrary, in other meta-analyses, the presence of DM seems to increase COVID-19 in hospital mortality, even after adjustment for confounding factors, age included (<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B84" ref-type="bibr">84</xref>).</p><p>The results of the above meta-analyses are depicted in <xref rid="T2" ref-type="table">
<bold>Table&#160;2</bold>
</xref>.</p></sec><sec id="s3_3_5"><title>3.3.1 DM as a Risk Factor for Mortality: Conflicting Data</title><p>Some conflicting data also exist. Harrison et&#160;al. observed a higher mortality in DM patients (unadjusted OR, 2.89; 95% CI, 2.56&#8211;3.26), but the association was attenuated after adjustment for age (<xref rid="B29" ref-type="bibr">29</xref>). In a smaller study from Brazil, also the presence of DM was not significantly associated with COVID-19 mortality in the multivariable analysis (<xref rid="B94" ref-type="bibr">94</xref>). According to an ICU study from Sweden, DM was not an independent risk factor for in ICU death (<xref rid="B95" ref-type="bibr">95</xref>). Observation based on very old individuals (age over 80 years old) also failed to identify DM as a risk factor for mortality after COVID-19 infection (<xref rid="B96" ref-type="bibr">96</xref>). Two meta-analysis as well reported a non-significant relationship among DM and mortality from COVID-19 infection (<xref rid="B97" ref-type="bibr">97</xref>, <xref rid="B98" ref-type="bibr">98</xref>).</p></sec></sec></sec><sec id="s4"><title>4 DM Patients&#8217; Characteristics Associated With Severe Infection</title><sec id="s4_1"><title>4.1 The Role of DM-Related Complications on Disease Severity</title><p>In order to address risk factors related to worse outcome among DM patients, Cariou et&#160;al. contacted the CORONADO study, a&#160;multicenter study from France (<xref rid="B99" ref-type="bibr">99</xref>). They observed that among 1,317 patients with DM (T2DM 88.5%) that they examined, the primary outcome, namely, intubation and/or death within 7 days of admission, was independently and positively associated with body mass index (BMI), dyspnea, C-reactive protein (CRP), and aspartate aminotransferase (AST) and negatively associated with lymphocyte count (<xref rid="B99" ref-type="bibr">99</xref>). Age, treated obstructive sleep apnea, microvascular and macrovascular DM complications, dyspnea, elevated CRP or AST, low platelet count, or estimated glomerular filtration rate (eGFR) independently increased the risk of death on day 7 of hospitalization (<xref rid="B99" ref-type="bibr">99</xref>). On the contrary, glycated hemoglobulin (HbA1c), on admission plasma glucose, and the type of DM were not predictors of death and/or intubation in the multivariable analysis (<xref rid="B99" ref-type="bibr">99</xref>). In addition, in a sub-analysis of the CORONADO study focused on T1DM, older age was the only predictor of poor prognosis in the multivariable analysis (<xref rid="B100" ref-type="bibr">100</xref>).</p></sec><sec id="s4_2"><title>4.2 Age, Sex, and Comorbidities as Risk Factors for Severe Disease Among Patients With DM</title><p>Holman et&#160;al. on the other hand, used UK national records and noticed that male sex, older age, renal or heart failure, history of stroke, non-white ethnicity, and socioeconomic deprivation were related to increased mortality among DM patients with COVID-19 infection (<xref rid="B101" ref-type="bibr">101</xref>). An HbA1c value &#8805;10% for type 1 DM (T1DM) and &#8805;7.6% for T2DM was also positively associated with mortality (HR, 2.23; 95% CI, 1.5&#8211;3.3; and HR, 1.22; 95% CI, 1.15&#8211;1.3 respectively) (<xref rid="B101" ref-type="bibr">101</xref>). A U-shaped relationship between BMI and risk of death was also observed; BMI &lt;20 kg/m<sup>2</sup> or &gt;40 kg/m<sup>2</sup> increased the risk for worse outcome compared with BMI of 25&#8211;29.9 kg/m<sup>2</sup> for DM patients (<xref rid="B101" ref-type="bibr">101</xref>). Similar were the results of a large population based study from Scotland; among patients with DM, the risk of death or critical care unit admission was associated positively with age, male sex, HbA1c value, residence in a care home or deprived area, prior hospitalization in the past 5 years, prior smoking history, retinopathy, comorbidities, and the number of hypoglycemic drugs or other medication and negatively with systolic blood pressure, eGFR, and anti-hypertensive drug therapy (<xref rid="B102" ref-type="bibr">102</xref>). In this study, a j-shaped relationship was observed between COVID-19 severity and BMI (<xref rid="B102" ref-type="bibr">102</xref>). The type of DM and DM duration were not independent predictors of worse outcome (<xref rid="B102" ref-type="bibr">102</xref>). In addition, in a large cohort from Turkey, older age, male sex, obesity, pulmonary infiltrates on admission computer tomography, preadmission insulin therapy, and lymphopenia were independent predictors of death among T2DM patients with COVID-19 infection (<xref rid="B59" ref-type="bibr">59</xref>). On the contrary, HbA1c and blood glucose were not independently associated with mortality in the multivariable analysis (<xref rid="B59" ref-type="bibr">59</xref>).</p></sec><sec id="s4_3"><title>4.3 Chronic Glycemic Control as Risk Factors for Severe Disease Among Patients With DM</title><p>Several other studies have also addressed the relationship between chronic glycemic control assessed by HbA1c value and COVID-19 infection outcome in patients with DM. A higher risk of death among patients with poorly controlled DM was reported by some authors (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B103" ref-type="bibr">103</xref>&#8211;<xref rid="B106" ref-type="bibr">106</xref>); however, the cutoff value of HbA1c for worse outcome was not consistent in the above studies. Williamson et&#160;al., in the OpenSAFELY study, observed that COVID-19-positive patients with DM and HbA1c values as low as 7.5% were at higher risk of death than those with HA1c &lt;7.5% after adjustment for confounding factors (aHR, 1.95; 95% CI, 1.83&#8211;2.08 for HbA1c &#8805;7.5%; aHR, 1.31; 95% CI, 1.24&#8211;1.37 for HbA1c &lt;7.5%, non-DM patients as reference group) (<xref rid="B64" ref-type="bibr">64</xref>). Moreover, in a study from China, not only high (&#8805;6%) but also low (3%&#8211;4.9%) HbA1c values were related to higher mortality, perhaps due to higher prevalence of hypoglycemia among patients with low HbA1c (<xref rid="B107" ref-type="bibr">107</xref>). Other investigators, on the contrary, reported a no significant effect of preadmission HbA1c value on COVID-19 infection course (<xref rid="B108" ref-type="bibr">108</xref>&#8211;<xref rid="B114" ref-type="bibr">114</xref>). In a meta-analysis of eight studies, when regarded as a continuous value, HbA1c had a linear relationship with composite outcome, namely, death or COVID-19 infection worsening (p &lt; 0.001), but not with mortality alone (p = 0.73); when however HbA1c was considered as a dichotomous value, poor glycemic control significantly increased the risk of death (p &lt; 0.001) (<xref rid="B115" ref-type="bibr">115</xref>). In accordance were the results of a recent meta-analysis by Zhu et&#160;al. (<xref rid="B116" ref-type="bibr">116</xref>).</p></sec><sec id="s4_4"><title>4.4 The Role of Glucose-Lowering Drugs on Disease Severity</title><p>Older age, male sex, comorbidities, and preadmission treatment with insulin were also reported as risk factors for poor prognosis after COVID-19 infection (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B105" ref-type="bibr">105</xref>, <xref rid="B108" ref-type="bibr">108</xref>, <xref rid="B117" ref-type="bibr">117</xref>&#8211;<xref rid="B122" ref-type="bibr">122</xref>). Confirmatory were the results of a meta-analysis including 22 studies (<xref rid="B123" ref-type="bibr">123</xref>). Preadmission DM medication may hence play a role in disease course among DM patients. Riahi et&#160;al. also observed that at-home use of insulin increased the risk of death among DM COVID-19-positive patients, independently of glycemic control and other confounding factors (<xref rid="B124" ref-type="bibr">124</xref>). On the contrary, at-home treatment with metformin was associated with lower mortality (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B125" ref-type="bibr">125</xref>&#8211;<xref rid="B127" ref-type="bibr">127</xref>), lower ICU (<xref rid="B128" ref-type="bibr">128</xref>), and hospital admission rates (<xref rid="B125" ref-type="bibr">125</xref>), and less complications, such as ARDS (<xref rid="B125" ref-type="bibr">125</xref>). In line were the results of a small meta-analysis, with a pooled OR of 0.59 for mortality among metformin users (95% CI, 0.43&#8211;0.79) (<xref rid="B129" ref-type="bibr">129</xref>). Interestingly, a large study with 27,493 T2DM patients reported a 30% lower risk of contracting COVID-19 among metformin users, although in-hospital mortality in case of infection was not affected by metformin treatment (<xref rid="B130" ref-type="bibr">130</xref>). Slightly lower mortality was also reported for sulfonylurea and glinides in two meta-analysis (<xref rid="B131" ref-type="bibr">131</xref>, <xref rid="B132" ref-type="bibr">132</xref>). With regard to dipeptidyl peptidase 4 (DPP-4) inhibitors, most studies indicate a neutral (<xref rid="B131" ref-type="bibr">131</xref>, <xref rid="B132" ref-type="bibr">132</xref>) or favorable effect on COVID-19 disease course (<xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B134" ref-type="bibr">134</xref>). In a large retrospective study by Emral et&#160;al. with 33,478 COVID-19-positive patients with T2DM, participants on treatment with DPP-4 inhibitors were at lower risk of dying compared with matched subjects on other antidiabetic drugs; however, no significant difference was observed in the risk for hospitalization or ICU admission between the two groups (<xref rid="B135" ref-type="bibr">135</xref>). In a meta-analysis, however, in-hospital but not preadmission use of DPP-4 inhibitors decreased the risk of death among selected COVID-19 patients with DM (<xref rid="B136" ref-type="bibr">136</xref>). Moreover, no significant impact of glucagon-like peptide-1 (GLP-1) analogues and sodium-glucose cotransporter 2 (SGLT2) inhibitors on COVID-19 outcomes was observed (<xref rid="B131" ref-type="bibr">131</xref>).</p></sec><sec id="s4_5"><title>4.5 Laboratory Findings and COVID-19 Disease Severity</title><p>With regard to laboratory findings, elevated markers of inflammation (high CRP, white blood cell count, neutrophil count, ferritin, IL-6, and TNF-a), coagulation (such as d-dimers), and organ dysfunction (e.g., creatinine and lactate dehydrogenase), and low serum albumin or lymphocyte count were associated with worse outcomes among COVID-19-infected patients with DM in some studies (<xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B109" ref-type="bibr">109</xref>, <xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B137" ref-type="bibr">137</xref>, <xref rid="B138" ref-type="bibr">138</xref>). Likewise, in a meta-analysis by Dhar et&#160;al., elevated CRP, d-dimers, and low lymphocyte count were predictors of poor prognosis among DM COVID-19-positive subjects (<xref rid="B139" ref-type="bibr">139</xref>).</p></sec><sec id="s4_6"><title>4.6 Body Weight as a Risk Factor for Severe Disease Among Patients With DM</title><p>Moreover, some studies assessed the link between BMI and COVID-19 infection course among DM subjects. Shukla et&#160;al. observed a j-shaped relationship with an increased risk among DM patients with BMI &lt;18.5 or &gt;35 kg/m<sup>2</sup> compared with normal weighted subjects (<xref rid="B122" ref-type="bibr">122</xref>). Similar were the results of Mc Gurnaghan et&#160;al. as mentioned above (<xref rid="B102" ref-type="bibr">102</xref>). Other authors also reported a worse outcome for obese DM patients after COVID-19 infection (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B108" ref-type="bibr">108</xref>).</p><p>In summary, age, male sex, comorbidities, DM microvascular or macrovascular complications, obesity or being underweight, and laboratory markers of inflammation, coagulation, and organ dysfunction are associated with worse outcomes among patients with DM and COVID-19 infection. Preadmission hypoglycemic agents also play a role in prognosis; metformin presents the more favorable profile, while insulin use may be a negative predictor. Poor chronic glycemic control, DM type, or duration may affect COVID-19 disease course, but there is no solid evidence. The role of acute hyperglycemia to COVID-19 infection deterioration will be discussed in detail below.</p></sec></sec><sec id="s5"><title>5 T1DM and COVID-19 Disease</title><p>The aforementioned studies either included patients with DM without any discrimination between T1DM and T2DM or focused on patients with T2DM, perhaps because of the low numbers of T1DM patients examined. There are, however, some data about patients with T1DM and COVID-19 infection in the literature. In a small ICU study, T2DM was independently associated with the need for intensive care (aOR, 2.47; 95% CI, 2.12&#8211;2.87), while T1DM was not (<xref rid="B95" ref-type="bibr">95</xref>). In accordance were the results reported by Dennis et&#160;al.; patients with DM and COVID-19 admitted to the hospital or ICU were at higher risk of death than patients without DM (aHR, 1.23; 95% CI, 1.14&#8211;1.32), but the relationship was not significant for patients with T1DM in subgroup analysis (aHR, 1.25; 95% CI, 0.86&#8211;1.84) (<xref rid="B140" ref-type="bibr">140</xref>). On the contrary, in a large study that included the whole population of Scotland, the risk of fatal or critical care unit treated COVID-19 infection was higher among T1DM (aOR, 2.39; 95% CI, 1.82&#8211;3.16) than T2DM patients (aOR, 1.37; 95% CI, 1.28&#8211;1.47) (<xref rid="B102" ref-type="bibr">102</xref>). The risk of death/critical disease was also higher for DM patients overall than for patients without DM (aOR, 1.39; 95% CI, 1.30&#8211;1.49) and had a reverse relationship with age among patients with DM (<xref rid="B102" ref-type="bibr">102</xref>) Similarly, in a whole-population survey from England, Barron et&#160;al. reported aORs for in-hospital mortality of 3.51 (95% CI, 3.16&#8211;3.9) and 2.03 (1.97&#8211;2.09) for T1DM and T2DM, respectively (<xref rid="B141" ref-type="bibr">141</xref>).</p><p>In conclusion, the relationship between T1DM and COVID-19 severity is less well established than that between T2DM and COVID-19 infection; several data, however, highlight that patients with T1DM are at increased risk of poor outcomes compared with patients without DM. Considering also the relatively younger age of patients with T1DM than that of T2DM patients, more research is needed to clarify whether DM type has an impact on COVID-19 disease course or not.</p></sec><sec id="s6"><title>6 Stress Hyperglycemia, DM Hyperglycemia, Newly Diagnosed DM, and COVID-19 Infection</title><p>The American Diabetes Association (ADA) defines new-onset hyperglycemia without diabetes when fasting plasma glucose (FPG) is between 5.6 and 6.9 mmol/L and/or HbA1c is between 5.7% and 6.4%, in the absence of pre-existing dysglycemia (<xref rid="B142" ref-type="bibr">142</xref>). Newly diagnosed diabetes (NDD) is defined as two abnormal samples either FPG &#8805;7.0 mmol/L, HbA1c &#8805;6.5%, or a random glucose level &#8805;11.1 mmol/L with symptoms of hyperglycemia, without pre-existing diabetes (<xref rid="B142" ref-type="bibr">142</xref>). During acute illness, the release of hormones that counter-regulate insulin and an excess cytokine action may cause the so-called stress hyperglycemia, even in persons with formerly normal glucose metabolism (<xref rid="B143" ref-type="bibr">143</xref>). Here, we try to assess the importance of glucose levels for COVID-19 infection course.</p><p>In a study by Cai et&#160;al., fasting blood glucose (FBG) higher than 7 mmol/L was a predictor of in-hospital mortality among COVID-19-infected patients, independently of the history of DM (<xref rid="B144" ref-type="bibr">144</xref>). Interestingly, in subgroup analysis, FBG &gt;7 mmol/L was a risk factor for death among non-DM patients (p &lt; 0.001), but the association was not statistically significant for patients with DM (<xref rid="B144" ref-type="bibr">144</xref>). Similar were the results of another small study from Korea (<xref rid="B145" ref-type="bibr">145</xref>). Sun et&#160;al. also observed that FBG &#8805;7 mmol/L was independently associated with COVID-19 severity and mortality (<xref rid="B60" ref-type="bibr">60</xref>). In addition, among 184 COVID-19-hospitalized patients examined, mean FBG on admission was positively related to risk of intubation (<xref rid="B146" ref-type="bibr">146</xref>). Moreover, in two cohorts of non-DM patients hospitalized for COVID-19 infection, high FPG was an independent predictor of mortality (aOR, 3.54; 95% CI, 1.25&#8211;10.06 and aHR, 2.30; 95% CI, 1.49&#8211;3.55, respectively) (<xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B148" ref-type="bibr">148</xref>). Song et&#160;al. also examined COVID-19 subjects without DM; high FBG patterns, composited by at least three measurements during hospitalization, were related to higher risk of death (<xref rid="B149" ref-type="bibr">149</xref>). Of note, patients with decreasing trends of FBG due to hypoglycemic therapy were at lower risk compared with those with increasing FBG values over time (<xref rid="B149" ref-type="bibr">149</xref>).</p><p>Interestingly, Alahmad et&#160;al. tried to quantify the relationship between FBG and COVID-19 outcomes; they observed that FBG &#8805;7 mmol/L was associated with a 15-fold higher risk of ICU admission (OR, 14.57; 95% CI, 6.87&#8211;32.59), when FBG considered as a dichotomous variable and that 1 mmol/L rise in FBG increased the risk of ICU admission 1.59 times (95% CI, 1.38&#8211;1.89) in the linear model (<xref rid="B150" ref-type="bibr">150</xref>). Comparable were the results of the categorical model (<xref rid="B150" ref-type="bibr">150</xref>). Likewise Alshukry et&#160;al. noticed a 1.52 times higher risk of death (95% CI, 1.34&#8211;1.72) for each 1 mmol/L increase in FBG value (<xref rid="B151" ref-type="bibr">151</xref>). In consistence were the findings of a small study from China; fasting plasma glucose was related positively with mortality and ICU admission, with the risk being extremely high for glucose &gt;11.1 mmol/l (HR, 11.55; 95% CI, 4.45&#8211;29.99) (<xref rid="B152" ref-type="bibr">152</xref>). Yuan et&#160;al., on the other hand, noticed that FBG values in the range of 3&#8211;4.9 mmol/L were related to the best prognosis (<xref rid="B107" ref-type="bibr">107</xref>).</p><p>Mean FBG over the first 7 days of hospitalization was also reported as an independent predictor of progression to severe disease (aRR, 2.09; 95% CI, 1.05&#8211;4.14), while 2 h postprandial blood glucose was not (<xref rid="B111" ref-type="bibr">111</xref>). Li et&#160;al. focused on DM patients and also noticed higher prevalence of death, in-hospital complications, and ICU admissions among DM patients with an admission glucose &gt;11 mmol/L (<xref rid="B153" ref-type="bibr">153</xref>). High blood glucose during the first day of hospitalization or FBG on admission were also related with worse radiological findings (<xref rid="B154" ref-type="bibr">154</xref>, <xref rid="B155" ref-type="bibr">155</xref>). Of note, in a study by Klonoff et&#160;al., admission hyperglycemia (glucose &gt;250 mg/dl) was an independent predictor of mortality among patients directly admitted in the ICU (aHR, 3.14; 95% CI, 1.44&#8211;6.88; reference group glucose &lt;140 mg/dl), but not for non-ICU hospitalized patients (<xref rid="B156" ref-type="bibr">156</xref>). For non-ICU patients, hyperglycemia on days 2&#8211;3 of hospitalization best correlated with mortality (aHR, 7.17; 95%CI, 2.62&#8211;19.62); hypoglycemia also increased the risk of death for both groups (OR, 2.2; 95% CI, 1.35&#8211;3.60) (<xref rid="B156" ref-type="bibr">156</xref>). Moreover, Wu et&#160;al. examined 2,041 hospitalized COVID-19 patients and divided them in two groups, namely, critical and non-critical (<xref rid="B80" ref-type="bibr">80</xref>). They observed that glucose on admission and median blood glucose were both independent predictors of mortality for critical cases and correlated with disease progression for non-critical cases (<xref rid="B80" ref-type="bibr">80</xref>).</p><p>In a UK cohort of 1,122 COVID-19 patients, DM, and/or uncontrolled hyperglycemia, defined as &#8805;2 blood glucoses measurements &gt;10mmol/L within any 24-h period, were associated with higher mortality and prolonged hospitalization compared with non-DM/non-hyperglycemic patients (<xref rid="B157" ref-type="bibr">157</xref>). Patients with uncontrolled hyperglycemia without DM were also at higher risk than patients with DM (<xref rid="B157" ref-type="bibr">157</xref>). Likewise, in a small study from the USA, hyperglycemia, defined as glucose &gt;11.1 mmol/L on admission, was a predictor of both mortality and complications among non-DM patients, while for patients with T2DM, elevated blood glucose was associated with ICU admission and AKI, but not with death (<xref rid="B158" ref-type="bibr">158</xref>). Similar were the results by Chen et&#160;al.; hyperglycemia (glucose &#8805;7.78 mmol/L) was a risk factor of mortality overall and among patients without DM, but the relationship was not significant among patients with DM (<xref rid="B117" ref-type="bibr">117</xref>). Zhang et&#160;al. also observed that hyperglycemia (defined as 2 or more glucose measurements &#8805;7.8 mmol/L) was related to high inflammatory markers and severe or critical disease, even after adjustment for confounding factors, while DM was not (<xref rid="B159" ref-type="bibr">159</xref>). Likewise, hyperglycemia was reported as the only independent predictor of COVID-19 infection course and related to 30% higher risk of death compared with patients with DM (<xref rid="B160" ref-type="bibr">160</xref>). Furthermore, based on findings from a small ICU cohort, authors noticed that mean blood glucose during ICU stay was independently related to mortality, in contrast with DM (<xref rid="B161" ref-type="bibr">161</xref>).</p><p>On the other hand, according to Leng et&#160;al., both glucose on admission and glucose variability were related to severe COVID-19 infection (<xref rid="B162" ref-type="bibr">162</xref>). Moreover, in a small cohort from Wuhan, glucose fluctuation and hyperglycemia during the first week of hospitalization, but not FBG on admission, were associated with increased mortality and COVID-19 complications among both DM and non-DM patients (<xref rid="B163" ref-type="bibr">163</xref>). Similarly, among DM patients, glucose fluctuation measured by a continuous glucose monitoring was associated with poor prognosis (<xref rid="B164" ref-type="bibr">164</xref>). Moreover, in a large study by Zhu et&#160;al., patients with DM and low glycemic variability (blood glucose, 3.9&#8211;10 mmol/L) were less likely to have COVID-19 complications or die compared with DM patients with poorly controlled blood glucose (<xref rid="B65" ref-type="bibr">65</xref>). With regard to random blood glucose (RBG), elevated values on admission were related to higher mortality, plasma levels of IL-6, and CRP (<xref rid="B165" ref-type="bibr">165</xref>), and increased severity of COVID-19 infection (<xref rid="B166" ref-type="bibr">166</xref>). According to other authors, however, RBG on admission was not significantly associated with disease prognosis (<xref rid="B109" ref-type="bibr">109</xref>, <xref rid="B113" ref-type="bibr">113</xref>, <xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B168" ref-type="bibr">168</xref>).</p><p>The above findings are summarized by some recent meta-analysis. In a meta-analysis of 16 studies by Yang et&#160;al., high blood glucose on admission (FBG or RBG) increased the risk of fatal (OR, 3.45; 95% CI, 2.26&#8211;5.26) and severe/critical (OR, 2.08; 95% CI, 1.45&#8211;2.99) disease among COVID-19-infected patients (<xref rid="B169" ref-type="bibr">169</xref>). However, no discrimination was made between DM and non-DM participants (<xref rid="B169" ref-type="bibr">169</xref>). According to another meta-analysis of 35 studies, elevated FBG on admission was independently associated to disease severity (risk ratio, 1.33; 95% CI, 1.26&#8211;1.40) with a 33% increase in risk of severe disease for each 1 mmol/L rise in FBG value (<xref rid="B170" ref-type="bibr">170</xref>). High FBG levels were also related to mortality (RR, 1.81; 95% CI, 1.41&#8211;2.33); the evidence was, however, weak. In addition, FBG was a better predictor of disease course among non-DM patients than those with DM (<xref rid="B170" ref-type="bibr">170</xref>). Of note, RBG was not independently related to COVID-19 infection outcomes (<xref rid="B170" ref-type="bibr">170</xref>). Moreover, Sachdeva et&#160;al. focused on patients without DM history and noticed higher rates of severe (OR, 1.837; 95% CI, 1.368&#8211;2.465) or fatal (OR, 2.822; 95% CI, 1.587&#8211;5.019) disease among hyperglycemic compared with normoglycemic individuals (<xref rid="B171" ref-type="bibr">171</xref>).</p><p>As it concerns NDD, Fadini et&#160;al. reported a significantly higher risk (p = 0.04) of ICU admission and/or death among patients with NDD (RR, 3.06; 95% CI, 2.04&#8211;4.57) than patients with pre-existing DM (RR, 1.55; 95% CI, 1.06&#8211;2.27), with non-DM patients being the reference group (<xref rid="B172" ref-type="bibr">172</xref>). High FPG on admission was also an independent predictor of severe COVID-19, with a 15% rise in the risk for each 2 mmol/L increase in FPG, and the association was stronger for non-DM subjects compared with DM (<xref rid="B172" ref-type="bibr">172</xref>). In accordance were the findings of a study from Mexico; patients with NDD were at higher risk for fatal COVID-19 infection (HR, 5.51; 95% CI, 1.28&#8211;23.81) than patients with known DM (HR, 4.98; 95% CI, 1.19&#8211;20.74) or pre-DM (HR, 3.35; 95% CI, 0.79&#8211;14.3) compared with non-DM subjects, even after adjustment for confounding factors (aHR, 5.50; 95% CI, 1.16&#8211;26.71) (<xref rid="B173" ref-type="bibr">173</xref>). An FBG value over 7.8 mmol/L was also an independent predictor of severity and mortality (<xref rid="B173" ref-type="bibr">173</xref>). A worse outcome among NDD compared to patients with known DM was also reported in a Chinese cohort of 2,880 COVID-19 patients (<xref rid="B107" ref-type="bibr">107</xref>). Likewise, NDD was related to higher mortality and in-hospital complications compared with both pre-existing DM and hyperglycemia without DM (<xref rid="B174" ref-type="bibr">174</xref>). As well, on admission, FBG correlated positively with the risk of death (<xref rid="B174" ref-type="bibr">174</xref>). On the contrary, in a sub-analysis of the CORONADO study, Cariou et&#160;al. observed a non-significant difference in mortality and COVID-19 complications between NDD and DM (<xref rid="B175" ref-type="bibr">175</xref>). Similarly, Liu et&#160;al. noticed that patients with DM overall were at higher risk of death than non-DM subjects, but there was no significant difference in mortality between patients with known DM and NDD (<xref rid="B176" ref-type="bibr">176</xref>).</p><p>The above evidence support high blood glucose as a predictor of poor prognosis regardless of the history of DM. Hence, a reasonable question is whether treatment of hyperglycemia can improve disease outcomes. Previous studies before COVID-19 pandemic failed to agree about the benefits of strict glucose control in critically ill hospitalized patients (<xref rid="B177" ref-type="bibr">177</xref>). In order to assess the effect of hypoglycemic treatment on COVID-19 infection course, Sardu et&#160;al. contacted a study including 59 COVID-19 hospitalized patients with initially moderate disease (<xref rid="B178" ref-type="bibr">178</xref>). Among hyperglycemic (defined as plasma glucose &gt;7.7 mmol/L on admission), both DM and non-DM patients, reduction in blood glucose with insulin infusion reduced the risk for severe disease or death compared with those with hyperglycemia not treated with an insulin pump (<xref rid="B178" ref-type="bibr">178</xref>). More precisely, a 0.56 mmol/L reduction in blood glucose between day 1 and 18 was related to 11% reduction in the risk of severe outcome for hyperglycemic participants (<xref rid="B178" ref-type="bibr">178</xref>). Of note, hyperglycemia and DM were positively associated with poor outcome; patients with both hyperglycemia and DM were at higher risk, followed by hyperglycemia alone, DM without hyperglycemia, and normoglycemic/non-DM subjects (<xref rid="B178" ref-type="bibr">178</xref>). Likewise, acute reduction in blood glucose during the first 24 h of hospitalization was related to lower risk of severe disease or death among patients with hyperglycemia with or without DM (<xref rid="B179" ref-type="bibr">179</xref>).</p><p>In summary, hyperglycemia during COVID-19 disease course is associated with worse clinical outcomes. Glucose fluctuation and FBG seem to be better predictors than RBG measurements. In addition, hyperglycemia is a stronger risk factor for patients without DM than patients with known DM, reflecting perhaps infection burden and not glucose metabolism defects in previously normoglycemic individuals. Newly diagnosed DM may also be related to worse prognosis than pre-existing DM, and measures for lowering blood glucose could prevent disease progression.</p></sec><sec id="s7"><title>7 Impact of COVID-19 on DM Course/Complications</title><p>An increase in admissions for diabetic ketoacidosis (DKA) was observed after the occurrence of COVID-19 pandemic compared with the previous years (<xref rid="B180" ref-type="bibr">180</xref>, <xref rid="B181" ref-type="bibr">181</xref>). A turn towards T2DM and new-onset DM-related DKA was also observed, in contrast with pre-COVID-19 era, in which T1DM was more frequently reported among patients with DKA (<xref rid="B180" ref-type="bibr">180</xref>). Therefore, it is possible that COVID-19 infection is responsible for the observed increase in DKA incidence, either directly or indirectly. Moreover, in an effort to assess possible changes in DKA patients&#8217; characteristics, Wallet et&#160;al. compared COVID-19-positive and COVID-19-negative subjects with DKA. The two groups did not differ in DKA severity; however, T2DM was more frequent in COVID-19-positive than COVID-19-negative DKA cases, and T1DM patients with COVID-19 had higher blood glucose than T1DM without COVID-19 (<xref rid="B182" ref-type="bibr">182</xref>). Shah et&#160;al. also assessed 82 cases of DKA or hyperglycemic hyperosmolar syndrome among COVID-19-positive and COVID-19-negative subjects; they observed a higher prevalence of T2DM among COVID-19-positive than COVID-19-negative individuals (<xref rid="B183" ref-type="bibr">183</xref>). Longer hospital stay and higher frequency of hypoglycemia were also reported among COVID-19-positive participants, although they experienced less severe acidosis (<xref rid="B183" ref-type="bibr">183</xref>). Hence, we could assume that COVID-19 infection may affect DM course. In addition, in a meta-analysis of 68 articles, 639 cases of DKA in patients with COVID-19 were investigated in order to picturize their profile; patients with T2DM had worse prognosis than T1DM (<xref rid="B184" ref-type="bibr">184</xref>). Older age, male sex, obesity, high blood glucose, and anion gap were also risk factors for increased mortality (<xref rid="B184" ref-type="bibr">184</xref>).</p><p>As discussed above, infection of b-cells by SARS-CoV-2 can lead to cell death and decrease in insulin release (<xref rid="B177" ref-type="bibr">177</xref>); excess inflammation may also increase insulin resistance in peripheral tissues (<xref rid="B176" ref-type="bibr">176</xref>). Thus, apart from complications in people with DM, it is also possible that COVID-19 triggers new-onset DM in formerly non-DM patients (<xref rid="B185" ref-type="bibr">185</xref>). Confirming were the findings from a meta-analysis of eight studies that reported a high prevalence of NDD among hospitalized COVID-19 patients (pooled proportion, 14.4%) (<xref rid="B186" ref-type="bibr">186</xref>).</p><p>On the other hand, an indirect effect of COVID-19 pandemic on glucose control is also possible; we could hypothesize that lockdown and consequent reduction in physical activity, mental stress, difficulties in access to health structures, and financial issues may impact DM control negatively. In a study from Japan, an increase in HbA1c was observed after COVID-19 pandemic outbreak (<xref rid="B187" ref-type="bibr">187</xref>). Likewise, in a small study with T1DM patients, deterioration in glucose control was noticed (<xref rid="B188" ref-type="bibr">188</xref>). Similar were the results from an Indian cohort (<xref rid="B189" ref-type="bibr">189</xref>). On the contrary, other studies did not report any deterioration in glucose parameters during lockdown (<xref rid="B190" ref-type="bibr">190</xref>&#8211;<xref rid="B193" ref-type="bibr">193</xref>).</p><p>Putting all together, SARS-CoV-2 may deteriorate glucose control and trigger deregulation or even evolve DM among infected patients. Changes in everyday life due to pandemic could have also a negative impact on DM patients. Hence, the relationship between COVID-19 infection and DM is not straightforward; a vicious cycle may better explain the way SARS CoV-2 and DM affect each other. <xref rid="f1" ref-type="fig">
<bold>Figure 1</bold>
</xref> below summarizes the interaction between COVID-19 infection and DM/ hyperglycemia.</p><fig position="float" id="f1" orientation="portrait"><label>Figure&#160;1</label><caption><p>The vicious cycle between diabetes mellitus, hyperglycemia, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcdhc-03-812134-g001.jpg"/></fig></sec><sec id="s8"><title>8 Post-Discharge Implications</title><p>Post-COVID-19 or long COVID-19 syndrome refers to symptoms that persist for several weeks after the acute face of COVID-19 infection and cannot be explained elsewhere (<xref rid="B194" ref-type="bibr">194</xref>). Fatigue, loss of smell, chest pain, shortness of breath, and digestive and neurological problems, such as depression and headache, are the most frequent complains (<xref rid="B195" ref-type="bibr">195</xref>, <xref rid="B196" ref-type="bibr">196</xref>). Patients with more severe disease during the acute phase are more likely to experience prolonged symptoms and residual lung dysfunction (<xref rid="B196" ref-type="bibr">196</xref>). Patients with DM are at higher risk for severe infection as discussed above; hence, we could assume that they are more prone to post-COVID-19 syndrome. Hence, according to a small study, the presence of DM increased the risk of persistent symptoms after recovery from COVID-19 infection (<xref rid="B197" ref-type="bibr">197</xref>). Similarly, in a cohort of 734 COVID-19-infected subjects, patients with DM reported pain and reduced mobility more frequently than non-DM individuals, 1 month after the COVID-19 acute infection was resolved (p &lt; 0.05) (<xref rid="B198" ref-type="bibr">198</xref>). No difference was, however, noticed in the incidence of other post-COVID-19 symptoms (<xref rid="B198" ref-type="bibr">198</xref>). In addition, the prevalence of T2DM among patients with post-COVID-19 syndrome was estimated at 15% according to a recent meta-analysis (<xref rid="B195" ref-type="bibr">195</xref>), which was higher than the prevalence of DM in the general population (<xref rid="B36" ref-type="bibr">36</xref>). In three other studies, however, patients with DM were not more symptomatic than patients without DM during post-COVID-19 period (<xref rid="B199" ref-type="bibr">199</xref>&#8211;<xref rid="B201" ref-type="bibr">201</xref>).</p><p>Other post-discharge complications constituted the need for readmission, and death. Kingery et&#160;al. observed higher readmission rates among patients with DM (HR, 1.54; 95% CI, 1.06&#8211;2.23) compared with non-DM subjects during a 30-day follow-up period after recovery from COVID-19 infection and hospital discharge (<xref rid="B202" ref-type="bibr">202</xref>). In addition, DM was associated with increased mortality during the first month post-discharge (HR, 1.98; 95% CI, 0.99&#8211;3.99) in the univariable analysis, but was attenuated after adjustment for confounding factors (<xref rid="B202" ref-type="bibr">202</xref>). Lavery et&#160;al. also reported higher risk for readmission among patients with DM compared with non-DM individuals (OR, 1.21; 95% CI, 1.14&#8211;1.28) (<xref rid="B203" ref-type="bibr">203</xref>). Similar were the results of two other studies (<xref rid="B204" ref-type="bibr">204</xref>, <xref rid="B205" ref-type="bibr">205</xref>). Likewise, the composite outcome readmission and/or death occurred more frequently among patients with DM during the post-COVID infection period (HR, 1.71; 95% CI, 1.17&#8211;2.52) (<xref rid="B206" ref-type="bibr">206</xref>). De Lorenzo et&#160;al. also estimated that history of DM, age, long of hospital stay, and non-invasive ventilation predicted the need for close follow-up post-discharge (<xref rid="B207" ref-type="bibr">207</xref>). Moreover, the risk for severe COVID-19 reinfection was reported to be higher among patients with DM (RR, 1.22; 95% CI, 1.07&#8211;1.38) (<xref rid="B208" ref-type="bibr">208</xref>). On the contrary, no association between DM and rehospitalization was observed in a retrospective study from New York City (<xref rid="B209" ref-type="bibr">209</xref>).</p><p>Moreover, after the COVID-19 pandemic outbreak, a rise in cases of mucormycosis was observed, and a new entity was described, COVID-19-associated mucormycosis (CAM) (<xref rid="B210" ref-type="bibr">210</xref>). The use of corticosteroids in the treatment of COVID-19 infection (<xref rid="B211" ref-type="bibr">211</xref>), changes in the iron metabolism and immune system responses, and endotheliitis caused by the virus itself (<xref rid="B12" ref-type="bibr">12</xref>) may predominate vulnerable individuals to mucor infections (<xref rid="B212" ref-type="bibr">212</xref>). Diabetes mellitus is also a well-documented risk factor for mucormycosis (<xref rid="B213" ref-type="bibr">213</xref>). In a large Indian cohort of 2,826 COVID-19 patients with mucormycosis, 71% were male, 87% received corticosteroids, 78% had history of DM, and 44% had uncontrolled DM or DKA (<xref rid="B214" ref-type="bibr">214</xref>). Although most cases of CAM were identified during the first 2 weeks of COVID-19 infection, in 44% of patients, the fungal infection was diagnosed 14 days or more after COVID-19 diagnosis (<xref rid="B214" ref-type="bibr">214</xref>). In line were the results of a recent review of 30 CAM cases (<xref rid="B215" ref-type="bibr">215</xref>). Likewise, in a pooled analysis of 28 articles, 40.6% of mucormycosis cases were diagnosed after recovery from COVID-19 infection (<xref rid="B216" ref-type="bibr">216</xref>). Male sex was also predominant, while 80% of patients had DM history and 14% simultaneous DKA (<xref rid="B216" ref-type="bibr">216</xref>). Physicians should, hence, be aware of symptoms of mucormycosis and follow-up high-risk patients, such as males patients with poorly controlled DM or a recent episode of DKA.</p></sec><sec id="s9"><title>9 Conclusions</title><p>In summary, patients with DM are more likely to experience severe or fatal COVID-19 infection than patients without DM and need hospitalization or ICU admission. Age, male sex, comorbidities, DM complications, obesity or low body weight, and laboratory markers of inflammation or coagulation increase the risk for unfavorable outcomes among DM patients. Acute hyperglycemia defined as high FBG or glucose fluctuation, rather than HbA1c, are also predictors of poor prognosis, especially in patients without pre-existing DM. Newly diagnosed DM also plays an important role in disease course. Measures for COVID-19 contracting prevention, vaccination for SARS-CoV-2, early diagnosis after infection, and close follow-up, and better glycemic control should be priorities for physicians when treating patients with DM. Post-discharge complications, such as post-COVID syndrome, readmission or mucormycosis may also be more frequent among patients with DM, and special attention should be paid. In the figure below, we summarize the main findings of our review.</p></sec><sec sec-type="author-contributions" id="s10"><title>Author Contributions</title><p>ET and ES conducted literature search. ET, ES, CS, AT, and NT composed the review. The manuscript was critically reviewed by NT. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="COI-statement" id="s11"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s12"><title>Publisher&#8217;s Note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walls</surname><given-names>AC</given-names></name><name name-style="western"><surname>Park</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Tortorici</surname><given-names>MA</given-names></name><name name-style="western"><surname>Wall</surname><given-names>A</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>AT</given-names></name><name name-style="western"><surname>Veesler</surname><given-names>D</given-names></name></person-group>. <article-title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</article-title>. <source>Cell</source> (<year>2020</year>) <volume>181</volume>(<issue>2</issue>):<fpage>281</fpage>&#8211;<lpage>92 e6</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="book"><source>WHO COVID-19 Dashboard</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://covid19whoint/">https://covid19whoint/</uri> (Accessed <date-in-citation content-type="access-date">31/10/21</date-in-citation>).</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>International Diabetes Federation</collab></person-group>. <source>IDF Diabetes Atlas</source>. <edition>9th edn</edition>. <publisher-loc>Brussels, Belgium</publisher-loc>: <publisher-name>International Diabetes Federation</publisher-name> (<year>2019</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wwwdiabetesatlasorg">https://wwwdiabetesatlasorg</uri>.</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>JK</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>MY</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>SY</given-names></name><name name-style="western"><surname>Fu</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>BY</given-names></name><etal/></person-group>. <article-title>Plasma Glucose Levels and Diabetes Are Independent Predictors for Mortality and Morbidity in Patients With SARS</article-title>. <source>Diabetes Med</source> (<year>2006</year>) <volume>23</volume>(<issue>6</issue>):<page-range>623&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/j.1464-5491.2006.01861.x</pub-id><pub-id pub-id-type="pmid">16759303</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zumla</surname><given-names>A</given-names></name><name name-style="western"><surname>Hui</surname><given-names>DS</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>S</given-names></name></person-group>. <article-title>Middle East Respiratory Syndrome</article-title>. <source>Lancet</source> (<year>2015</year>) <volume>386</volume>(<issue>9997</issue>):<fpage>995</fpage>&#8211;<lpage>1007</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S0140-6736(15)60454-8</pub-id><pub-id pub-id-type="pmid">26049252</pub-id><pub-id pub-id-type="pmcid">PMC4721578</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Kleine-Weber</surname><given-names>H</given-names></name><name name-style="western"><surname>Schroeder</surname><given-names>S</given-names></name><name name-style="western"><surname>Kruger</surname><given-names>N</given-names></name><name name-style="western"><surname>Herrler</surname><given-names>T</given-names></name><name name-style="western"><surname>Erichsen</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>. <source>Cell</source> (<year>2020</year>) <volume>181</volume>(<issue>2</issue>):<fpage>271</fpage>&#8211;<lpage>80 e8</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id><pub-id pub-id-type="pmid">32142651</pub-id><pub-id pub-id-type="pmcid">PMC7102627</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gheblawi</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Viveiros</surname><given-names>A</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>JC</given-names></name><name name-style="western"><surname>Turner</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2</article-title>. <source>Circ Res</source> (<year>2020</year>) <volume>126</volume>(<issue>10</issue>):<page-range>1456&#8211;74</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.317015</pub-id><pub-id pub-id-type="pmcid">PMC7188049</pub-id><pub-id pub-id-type="pmid">32264791</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>S</given-names></name><name name-style="western"><surname>Lau</surname><given-names>A</given-names></name><name name-style="western"><surname>So</surname><given-names>HC</given-names></name></person-group>. <article-title>Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>7</issue>):<page-range>1416&#8211;26</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-0643</pub-id><pub-id pub-id-type="pmid">32430459</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>R</given-names></name><name name-style="western"><surname>Bhadada</surname><given-names>SK</given-names></name></person-group>. <article-title>Should Anti-Diabetic Medications be Reconsidered Amid COVID-19 Pandemic</article-title>? <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>163</volume>:<elocation-id>108146</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108146</pub-id><pub-id pub-id-type="pmid">32283128</pub-id><pub-id pub-id-type="pmcid">PMC7151403</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brufsky</surname><given-names>A</given-names></name></person-group>. <article-title>Hyperglycemia, Hydroxychloroquine, and the COVID-19 Pandemic</article-title>. <source>J Med Virol</source> (<year>2020</year>) <volume>92</volume>(<issue>7</issue>):<page-range>770&#8211;5</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jmv.25887</pub-id><pub-id pub-id-type="pmcid">PMC7262330</pub-id><pub-id pub-id-type="pmid">32293710</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Codo</surname><given-names>AC</given-names></name><name name-style="western"><surname>Davanzo</surname><given-names>GG</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>LB</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>GF</given-names></name><name name-style="western"><surname>Muraro</surname><given-names>SP</given-names></name><name name-style="western"><surname>Virgilio-da-Silva</surname><given-names>JV</given-names></name><etal/></person-group>. <article-title>Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response Through a HIF-1alpha/Glycolysis-Dependent Axis</article-title>. <source>Cell Metab</source> (<year>2020</year>) <volume>32</volume>(<issue>3</issue>):<fpage>437</fpage>&#8211;<lpage>46 e5</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.cmet.2020.07.007</pub-id><pub-id pub-id-type="pmid">32697943</pub-id><pub-id pub-id-type="pmcid">PMC7367032</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaklamanos</surname><given-names>A</given-names></name><name name-style="western"><surname>Belogiannis</surname><given-names>K</given-names></name><name name-style="western"><surname>Skendros</surname><given-names>P</given-names></name><name name-style="western"><surname>Gorgoulis</surname><given-names>VG</given-names></name><name name-style="western"><surname>Vlachoyiannopoulos</surname><given-names>PG</given-names></name><name name-style="western"><surname>Tzioufas</surname><given-names>AG</given-names></name></person-group>. <article-title>COVID-19 Immunobiology: Lessons Learned, New Questions Arise</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>719023</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fimmu.2021.719023</pub-id><pub-id pub-id-type="pmid">34512643</pub-id><pub-id pub-id-type="pmcid">PMC8427766</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Meng</surname><given-names>W</given-names></name></person-group>. <article-title>COVID-19 and Diabetes: The Contributions of Hyperglycemia</article-title>. <source>J&#160;Mol Cell Biol</source> (<year>2021</year>) <volume>12</volume>(<issue>12</issue>):<page-range>958&#8211;62</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1093/jmcb/mjaa054</pub-id><pub-id pub-id-type="pmcid">PMC7543402</pub-id><pub-id pub-id-type="pmid">33002109</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lontchi-Yimagou</surname><given-names>E</given-names></name><name name-style="western"><surname>Sobngwi</surname><given-names>E</given-names></name><name name-style="western"><surname>Matsha</surname><given-names>TE</given-names></name><name name-style="western"><surname>Kengne</surname><given-names>AP</given-names></name></person-group>. <article-title>Diabetes Mellitus and Inflammation</article-title>. <source>Curr Diabetes Rep</source> (<year>2013</year>) <volume>13</volume>(<issue>3</issue>):<page-range>435&#8211;44</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s11892-013-0375-y</pub-id><pub-id pub-id-type="pmid">23494755</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>A</given-names></name><name name-style="western"><surname>Magro</surname><given-names>DO</given-names></name><name name-style="western"><surname>Evangelista-Poderoso</surname><given-names>R</given-names></name><name name-style="western"><surname>Saad</surname><given-names>MJA</given-names></name></person-group>. <article-title>Diabetes, Obesity, and Insulin Resistance in COVID-19: Molecular Interrelationship and Therapeutic Implications</article-title>. <source>Diabetol Metab Syndr</source> (<year>2021</year>) <volume>13</volume>(<issue>1</issue>):<fpage>23</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s13098-021-00639-2</pub-id><pub-id pub-id-type="pmid">33648564</pub-id><pub-id pub-id-type="pmcid">PMC7919999</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayden</surname><given-names>MR</given-names></name></person-group>. <article-title>An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of Beta-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms</article-title>. <source>Cells</source> (<year>2020</year>) <volume>9</volume>(<issue>11</issue>):<elocation-id>2475</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/cells9112475</pub-id><pub-id pub-id-type="pmid">33202960</pub-id><pub-id pub-id-type="pmcid">PMC7697826</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delgado-Roche</surname><given-names>L</given-names></name><name name-style="western"><surname>Mesta</surname><given-names>F</given-names></name></person-group>. <article-title>Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection</article-title>. <source>Arch Med Res</source> (<year>2020</year>) <volume>51</volume>(<issue>5</issue>):<page-range>384&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.arcmed.2020.04.019</pub-id><pub-id pub-id-type="pmcid">PMC7190501</pub-id><pub-id pub-id-type="pmid">32402576</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yaribeygi</surname><given-names>H</given-names></name><name name-style="western"><surname>Atkin</surname><given-names>SL</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>A Review of the Molecular Mechanisms of Hyperglycemia-Induced Free Radical Generation Leading to Oxidative Stress</article-title>. <source>J Cell Physiol</source> (<year>2019</year>) <volume>234</volume>(<issue>2</issue>):<page-range>1300&#8211;12</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jcp.27164</pub-id><pub-id pub-id-type="pmid">30146696</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajpal</surname><given-names>A</given-names></name><name name-style="western"><surname>Rahimi</surname><given-names>L</given-names></name><name name-style="western"><surname>Ismail-Beigi</surname><given-names>F</given-names></name></person-group>. <article-title>Factors Leading to High Morbidity and Mortality of COVID-19 in Patients With Type 2 Diabetes</article-title>. <source>J Diabetes</source> (<year>2020</year>) <volume>12</volume>(<issue>12</issue>):<fpage>895</fpage>&#8211;<lpage>908</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1111/1753-0407.13085</pub-id><pub-id pub-id-type="pmid">32671936</pub-id><pub-id pub-id-type="pmcid">PMC7405270</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carey</surname><given-names>IM</given-names></name><name name-style="western"><surname>Critchley</surname><given-names>JA</given-names></name><name name-style="western"><surname>DeWilde</surname><given-names>S</given-names></name><name name-style="western"><surname>Harris</surname><given-names>T</given-names></name><name name-style="western"><surname>Hosking</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Cook</surname><given-names>DG</given-names></name></person-group>. <article-title>Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study</article-title>. <source>Diabetes Care</source> (<year>2018</year>) <volume>41</volume>(<issue>3</issue>):<page-range>513&#8211;21</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc17-2131</pub-id><pub-id pub-id-type="pmid">29330152</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alam</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kabir</surname><given-names>MR</given-names></name><name name-style="western"><surname>Reza</surname><given-names>S</given-names></name></person-group>. <article-title>Comorbidities Might be a Risk Factor for the Incidence of COVID-19: Evidence From a Web-Based Survey</article-title>. <source>Prev Med Rep</source> (<year>2021</year>) <volume>21</volume>:<elocation-id>101319</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.pmedr.2021.101319</pub-id><pub-id pub-id-type="pmid">33489728</pub-id><pub-id pub-id-type="pmcid">PMC7811036</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SC</given-names></name><name name-style="western"><surname>Won</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>NH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>H</given-names></name><name name-style="western"><surname>Youk</surname><given-names>TM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections: A Nationwide Population-Based Study</article-title>. <source>Ann Transl Med</source> (<year>2021</year>) <volume>9</volume>(<issue>3</issue>):<fpage>211</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.21037/atm-20-5958</pub-id><pub-id pub-id-type="pmid">33708838</pub-id><pub-id pub-id-type="pmcid">PMC7940880</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crouse</surname><given-names>AB</given-names></name><name name-style="western"><surname>Grimes</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Might</surname><given-names>M</given-names></name><name name-style="western"><surname>Ovalle</surname><given-names>F</given-names></name><name name-style="western"><surname>Shalev</surname><given-names>A</given-names></name></person-group>. <article-title>Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>600439</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fendo.2020.600439</pub-id><pub-id pub-id-type="pmid">33519709</pub-id><pub-id pub-id-type="pmcid">PMC7838490</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutierrez</surname><given-names>JP</given-names></name><name name-style="western"><surname>Bertozzi</surname><given-names>SM</given-names></name></person-group>. <article-title>Non-Communicable Diseases and Inequalities Increase Risk of Death Among COVID-19 Patients in Mexico</article-title>. <source>PloS One</source> (<year>2020</year>) <volume>15</volume>(<issue>10</issue>):<elocation-id>e0240394</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0240394</pub-id><pub-id pub-id-type="pmid">33031467</pub-id><pub-id pub-id-type="pmcid">PMC7544063</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leon-Pedroza</surname><given-names>JI</given-names></name><name name-style="western"><surname>Rodriguez-Cortes</surname><given-names>O</given-names></name><name name-style="western"><surname>Flores-Mejia</surname><given-names>R</given-names></name><name name-style="western"><surname>Gaona-Aguas</surname><given-names>CV</given-names></name><name name-style="western"><surname>Gonzalez-Chavez</surname><given-names>A</given-names></name></person-group>. <article-title>Impact of Metabolic Syndrome in the Clinical Outcome of Disease by SARS-COV-2 in Mexican Population</article-title>. <source>Arch Med Res</source> (<year>2021</year>) <volume>52</volume>(<issue>7</issue>):<page-range>738&#8211;45</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.arcmed.2021.04.001</pub-id><pub-id pub-id-type="pmcid">PMC8041184</pub-id><pub-id pub-id-type="pmid">33926762</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parra-Bracamonte</surname><given-names>GM</given-names></name><name name-style="western"><surname>Lopez-Villalobos</surname><given-names>N</given-names></name><name name-style="western"><surname>Parra-Bracamonte</surname><given-names>FE</given-names></name></person-group>. <article-title>Clinical Characteristics and Risk Factors for Mortality of Patients With COVID-19 in a Large Data Set From Mexico</article-title>. <source>Ann Epidemiol</source> (<year>2020</year>) <volume>52</volume>:<fpage>93</fpage>&#8211;<lpage>8.e2</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.annepidem.2020.08.005</pub-id><pub-id pub-id-type="pmid">32798701</pub-id><pub-id pub-id-type="pmcid">PMC7426229</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prado-Galbarro</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Sanchez-Piedra</surname><given-names>C</given-names></name><name name-style="western"><surname>Gamino-Arroyo</surname><given-names>AE</given-names></name><name name-style="western"><surname>Cruz-Cruz</surname><given-names>C</given-names></name></person-group>. <article-title>Determinants of Survival After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Mexican Outpatients and Hospitalised Patients</article-title>. <source>Public Health</source> (<year>2020</year>) <volume>189</volume>:<fpage>66</fpage>&#8211;<lpage>72</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.puhe.2020.09.014</pub-id><pub-id pub-id-type="pmid">33166857</pub-id><pub-id pub-id-type="pmcid">PMC7524658</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sosa-Rubi</surname><given-names>SG</given-names></name><name name-style="western"><surname>Seiglie</surname><given-names>JA</given-names></name><name name-style="western"><surname>Chivardi</surname><given-names>C</given-names></name><name name-style="western"><surname>Manne-Goehler</surname><given-names>J</given-names></name><name name-style="western"><surname>Meigs</surname><given-names>JB</given-names></name><name name-style="western"><surname>Wexler</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages</article-title>. <source>Diabetes Care</source> (<year>2021</year>) <volume>44</volume>(<issue>2</issue>):<page-range>373&#8211;80</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-2192</pub-id><pub-id pub-id-type="pmcid">PMC7818336</pub-id><pub-id pub-id-type="pmid">33208487</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrison</surname><given-names>SL</given-names></name><name name-style="western"><surname>Fazio-Eynullayeva</surname><given-names>E</given-names></name><name name-style="western"><surname>Lane</surname><given-names>DA</given-names></name><name name-style="western"><surname>Underhill</surname><given-names>P</given-names></name><name name-style="western"><surname>Lip</surname><given-names>GYH</given-names></name></person-group>. <article-title>Comorbidities Associated With Mortality in 31,461 Adults With COVID-19 in the United States: A Federated Electronic Medical Record Analysis</article-title>. <source>PloS Med</source> (<year>2020</year>) <volume>17</volume>(<issue>9</issue>):<elocation-id>e1003321</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pmed.1003321</pub-id><pub-id pub-id-type="pmid">32911500</pub-id><pub-id pub-id-type="pmcid">PMC7482833</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos-Nonato</surname><given-names>I</given-names></name><name name-style="western"><surname>Ramirez-Villalobos</surname><given-names>M</given-names></name><name name-style="western"><surname>Flores-Coria</surname><given-names>A</given-names></name><name name-style="western"><surname>Valdez</surname><given-names>A</given-names></name><name name-style="western"><surname>Monterrubio-Flores</surname><given-names>E</given-names></name></person-group>. <article-title>Prevalence of Previously Diagnosed Diabetes and Glycemic Control Strategies in Mexican Adults: ENSANUT-2016</article-title>. <source>PloS One</source> (<year>2020</year>) <volume>15</volume>(<issue>4</issue>):<elocation-id>e0230752</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0230752</pub-id><pub-id pub-id-type="pmid">32298264</pub-id><pub-id pub-id-type="pmcid">PMC7162504</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><name name-style="western"><surname>Snetselaar</surname><given-names>LG</given-names></name><name name-style="western"><surname>Hu</surname><given-names>FB</given-names></name><etal/></person-group>. <article-title>Prevalence of Diagnosed Type 1 and Type 2 Diabetes Among US Adults in 2016 and 2017: Population Based Study</article-title>. <source>BMJ</source> (<year>2018</year>) <volume>362</volume>:<elocation-id>k1497</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmj.k1497</pub-id><pub-id pub-id-type="pmid">30181166</pub-id><pub-id pub-id-type="pmcid">PMC6122253</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chun</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>JH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>YJ</given-names></name><etal/></person-group>. <article-title>Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea</article-title>. <source>Diabetes Metab J</source> (<year>2020</year>) <volume>44</volume>(<issue>6</issue>):<fpage>897</fpage>&#8211;<lpage>907</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.4093/dmj.2020.0199</pub-id><pub-id pub-id-type="pmid">33389959</pub-id><pub-id pub-id-type="pmcid">PMC7801768</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ying</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Z</given-names></name></person-group>. <article-title>Prevalence of Comorbidity in Chinese Patients With COVID-19: Systematic Review and Meta-Analysis of Risk Factors</article-title>. <source>BMC Infect Dis</source> (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>200</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s12879-021-05915-0</pub-id><pub-id pub-id-type="pmid">33618678</pub-id><pub-id pub-id-type="pmcid">PMC7897883</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pena</surname><given-names>JE</given-names></name><name name-style="western"><surname>Rascon-Pacheco</surname><given-names>RA</given-names></name><name name-style="western"><surname>Ascencio-Montiel</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Gonzalez-Figueroa</surname><given-names>E</given-names></name><name name-style="western"><surname>Fernandez-Garate</surname><given-names>JE</given-names></name><name name-style="western"><surname>Medina-Gomez</surname><given-names>OS</given-names></name><etal/></person-group>. <article-title>Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients With COVID-19 in Mexico</article-title>. <source>Arch Med Res</source> (<year>2021</year>) <volume>52</volume>(<issue>4</issue>):<page-range>443&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.arcmed.2020.12.002</pub-id><pub-id pub-id-type="pmcid">PMC7832055</pub-id><pub-id pub-id-type="pmid">33380361</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DQ</given-names></name><name name-style="western"><surname>Zou</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Hui</surname><given-names>WZ</given-names></name><name name-style="western"><surname>Rui</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Epidemiology of COVID-19: A Systematic Review and Meta-Analysis of Clinical Characteristics, Risk Factors, and Outcomes</article-title>. <source>J Med Virol</source> (<year>2021</year>) <volume>93</volume>(<issue>3</issue>):<page-range>1449&#8211;58</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jmv.26424</pub-id><pub-id pub-id-type="pmcid">PMC7436673</pub-id><pub-id pub-id-type="pmid">32790106</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saeedi</surname><given-names>P</given-names></name><name name-style="western"><surname>Petersohn</surname><given-names>I</given-names></name><name name-style="western"><surname>Salpea</surname><given-names>P</given-names></name><name name-style="western"><surname>Malanda</surname><given-names>B</given-names></name><name name-style="western"><surname>Karuranga</surname><given-names>S</given-names></name><name name-style="western"><surname>Unwin</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results From the International Diabetes Federation Diabetes Atlas, 9(Th) Edition</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2019</year>) <volume>157</volume>:<elocation-id>107843</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2019.107843</pub-id><pub-id pub-id-type="pmid">31518657</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrillo-Vega</surname><given-names>MF</given-names></name><name name-style="western"><surname>Salinas-Escudero</surname><given-names>G</given-names></name><name name-style="western"><surname>Garcia-Pena</surname><given-names>C</given-names></name><name name-style="western"><surname>Gutierrez-Robledo</surname><given-names>LM</given-names></name><name name-style="western"><surname>Parra-Rodriguez</surname><given-names>L</given-names></name></person-group>. <article-title>Early Estimation of the Risk Factors for Hospitalization and Mortality by COVID-19 in Mexico</article-title>. <source>PloS One</source> (<year>2020</year>) <volume>15</volume>(<issue>9</issue>):<elocation-id>e0238905</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0238905</pub-id><pub-id pub-id-type="pmid">32915872</pub-id><pub-id pub-id-type="pmcid">PMC7485801</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez-Galdamez</surname><given-names>DR</given-names></name><name name-style="western"><surname>Gonzalez-Block</surname><given-names>MA</given-names></name><name name-style="western"><surname>Romo-Duenas</surname><given-names>DK</given-names></name><name name-style="western"><surname>Lima-Morales</surname><given-names>R</given-names></name><name name-style="western"><surname>Hernandez-Vicente</surname><given-names>IA</given-names></name><name name-style="western"><surname>Lumbreras-Guzman</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Increased Risk of Hospitalization and Death in Patients With COVID-19 and Pre-Existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico</article-title>. <source>Arch Med Res</source> (<year>2020</year>) <volume>51</volume>(<issue>7</issue>):<page-range>683&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.arcmed.2020.07.003</pub-id><pub-id pub-id-type="pmcid">PMC7375298</pub-id><pub-id pub-id-type="pmid">32747155</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gottlieb</surname><given-names>M</given-names></name><name name-style="western"><surname>Sansom</surname><given-names>S</given-names></name><name name-style="western"><surname>Frankenberger</surname><given-names>C</given-names></name><name name-style="western"><surname>Ward</surname><given-names>E</given-names></name><name name-style="western"><surname>Hota</surname><given-names>B</given-names></name></person-group>. <article-title>Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois</article-title>. <source>Acad Emerg Med</source> (<year>2020</year>) <volume>27</volume>(<issue>10</issue>):<page-range>963&#8211;73</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/acem.14104</pub-id><pub-id pub-id-type="pmcid">PMC7436503</pub-id><pub-id pub-id-type="pmid">32762106</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martos-Benitez</surname><given-names>FD</given-names></name><name name-style="western"><surname>Soler-Morejon</surname><given-names>CD</given-names></name><name name-style="western"><surname>Garcia-Del Barco</surname><given-names>D</given-names></name></person-group>. <article-title>Chronic Comorbidities and Clinical Outcomes in Patients With and Without COVID-19: A Large Population-Based Study Using National Administrative Healthcare Open Data of Mexico</article-title>. <source>Intern Emerg Med</source> (<year>2021</year>) <volume>16</volume>(<issue>6</issue>):<page-range>1507&#8211;17</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s11739-020-02597-5</pub-id><pub-id pub-id-type="pmcid">PMC7788175</pub-id><pub-id pub-id-type="pmid">33411264</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halalau</surname><given-names>A</given-names></name><name name-style="western"><surname>Odish</surname><given-names>F</given-names></name><name name-style="western"><surname>Imam</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sharrak</surname><given-names>A</given-names></name><name name-style="western"><surname>Brickner</surname><given-names>E</given-names></name><name name-style="western"><surname>Lee</surname><given-names>PB</given-names></name><etal/></person-group>. <article-title>Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan</article-title>. <source>Int J Gen Med</source> (<year>2021</year>) <volume>14</volume>:<page-range>1555&#8211;63</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2147/IJGM.S305295</pub-id><pub-id pub-id-type="pmcid">PMC8089468</pub-id><pub-id pub-id-type="pmid">33953603</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Hearn</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Cudhea</surname><given-names>F</given-names></name><name name-style="western"><surname>Micha</surname><given-names>R</given-names></name><name name-style="western"><surname>Mozaffarian</surname><given-names>D</given-names></name></person-group>. <article-title>Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis</article-title>. <source>J Am Heart Assoc</source> (<year>2021</year>) <volume>10</volume>(<issue>5</issue>):<elocation-id>e019259</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1161/JAHA.120.019259</pub-id><pub-id pub-id-type="pmid">33629868</pub-id><pub-id pub-id-type="pmcid">PMC8174244</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>S</given-names></name><name name-style="western"><surname>Hirsch</surname><given-names>JS</given-names></name><name name-style="western"><surname>Narasimhan</surname><given-names>M</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>JM</given-names></name><name name-style="western"><surname>McGinn</surname><given-names>T</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>KW</given-names></name><etal/></person-group>. <article-title>Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area</article-title>. <source>JAMA</source> (<year>2020</year>) <volume>323</volume>(<issue>20</issue>):<page-range>2052&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1001/jama.2020.6775</pub-id><pub-id pub-id-type="pmcid">PMC7177629</pub-id><pub-id pub-id-type="pmid">32320003</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casas-Rojo</surname><given-names>JM</given-names></name><name name-style="western"><surname>Anton-Santos</surname><given-names>JM</given-names></name><name name-style="western"><surname>Millan-Nunez-Cortes</surname><given-names>J</given-names></name><name name-style="western"><surname>Lumbreras-Bermejo</surname><given-names>C</given-names></name><name name-style="western"><surname>Ramos-Rincon</surname><given-names>JM</given-names></name><name name-style="western"><surname>Roy-Vallejo</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics of Patients Hospitalized With COVID-19 in Spain: Results From the SEMI-COVID-19 Registry</article-title>. <source>Rev Clin Esp (Barc)</source> (<year>2020</year>) <volume>220</volume>(<issue>8</issue>):<page-range>480&#8211;94</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.rce.2020.07.003</pub-id><pub-id pub-id-type="pmcid">PMC7480740</pub-id><pub-id pub-id-type="pmid">32762922</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Jung</surname><given-names>JH</given-names></name><name name-style="western"><surname>Han</surname><given-names>KD</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SR</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WY</given-names></name><etal/></person-group>. <article-title>Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study</article-title>. <source>Diabetes Metab J</source> (<year>2020</year>) <volume>44</volume>(<issue>5</issue>):<page-range>737&#8211;46</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.4093/dmj.2020.0141</pub-id><pub-id pub-id-type="pmcid">PMC7643598</pub-id><pub-id pub-id-type="pmid">33115212</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maddaloni</surname><given-names>E</given-names></name><name name-style="western"><surname>D'Onofrio</surname><given-names>L</given-names></name><name name-style="western"><surname>Alessandri</surname><given-names>F</given-names></name><name name-style="western"><surname>Mignogna</surname><given-names>C</given-names></name><name name-style="western"><surname>Leto</surname><given-names>G</given-names></name><name name-style="western"><surname>Coraggio</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Clinical Features of Patients With Type 2 Diabetes With and Without Covid-19: A Case Control Study (CoViDiab I)</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>169</volume>:<elocation-id>108454</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108454</pub-id><pub-id pub-id-type="pmid">32971157</pub-id><pub-id pub-id-type="pmcid">PMC7505069</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abohamr</surname><given-names>SI</given-names></name><name name-style="western"><surname>Abazid</surname><given-names>RM</given-names></name><name name-style="western"><surname>Aldossari</surname><given-names>MA</given-names></name><name name-style="western"><surname>Amer</surname><given-names>HA</given-names></name><name name-style="western"><surname>Badhawi</surname><given-names>OS</given-names></name><name name-style="western"><surname>Aljunaidi</surname><given-names>OM</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and in-Hospital Mortality of COVID-19 Adult Patients in Saudi Arabia</article-title>. <source>Saudi Med J</source> (<year>2020</year>) <volume>41</volume>(<issue>11</issue>):<page-range>1217&#8211;26</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.15537/smj.2020.11.25495</pub-id><pub-id pub-id-type="pmcid">PMC7804238</pub-id><pub-id pub-id-type="pmid">33130842</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denova-Gutierrez</surname><given-names>E</given-names></name><name name-style="western"><surname>Lopez-Gatell</surname><given-names>H</given-names></name><name name-style="western"><surname>Alomia-Zegarra</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lopez-Ridaura</surname><given-names>R</given-names></name><name name-style="western"><surname>Zaragoza-Jimenez</surname><given-names>CA</given-names></name><name name-style="western"><surname>Dyer-Leal</surname><given-names>DD</given-names></name><etal/></person-group>. <article-title>The Association of Obesity, Type 2 Diabetes, and Hypertension With Severe Coronavirus Disease 2019 on Admission Among Mexican Patients</article-title>. <source>Obesity (Silver Spring)</source> (<year>2020</year>) <volume>28</volume>(<issue>10</issue>):<page-range>1826&#8211;32</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/oby.22946</pub-id><pub-id pub-id-type="pmcid">PMC7361939</pub-id><pub-id pub-id-type="pmid">32610364</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galloway</surname><given-names>JB</given-names></name><name name-style="western"><surname>Norton</surname><given-names>S</given-names></name><name name-style="western"><surname>Barker</surname><given-names>RD</given-names></name><name name-style="western"><surname>Brookes</surname><given-names>A</given-names></name><name name-style="western"><surname>Carey</surname><given-names>I</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>BD</given-names></name><etal/></person-group>. <article-title>A Clinical Risk Score to Identify Patients With COVID-19 at High Risk of Critical Care Admission or Death: An Observational Cohort Study</article-title>. <source>J Infect</source> (<year>2020</year>) <volume>81</volume>(<issue>2</issue>):<page-range>282&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.064</pub-id><pub-id pub-id-type="pmcid">PMC7258846</pub-id><pub-id pub-id-type="pmid">32479771</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capak</surname><given-names>K</given-names></name><name name-style="western"><surname>Brkic-Bilos</surname><given-names>I</given-names></name><name name-style="western"><surname>Kralj</surname><given-names>V</given-names></name><name name-style="western"><surname>Poljicanin</surname><given-names>T</given-names></name><name name-style="western"><surname>Sekerija</surname><given-names>M</given-names></name><name name-style="western"><surname>Ivanko</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Prevalence of Somatic Comorbidities Among Coronavirus Disease 2019 Patients in Croatia in the First Pandemic Wave: Data From National Public Health Databases</article-title>. <source>Croat Med J</source> (<year>2020</year>) <volume>61</volume>(<issue>6</issue>):<page-range>518&#8211;24</page-range>. doi: <pub-id pub-id-type="doi">10.3325/cmj.2020.61.518</pub-id><pub-id pub-id-type="pmcid">PMC7821369</pub-id><pub-id pub-id-type="pmid">33410298</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jakob</surname><given-names>CEM</given-names></name><name name-style="western"><surname>Borgmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Duygu</surname><given-names>F</given-names></name><name name-style="western"><surname>Behrends</surname><given-names>U</given-names></name><name name-style="western"><surname>Hower</surname><given-names>M</given-names></name><name name-style="western"><surname>Merle</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>First Results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)"</article-title>. <source>Infection</source> (<year>2021</year>) <volume>49</volume>(<issue>1</issue>):<fpage>63</fpage>&#8211;<lpage>73</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s15010-020-01499-0</pub-id><pub-id pub-id-type="pmid">33001409</pub-id><pub-id pub-id-type="pmcid">PMC7527665</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Deng</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients With COVID-19 and Diabetes</article-title>. <source>Infect Dis Ther</source> (<year>2020</year>) <volume>9</volume>(<issue>4</issue>):<fpage>981</fpage>&#8211;<lpage>1002</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s40121-020-00359-6</pub-id><pub-id pub-id-type="pmid">33113119</pub-id><pub-id pub-id-type="pmcid">PMC7591692</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Kuwari</surname><given-names>HM</given-names></name><name name-style="western"><surname>Abdul Rahim</surname><given-names>HF</given-names></name><name name-style="western"><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Abou-Samra</surname><given-names>AB</given-names></name><name name-style="western"><surname>Al Kanaani</surname><given-names>Z</given-names></name><name name-style="western"><surname>Al Khal</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Epidemiological Investigation of the First 5685 Cases of SARS-CoV-2 Infection in Qatar, 28 February-18 April 2020</article-title>. <source>BMJ Open</source> (<year>2020</year>) <volume>10</volume>(<issue>10</issue>):<elocation-id>e040428</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmjopen-2020-040428</pub-id><pub-id pub-id-type="pmcid">PMC7542927</pub-id><pub-id pub-id-type="pmid">33033033</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health O</collab></person-group>. <source>Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease Is Suspected: Interim Guidance, 13 March 2020</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. (<year>2020</year>). Report No.: Contract No.: WHO/2019-nCoV/clinical/2020.4. Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://apps.who.int/iris/handle/10665/331446">https://apps.who.int/iris/handle/10665/331446</uri>. (accessed <date-in-citation content-type="access-date">31/10/2021</date-in-citation>).</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez-Gonzalez</surname><given-names>CG</given-names></name><name name-style="western"><surname>Chamorro-de-Vega</surname><given-names>E</given-names></name><name name-style="western"><surname>Valerio</surname><given-names>M</given-names></name><name name-style="western"><surname>Amor-Garcia</surname><given-names>MA</given-names></name><name name-style="western"><surname>Tejerina</surname><given-names>F</given-names></name><name name-style="western"><surname>Sancho-Gonzalez</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>COVID-19 in Hospitalised Patients in Spain: A Cohort Study in Madrid</article-title>. <source>Int J Antimicrob Agents</source> (<year>2021</year>) <volume>57</volume>(<issue>2</issue>):<elocation-id>106249</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.106249</pub-id><pub-id pub-id-type="pmid">33259918</pub-id><pub-id pub-id-type="pmcid">PMC7698681</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>N</given-names></name><name name-style="western"><surname>Bimu</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>7</issue>):<page-range>1382&#8211;91</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-0598</pub-id><pub-id pub-id-type="pmid">32409504</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wei</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chao</surname><given-names>YC</given-names></name><etal/></person-group>. <article-title>Coagulopathy is a Major Extrapulmonary Risk Factor for Mortality in Hospitalized Patients With COVID-19 With Type 2 Diabetes</article-title>. <source>BMJ Open Diabetes Res Care</source> (<year>2020</year>) <volume>8</volume>(<issue>2</issue>):<elocation-id>e001851</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmjdrc-2020-001851</pub-id><pub-id pub-id-type="pmcid">PMC7677866</pub-id><pub-id pub-id-type="pmid">33214191</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SA</given-names></name><name name-style="western"><surname>Chun</surname><given-names>SY</given-names></name><name name-style="western"><surname>Song</surname><given-names>SO</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Population-Based Study in Korea</article-title>. <source>Endocrinol Metab (Seoul)</source> (<year>2020</year>) <volume>35</volume>(<issue>4</issue>):<page-range>901&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.3803/EnM.2020.787</pub-id><pub-id pub-id-type="pmcid">PMC7803612</pub-id><pub-id pub-id-type="pmid">33297603</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonmez</surname><given-names>A</given-names></name><name name-style="western"><surname>Demirci</surname><given-names>I</given-names></name><name name-style="western"><surname>Haymana</surname><given-names>C</given-names></name><name name-style="western"><surname>Tasci</surname><given-names>I</given-names></name><name name-style="western"><surname>Dagdelen</surname><given-names>S</given-names></name><name name-style="western"><surname>Salman</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and Outcomes of COVID-19 in Patients With Type 2 Diabetes in Turkey: A Nationwide Study (TurCoviDia)</article-title>. <source>J Diabetes</source> (<year>2021</year>) <volume>13</volume>(<issue>7</issue>):<page-range>585&#8211;95</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/1753-0407.13171</pub-id><pub-id pub-id-type="pmcid">PMC8013711</pub-id><pub-id pub-id-type="pmid">33655669</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guan</surname><given-names>X</given-names></name><name name-style="western"><surname>Jia</surname><given-names>L</given-names></name><name name-style="western"><surname>Xing</surname><given-names>N</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Independent and Combined Effects of Hypertension and Diabetes on Clinical Outcomes in Patients With COVID-19: A Retrospective Cohort Study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital</article-title>. <source>J Clin Hypertens (Greenwich)</source> (<year>2021</year>) <volume>23</volume>(<issue>2</issue>):<page-range>218&#8211;31</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/jch.14146</pub-id><pub-id pub-id-type="pmcid">PMC8029850</pub-id><pub-id pub-id-type="pmid">33369066</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YC</given-names></name><name name-style="western"><surname>Park</surname><given-names>JY</given-names></name><name name-style="western"><surname>Jung</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JP</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name></person-group>. <article-title>Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment</article-title>. <source>Int J Environ Res Public Health</source> (<year>2021</year>) <volume>18</volume>(<issue>10</issue>):<elocation-id>5342</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/ijerph18105342</pub-id><pub-id pub-id-type="pmid">34067850</pub-id><pub-id pub-id-type="pmcid">PMC8157012</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Najera</surname><given-names>H</given-names></name><name name-style="western"><surname>Ortega-Avila</surname><given-names>AG</given-names></name></person-group>. <article-title>Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020</article-title>. <source>Am J Prev Med</source> (<year>2021</year>) <volume>60</volume>(<issue>4</issue>):<page-range>471&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.amepre.2020.10.015</pub-id><pub-id pub-id-type="pmcid">PMC7832683</pub-id><pub-id pub-id-type="pmid">33745520</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Souza</surname><given-names>CD</given-names></name><name name-style="western"><surname>de Arruda Magalhaes</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Lima</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>DN</given-names></name><name name-style="western"><surname>de Fatima Machado Soares</surname><given-names>E</given-names></name><name name-style="western"><surname>de Castro Silva</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Clinical Manifestations and Factors Associated With Mortality From COVID-19 in Older Adults: Retrospective Population-Based Study With 9807 Older Brazilian COVID-19 Patients</article-title>. <source>Geriatr Gerontol Int</source> (<year>2020</year>) <volume>20</volume>(<issue>12</issue>):<page-range>1177&#8211;81</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/ggi.14061</pub-id><pub-id pub-id-type="pmid">33111433</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williamson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Walker</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Bhaskaran</surname><given-names>K</given-names></name><name name-style="western"><surname>Bacon</surname><given-names>S</given-names></name><name name-style="western"><surname>Bates</surname><given-names>C</given-names></name><name name-style="western"><surname>Morton</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>Factors Associated With COVID-19-Related Death Using OpenSAFELY</article-title>. <source>Nature</source> (<year>2020</year>) <volume>584</volume>(<issue>7821</issue>):<page-range>430&#8211;6</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1038/s41586-020-2521-4</pub-id><pub-id pub-id-type="pmcid">PMC7611074</pub-id><pub-id pub-id-type="pmid">32640463</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>She</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Qin</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Association of Blood Glucose Control and Outcomes in Patients With COVID-19 and Pre-Existing Type 2 Diabetes</article-title>. <source>Cell Metab</source> (<year>2020</year>) <volume>31</volume>(<issue>6</issue>):<fpage>1068</fpage>&#8211;<lpage>77 e3</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.cmet.2020.04.021</pub-id><pub-id pub-id-type="pmid">32369736</pub-id><pub-id pub-id-type="pmcid">PMC7252168</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>PVD</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SB</given-names></name><name name-style="western"><surname>Escalante</surname><given-names>JJC</given-names></name><name name-style="western"><surname>Almiron</surname><given-names>M</given-names></name><name name-style="western"><surname>Tsuha</surname><given-names>DH</given-names></name><name name-style="western"><surname>Sato</surname><given-names>HK</given-names></name><etal/></person-group>. <article-title>Risk Factors for Death Among 120,804 Hospitalized Patients With Confirmed COVID-19 in Sao Paulo, Brazil</article-title>. <source>Am J Trop Med Hyg</source> (<year>2021</year>) <volume>105</volume>(<issue>1</issue>):<fpage>88</fpage>&#8211;<lpage>92</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.4269/ajtmh.20-1598</pub-id><pub-id pub-id-type="pmid">34061773</pub-id><pub-id pub-id-type="pmcid">PMC8274770</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>EK</given-names></name><name name-style="western"><surname>Choi</surname><given-names>HY</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>N</given-names></name></person-group>. <article-title>The Anatomy of COVID-19 Comorbidity Networks Among Hospitalized Korean Patients</article-title>. <source>Epidemiol Health</source> (<year>2021</year>) <volume>43</volume>:<elocation-id>e2021035</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.4178/epih.e2021035</pub-id><pub-id pub-id-type="pmid">33971700</pub-id><pub-id pub-id-type="pmcid">PMC8289479</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esme</surname><given-names>M</given-names></name><name name-style="western"><surname>Koca</surname><given-names>M</given-names></name><name name-style="western"><surname>Dikmeer</surname><given-names>A</given-names></name><name name-style="western"><surname>Balci</surname><given-names>C</given-names></name><name name-style="western"><surname>Ata</surname><given-names>N</given-names></name><name name-style="western"><surname>Dogu</surname><given-names>BB</given-names></name><etal/></person-group>. <article-title>Older Adults With Coronavirus Disease 2019: A Nationwide Study in Turkey</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> (<year>2021</year>) <volume>76</volume>(<issue>3</issue>):<page-range>e68&#8211;75</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1093/gerona/glaa219</pub-id><pub-id pub-id-type="pmcid">PMC7499528</pub-id><pub-id pub-id-type="pmid">32871002</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Epidemiological, Comorbidity Factors With Severity and Prognosis of COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>Aging (Albany NY)</source> (<year>2020</year>) <volume>12</volume>(<issue>13</issue>):<page-range>12493&#8211;503</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.18632/aging.103579</pub-id><pub-id pub-id-type="pmcid">PMC7377860</pub-id><pub-id pub-id-type="pmid">32658868</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>I</given-names></name><name name-style="western"><surname>Lim</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pranata</surname><given-names>R</given-names></name></person-group>. <article-title>Diabetes Mellitus is Associated With Increased Mortality and Severity of Disease in COVID-19 Pneumonia - A Systematic Review, Meta-Analysis, and Meta-Regression</article-title>. <source>Diabetes Metab Syndr</source> (<year>2020</year>) <volume>14</volume>(<issue>4</issue>):<fpage>395</fpage>&#8211;<lpage>403</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2020.04.018</pub-id><pub-id pub-id-type="pmid">32334395</pub-id><pub-id pub-id-type="pmcid">PMC7162793</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>The Clinical Characteristics and Risk Factors of Severe COVID-19</article-title>. <source>Gerontology</source> (<year>2021</year>) <volume>67</volume>(<issue>3</issue>):<page-range>255&#8211;66</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1159/000513400</pub-id><pub-id pub-id-type="pmcid">PMC7900480</pub-id><pub-id pub-id-type="pmid">33406518</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Baxi</surname><given-names>H</given-names></name><name name-style="western"><surname>Chand Jamali</surname><given-names>M</given-names></name><name name-style="western"><surname>Nisar</surname><given-names>N</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>MS</given-names></name></person-group>. <article-title>Burden of Diabetes Mellitus and Its Impact on COVID-19 Patients: A Meta-Analysis of Real-World Evidence</article-title>. <source>Diabetes Metab Syndr</source> (<year>2020</year>) <volume>14</volume>(<issue>6</issue>):<page-range>1595&#8211;602</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2020.08.014</pub-id><pub-id pub-id-type="pmcid">PMC7439970</pub-id><pub-id pub-id-type="pmid">32862098</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Arora</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>P</given-names></name><name name-style="western"><surname>Anikhindi</surname><given-names>SA</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>N</given-names></name><name name-style="western"><surname>Singla</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Clinical Features of COVID-19 and Factors Associated With Severe Clinical Course: A Systematic Review and Meta-Analysis</article-title>. <source>SSRN</source> (<year>2020</year>):<elocation-id>3566166</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.2139/ssrn.3566166</pub-id><pub-id pub-id-type="pmid">32714109</pub-id><pub-id pub-id-type="pmcid">PMC7366815</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name></person-group>. <article-title>Clinical Determinants of the Severity of COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>PloS One</source> (<year>2021</year>) <volume>16</volume>(<issue>5</issue>):<elocation-id>e0250602</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0250602</pub-id><pub-id pub-id-type="pmid">33939733</pub-id><pub-id pub-id-type="pmcid">PMC8092779</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giri</surname><given-names>M</given-names></name><name name-style="western"><surname>Puri</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S</given-names></name></person-group>. <article-title>Comparison of Clinical Manifestations, Pre-Existing Comorbidities, Complications and Treatment Modalities in Severe and Non-Severe COVID-19 Patients: A Systemic Review and Meta-Analysis</article-title>. <source>Sci Prog</source> (<year>2021</year>) <volume>104</volume>(<issue>1</issue>):<elocation-id>368504211000906</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1177/00368504211000906</pub-id><pub-id pub-id-type="pmid">33752530</pub-id><pub-id pub-id-type="pmcid">PMC7992103</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honardoost</surname><given-names>M</given-names></name><name name-style="western"><surname>Janani</surname><given-names>L</given-names></name><name name-style="western"><surname>Aghili</surname><given-names>R</given-names></name><name name-style="western"><surname>Emami</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khamseh</surname><given-names>ME</given-names></name></person-group>. <article-title>The Association Between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis</article-title>. <source>Cerebrovasc Dis</source> (<year>2021</year>) <volume>50</volume>(<issue>2</issue>):<page-range>132&#8211;40</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1159/000513288</pub-id><pub-id pub-id-type="pmcid">PMC7900456</pub-id><pub-id pub-id-type="pmid">33530081</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>WH</given-names></name><name name-style="western"><surname>Tipih</surname><given-names>T</given-names></name><name name-style="western"><surname>Makoah</surname><given-names>NA</given-names></name><name name-style="western"><surname>Vermeulen</surname><given-names>JG</given-names></name><name name-style="western"><surname>Goedhals</surname><given-names>D</given-names></name><name name-style="western"><surname>Sempa</surname><given-names>JB</given-names></name><etal/></person-group>. <article-title>Comorbidities in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis</article-title>. <source>mBio</source> (<year>2021</year>) <volume>12</volume>(<issue>1</issue>):<elocation-id>e03647&#8211;20</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1128/mBio.03647-20</pub-id><pub-id pub-id-type="pmid">33563817</pub-id><pub-id pub-id-type="pmcid">PMC7885108</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>W</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name></person-group>. <article-title>The Association of Diabetes With COVID-19 Disease Severity: Evidence From Adjusted Effect Estimates</article-title>. <source>Hormones (Athens)</source> (<year>2021</year>) <volume>20</volume>(<issue>2</issue>):<page-range>409&#8211;14</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s42000-020-00259-x</pub-id><pub-id pub-id-type="pmcid">PMC7685958</pub-id><pub-id pub-id-type="pmid">33236191</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaminska</surname><given-names>H</given-names></name><name name-style="western"><surname>Szarpak</surname><given-names>L</given-names></name><name name-style="western"><surname>Kosior</surname><given-names>D</given-names></name><name name-style="western"><surname>Wieczorek</surname><given-names>W</given-names></name><name name-style="western"><surname>Szarpak</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Jeabory</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Impact of Diabetes Mellitus on in-Hospital Mortality in Adult Patients With COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>Acta Diabetol</source> (<year>2021</year>) <volume>58</volume>(<issue>8</issue>):<page-range>1101&#8211;10</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00592-021-01701-1</pub-id><pub-id pub-id-type="pmcid">PMC8005367</pub-id><pub-id pub-id-type="pmid">33778910</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></name></person-group>. <article-title>Diabetes Increases the Mortality of Patients With COVID-19: A Meta-Analysis</article-title>. <source>Acta Diabetol</source> (<year>2021</year>) <volume>58</volume>(<issue>2</issue>):<page-range>139&#8211;44</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00592-020-01546-0</pub-id><pub-id pub-id-type="pmcid">PMC7311595</pub-id><pub-id pub-id-type="pmid">32583078</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varikasuvu</surname><given-names>SR</given-names></name><name name-style="western"><surname>Dutt</surname><given-names>N</given-names></name><name name-style="western"><surname>Thangappazham</surname><given-names>B</given-names></name><name name-style="western"><surname>Varshney</surname><given-names>S</given-names></name></person-group>. <article-title>Diabetes and COVID-19: A Pooled Analysis Related to Disease Severity and Mortality</article-title>. <source>Prim Care Diabetes</source> (<year>2021</year>) <volume>15</volume>(<issue>1</issue>):<page-range>24&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.pcd.2020.08.015</pub-id><pub-id pub-id-type="pmcid">PMC7456278</pub-id><pub-id pub-id-type="pmid">32891525</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palaiodimos</surname><given-names>L</given-names></name><name name-style="western"><surname>Chamorro-Pareja</surname><given-names>N</given-names></name><name name-style="western"><surname>Karamanis</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Zavras</surname><given-names>PD</given-names></name><name name-style="western"><surname>Chang</surname><given-names>KM</given-names></name><etal/></person-group>. <article-title>Diabetes is Associated With Increased Risk for in-Hospital Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis Comprising 18,506 Patients</article-title>. <source>Hormones (Athens)</source> (<year>2021</year>) <volume>20</volume>(<issue>2</issue>):<page-range>305&#8211;14</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s42000-020-00246-2</pub-id><pub-id pub-id-type="pmcid">PMC7595056</pub-id><pub-id pub-id-type="pmid">33123973</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silverio</surname><given-names>A</given-names></name><name name-style="western"><surname>Di Maio</surname><given-names>M</given-names></name><name name-style="western"><surname>Citro</surname><given-names>R</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>L</given-names></name><name name-style="western"><surname>Iuliano</surname><given-names>G</given-names></name><name name-style="western"><surname>Bellino</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Cardiovascular Risk Factors and Mortality in Hospitalized Patients With COVID-19: Systematic Review and Meta-Analysis of 45 Studies and 18,300 Patients</article-title>. <source>BMC Cardiovasc Disord</source> (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>23</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s12872-020-01816-3</pub-id><pub-id pub-id-type="pmid">33413093</pub-id><pub-id pub-id-type="pmcid">PMC7789083</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>CD</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>MH</given-names></name><name name-style="western"><surname>Targher</surname><given-names>G</given-names></name></person-group>. <article-title>Diabetes as a Risk Factor for Greater COVID-19 Severity and in-Hospital Death: A Meta-Analysis of Observational Studies</article-title>. <source>Nutr Metab Cardiovasc Dis</source> (<year>2020</year>) <volume>30</volume>(<issue>8</issue>):<page-range>1236&#8211;48</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.numecd.2020.05.014</pub-id><pub-id pub-id-type="pmcid">PMC7258796</pub-id><pub-id pub-id-type="pmid">32571616</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasani</surname><given-names>WSR</given-names></name><name name-style="western"><surname>Ganapathy</surname><given-names>SS</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CZ</given-names></name><name name-style="western"><surname>Rifin</surname><given-names>HM</given-names></name><name name-style="western"><surname>Bahari</surname><given-names>MN</given-names></name><name name-style="western"><surname>Ghazali</surname><given-names>MH</given-names></name><etal/></person-group>. <article-title>Comorbidities and Clinical Features Related to Severe Outcomes Among COVID-19 Cases in Selangor, Malaysia</article-title>. <source>Western Pac Surveill Response J</source> (<year>2021</year>) <volume>12</volume>(<issue>1</issue>):<fpage>46</fpage>&#8211;<lpage>52</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.5365/wpsar.2020.11.3.007</pub-id><pub-id pub-id-type="pmid">34094624</pub-id><pub-id pub-id-type="pmcid">PMC8143935</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>SR</given-names></name><name name-style="western"><surname>Nam</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YR</given-names></name></person-group>. <article-title>Risk Factors on the Progression to Clinical Outcomes of COVID-19 Patients in South Korea: Using National Data</article-title>. <source>Int J Environ Res Public Health</source> (<year>2020</year>) <volume>17</volume>(<issue>23</issue>):<elocation-id>8847</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/ijerph17238847</pub-id><pub-id pub-id-type="pmid">33260724</pub-id><pub-id pub-id-type="pmcid">PMC7730903</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrilli</surname><given-names>CM</given-names></name><name name-style="western"><surname>Jones</surname><given-names>SA</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Rajagopalan</surname><given-names>H</given-names></name><name name-style="western"><surname>O'Donnell</surname><given-names>L</given-names></name><name name-style="western"><surname>Chernyak</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Factors Associated With Hospital Admission and Critical Illness Among 5279 People With Coronavirus Disease 2019 in New York City: Prospective Cohort Study</article-title>. <source>BMJ</source> (<year>2020</year>) <volume>369</volume>:<elocation-id>m1966</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmj.m1966</pub-id><pub-id pub-id-type="pmid">32444366</pub-id><pub-id pub-id-type="pmcid">PMC7243801</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tchang</surname><given-names>BG</given-names></name><name name-style="western"><surname>Askin</surname><given-names>G</given-names></name><name name-style="western"><surname>Sahagun</surname><given-names>A</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Mendelsohn Curanaj</surname><given-names>FA</given-names></name><etal/></person-group>. <article-title>The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study</article-title>. <source>Obesity (Silver Spring)</source> (<year>2021</year>) <volume>29</volume>(<issue>6</issue>):<page-range>971&#8211;5</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/oby.23172</pub-id><pub-id pub-id-type="pmcid">PMC8206993</pub-id><pub-id pub-id-type="pmid">33694267</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrera</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Shekhar</surname><given-names>S</given-names></name><name name-style="western"><surname>Wurth</surname><given-names>R</given-names></name><name name-style="western"><surname>Moreno-Pena</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Ponce</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Hajdenberg</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients</article-title>. <source>J Endocr Soc</source> (<year>2020</year>) <volume>4</volume>(<issue>9</issue>):<elocation-id>bvaa102</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1210/jendso/bvaa102</pub-id><pub-id pub-id-type="pmid">32885126</pub-id><pub-id pub-id-type="pmcid">PMC7454711</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asfahan</surname><given-names>S</given-names></name><name name-style="western"><surname>Deokar</surname><given-names>K</given-names></name><name name-style="western"><surname>Dutt</surname><given-names>N</given-names></name><name name-style="western"><surname>Niwas</surname><given-names>R</given-names></name><name name-style="western"><surname>Jain</surname><given-names>P</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>M</given-names></name></person-group>. <article-title>Extrapolation of Mortality in COVID-19: Exploring the Role of Age, Sex, Co-Morbidities and Health-Care Related Occupation</article-title>. <source>Monaldi Arch Chest Dis</source> (<year>2020</year>) <volume>90</volume>(<issue>2</issue>). doi:&#160;<pub-id pub-id-type="doi">10.4081/monaldi.2020.1325</pub-id><pub-id pub-id-type="pmid">32447949</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>S</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name></person-group>. <article-title>Estimation of Case-Fatality Rate in COVID-19 Patients With Hypertension and Diabetes Mellitus in the New York State: A Preliminary Report</article-title>. <source>Epidemiol Infect</source> (<year>2021</year>) <volume>149</volume>:<fpage>e14</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1017/S0950268821000066</pub-id><pub-id pub-id-type="pmid">33413720</pub-id><pub-id pub-id-type="pmcid">PMC7844175</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woolcott</surname><given-names>OO</given-names></name><name name-style="western"><surname>Castilla-Bancayan</surname><given-names>JP</given-names></name></person-group>. <article-title>The Effect of Age on the Association Between Diabetes and Mortality in Adult Patients With COVID-19 in Mexico</article-title>. <source>Sci Rep</source> (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>8386</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1038/s41598-021-88014-z</pub-id><pub-id pub-id-type="pmid">33863997</pub-id><pub-id pub-id-type="pmcid">PMC8052362</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corona</surname><given-names>G</given-names></name><name name-style="western"><surname>Pizzocaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Vena</surname><given-names>W</given-names></name><name name-style="western"><surname>Rastrelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Semeraro</surname><given-names>F</given-names></name><name name-style="western"><surname>Isidori</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Diabetes is Most Important Cause for Mortality in COVID-19 Hospitalized Patients: Systematic Review and Meta-Analysis</article-title>. <source>Rev Endocr Metab Disord</source> (<year>2021</year>) <volume>22</volume>(<issue>2</issue>):<page-range>275&#8211;96</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s11154-021-09630-8</pub-id><pub-id pub-id-type="pmcid">PMC7899074</pub-id><pub-id pub-id-type="pmid">33616801</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sousa</surname><given-names>GJB</given-names></name><name name-style="western"><surname>Garces</surname><given-names>TS</given-names></name><name name-style="western"><surname>Cestari</surname><given-names>VRF</given-names></name><name name-style="western"><surname>Florencio</surname><given-names>RS</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>TMM</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>MLD</given-names></name></person-group>. <article-title>Mortality and Survival of COVID-19</article-title>. <source>Epidemiol Infect</source> (<year>2020</year>) <volume>148</volume>:<fpage>e123</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1017/S0950268820001405</pub-id><pub-id pub-id-type="pmid">32580809</pub-id><pub-id pub-id-type="pmcid">PMC7330281</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahlstrom</surname><given-names>B</given-names></name><name name-style="western"><surname>Frithiof</surname><given-names>R</given-names></name><name name-style="western"><surname>Hultstrom</surname><given-names>M</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>IM</given-names></name><name name-style="western"><surname>Strandberg</surname><given-names>G</given-names></name><name name-style="western"><surname>Lipcsey</surname><given-names>M</given-names></name></person-group>. <article-title>The Swedish Covid-19 Intensive Care Cohort: Risk Factors of ICU Admission and ICU Mortality</article-title>. <source>Acta Anaesthesiol Scand</source> (<year>2021</year>) <volume>65</volume>(<issue>4</issue>):<page-range>525&#8211;33</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/aas.13781</pub-id><pub-id pub-id-type="pmcid">PMC8013403</pub-id><pub-id pub-id-type="pmid">33438198</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos-Rincon</surname><given-names>JM</given-names></name><name name-style="western"><surname>Buonaiuto</surname><given-names>V</given-names></name><name name-style="western"><surname>Ricci</surname><given-names>M</given-names></name><name name-style="western"><surname>Martin-Carmona</surname><given-names>J</given-names></name><name name-style="western"><surname>Paredes-Ruiz</surname><given-names>D</given-names></name><name name-style="western"><surname>Calderon-Moreno</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain</article-title>. <source>J&#160;Gerontol A Biol Sci Med Sci</source> (<year>2021</year>) <volume>76</volume>(<issue>3</issue>):<page-range>e28&#8211;37</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1093/gerona/glaa243</pub-id><pub-id pub-id-type="pmcid">PMC7797762</pub-id><pub-id pub-id-type="pmid">33103720</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Gillies</surname><given-names>CL</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Chudasama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Coles</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Prevalence of Co-Morbidities and Their Association With Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>Diabetes Obes Metab</source> (<year>2020</year>) <volume>22</volume>(<issue>10</issue>):<page-range>1915&#8211;24</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/dom.14124</pub-id><pub-id pub-id-type="pmcid">PMC7361304</pub-id><pub-id pub-id-type="pmid">32573903</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bajgain</surname><given-names>KT</given-names></name><name name-style="western"><surname>Badal</surname><given-names>S</given-names></name><name name-style="western"><surname>Bajgain</surname><given-names>BB</given-names></name><name name-style="western"><surname>Santana</surname><given-names>MJ</given-names></name></person-group>. <article-title>Prevalence of Comorbidities Among Individuals With COVID-19: A Rapid Review of Current Literature</article-title>. <source>Am J Infect Control</source> (<year>2021</year>) <volume>49</volume>(<issue>2</issue>):<page-range>238&#8211;46</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.ajic.2020.06.213</pub-id><pub-id pub-id-type="pmcid">PMC7351042</pub-id><pub-id pub-id-type="pmid">32659414</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cariou</surname><given-names>B</given-names></name><name name-style="western"><surname>Hadjadj</surname><given-names>S</given-names></name><name name-style="western"><surname>Wargny</surname><given-names>M</given-names></name><name name-style="western"><surname>Pichelin</surname><given-names>M</given-names></name><name name-style="western"><surname>Al-Salameh</surname><given-names>A</given-names></name><name name-style="western"><surname>Allix</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Phenotypic Characteristics and Prognosis of Inpatients With COVID-19 and Diabetes: The CORONADO Study</article-title>. <source>Diabetologia</source> (<year>2020</year>) <volume>63</volume>(<issue>8</issue>):<page-range>1500&#8211;15</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00125-020-05180-x</pub-id><pub-id pub-id-type="pmcid">PMC7256180</pub-id><pub-id pub-id-type="pmid">32472191</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wargny</surname><given-names>M</given-names></name><name name-style="western"><surname>Gourdy</surname><given-names>P</given-names></name><name name-style="western"><surname>Ludwig</surname><given-names>L</given-names></name><name name-style="western"><surname>Seret-Begue</surname><given-names>D</given-names></name><name name-style="western"><surname>Bourron</surname><given-names>O</given-names></name><name name-style="western"><surname>Darmon</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>11</issue>):<page-range>e174&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1217</pub-id><pub-id pub-id-type="pmcid">PMC7576421</pub-id><pub-id pub-id-type="pmid">32847826</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holman</surname><given-names>N</given-names></name><name name-style="western"><surname>Knighton</surname><given-names>P</given-names></name><name name-style="western"><surname>Kar</surname><given-names>P</given-names></name><name name-style="western"><surname>O'Keefe</surname><given-names>J</given-names></name><name name-style="western"><surname>Curley</surname><given-names>M</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Risk Factors for COVID-19-Related Mortality in People With Type 1 and Type 2 Diabetes in England: A Population-Based Cohort Study</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2020</year>) <volume>8</volume>(<issue>10</issue>):<page-range>823&#8211;33</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S2213-8587(20)30271-0</pub-id><pub-id pub-id-type="pmcid">PMC7426091</pub-id><pub-id pub-id-type="pmid">32798471</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGurnaghan</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Weir</surname><given-names>A</given-names></name><name name-style="western"><surname>Bishop</surname><given-names>J</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>S</given-names></name><name name-style="western"><surname>Blackbourn</surname><given-names>LAK</given-names></name><name name-style="western"><surname>McAllister</surname><given-names>DA</given-names></name><etal/></person-group>. <article-title>Risks of and Risk Factors for COVID-19 Disease in People With Diabetes: A Cohort Study of the Total Population of Scotland</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2021</year>) <volume>9</volume>(<issue>2</issue>):<fpage>82</fpage>&#8211;<lpage>93</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S2213-8587(20)30405-8</pub-id><pub-id pub-id-type="pmid">33357491</pub-id><pub-id pub-id-type="pmcid">PMC7832778</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altonen</surname><given-names>BL</given-names></name><name name-style="western"><surname>Arreglado</surname><given-names>TM</given-names></name><name name-style="western"><surname>Leroux</surname><given-names>O</given-names></name><name name-style="western"><surname>Murray-Ramcharan</surname><given-names>M</given-names></name><name name-style="western"><surname>Engdahl</surname><given-names>R</given-names></name></person-group>. <article-title>Characteristics, Comorbidities and Survival Analysis of Young Adults Hospitalized With COVID-19 in New York City</article-title>. <source>PloS One</source> (<year>2020</year>) <volume>15</volume>(<issue>12</issue>):<elocation-id>e0243343</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0243343</pub-id><pub-id pub-id-type="pmid">33315929</pub-id><pub-id pub-id-type="pmcid">PMC7735602</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>M</given-names></name><name name-style="western"><surname>Lin</surname><given-names>K</given-names></name><name name-style="western"><surname>Pi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Fan</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients With Diabetes</article-title>. <source>J Diabetes Res</source> (<year>2020</year>) <volume>2020</volume>:<elocation-id>5237840</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1155/2020/5237840</pub-id><pub-id pub-id-type="pmid">33381599</pub-id><pub-id pub-id-type="pmcid">PMC7755491</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Hayek</surname><given-names>AA</given-names></name><name name-style="western"><surname>Robert</surname><given-names>AA</given-names></name><name name-style="western"><surname>Matar</surname><given-names>AB</given-names></name><name name-style="western"><surname>Algarni</surname><given-names>A</given-names></name><name name-style="western"><surname>Alkubedan</surname><given-names>H</given-names></name><name name-style="western"><surname>Alharbi</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Risk Factors for Hospital Admission Among COVID-19 Patients With Diabetes. A Study From Saudi Arabia</article-title>. <source>Saudi Med J</source> (<year>2020</year>) <volume>41</volume>(<issue>10</issue>):<page-range>1090&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.15537/smj.2020.10.25419</pub-id><pub-id pub-id-type="pmcid">PMC7841525</pub-id><pub-id pub-id-type="pmid">33026050</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X</given-names></name><name name-style="western"><surname>Han</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The Association of Diabetes and the Prognosis of COVID-19 Patients: A Retrospective Study</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>169</volume>:<elocation-id>108386</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108386</pub-id><pub-id pub-id-type="pmid">32853685</pub-id><pub-id pub-id-type="pmcid">PMC7445120</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>DW</given-names></name></person-group>. <article-title>Association of Glycosylated Haemoglobin HbA1c Levels With Outcome in Patients With COVID-19: A Retrospective Study</article-title>. <source>J Cell Mol Med</source> (<year>2021</year>) <volume>25</volume>(<issue>7</issue>):<page-range>3484&#8211;97</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/jcmm.16431</pub-id><pub-id pub-id-type="pmcid">PMC8034481</pub-id><pub-id pub-id-type="pmid">33694276</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>S</given-names></name><name name-style="western"><surname>Schechter</surname><given-names>C</given-names></name><name name-style="western"><surname>Southern</surname><given-names>W</given-names></name><name name-style="western"><surname>Crandall</surname><given-names>JP</given-names></name><name name-style="western"><surname>Tomer</surname><given-names>Y</given-names></name></person-group>. <article-title>Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>10</issue>):<page-range>2339&#8211;44</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1543</pub-id><pub-id pub-id-type="pmcid">PMC7510015</pub-id><pub-id pub-id-type="pmid">32769128</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koh</surname><given-names>H</given-names></name><name name-style="western"><surname>Moh</surname><given-names>AMC</given-names></name><name name-style="western"><surname>Yeoh</surname><given-names>E</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Low</surname><given-names>SKM</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>ST</given-names></name><etal/></person-group>. <article-title>Diabetes Predicts Severity of COVID-19 Infection in a Retrospective Cohort: A Mediatory Role of the Inflammatory Biomarker C-Reactive Protein</article-title>. <source>J Med Virol</source> (<year>2021</year>) <volume>93</volume>(<issue>5</issue>):<page-range>3023&#8211;32</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jmv.26837</pub-id><pub-id pub-id-type="pmcid">PMC8013709</pub-id><pub-id pub-id-type="pmid">33527464</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lasbleiz</surname><given-names>A</given-names></name><name name-style="western"><surname>Cariou</surname><given-names>B</given-names></name><name name-style="western"><surname>Darmon</surname><given-names>P</given-names></name><name name-style="western"><surname>Soghomonian</surname><given-names>A</given-names></name><name name-style="western"><surname>Ancel</surname><given-names>P</given-names></name><name name-style="western"><surname>Boullu</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients With Diabetes and COVID-19: The DIABCOVID Study</article-title>. <source>J Clin Med</source> (<year>2020</year>) <volume>9</volume>(<issue>11</issue>):<elocation-id>3726</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/jcm9113726</pub-id><pub-id pub-id-type="pmid">33233575</pub-id><pub-id pub-id-type="pmcid">PMC7699790</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>P</given-names></name><name name-style="western"><surname>Luo</surname><given-names>S</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Cai</surname><given-names>G</given-names></name><name name-style="western"><surname>Weng</surname><given-names>J</given-names></name></person-group>. <article-title>Elevated Fasting Blood Glucose Within the First Week of Hospitalization was Associated With Progression to Severe Illness of COVID-19 in Patients With Preexisting Diabetes: A Multicenter Observational Study</article-title>. <source>J Diabetes</source> (<year>2021</year>) <volume>13</volume>(<issue>1</issue>):<fpage>89</fpage>&#8211;<lpage>93</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1111/1753-0407.13121</pub-id><pub-id pub-id-type="pmid">33040469</pub-id><pub-id pub-id-type="pmcid">PMC7675481</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raoufi</surname><given-names>M</given-names></name><name name-style="western"><surname>Khalili</surname><given-names>S</given-names></name><name name-style="western"><surname>Mansouri</surname><given-names>M</given-names></name><name name-style="western"><surname>Mahdavi</surname><given-names>A</given-names></name><name name-style="western"><surname>Khalili</surname><given-names>N</given-names></name></person-group>. <article-title>Well-Controlled vs Poorly-Controlled Diabetes in Patients With COVID-19: Are There Any Differences in Outcomes and Imaging Findings</article-title>? <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>166</volume>:<elocation-id>108286</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108286</pub-id><pub-id pub-id-type="pmid">32592836</pub-id><pub-id pub-id-type="pmcid">PMC7314673</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarigumba</surname><given-names>M</given-names></name><name name-style="western"><surname>Aragon</surname><given-names>J</given-names></name><name name-style="western"><surname>Kanapi</surname><given-names>MP</given-names></name></person-group>. <article-title>Baseline Glycemic Status and Outcome of Persons With Type 2 Diabetes With COVID-19 Infections: A Single-Center Retrospective Study</article-title>. <source>J ASEAN Fed Endocr Soc</source> (<year>2021</year>) <volume>36</volume>(<issue>1</issue>):<page-range>45&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.15605/jafes.036.01.06</pub-id><pub-id pub-id-type="pmcid">PMC8214355</pub-id><pub-id pub-id-type="pmid">34177087</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seiglie</surname><given-names>J</given-names></name><name name-style="western"><surname>Platt</surname><given-names>J</given-names></name><name name-style="western"><surname>Cromer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Bunda</surname><given-names>B</given-names></name><name name-style="western"><surname>Foulkes</surname><given-names>AS</given-names></name><name name-style="western"><surname>Bassett</surname><given-names>IV</given-names></name><etal/></person-group>. <article-title>Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>12</issue>):<page-range>2938&#8211;44</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1506</pub-id><pub-id pub-id-type="pmcid">PMC7770271</pub-id><pub-id pub-id-type="pmid">32847827</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prattichizzo</surname><given-names>F</given-names></name><name name-style="western"><surname>de Candia</surname><given-names>P</given-names></name><name name-style="western"><surname>Nicolucci</surname><given-names>A</given-names></name><name name-style="western"><surname>Ceriello</surname><given-names>A</given-names></name></person-group>. <article-title>Elevated HbA1c Levels in Pre-Covid-19 Infection Increases the Risk of Mortality: A Sistematic Review and Meta-Analysis</article-title>. <source>Diabetes Metab Res Rev</source> (<year>2021</year>) <volume>38</volume>(<issue>1</issue>):<elocation-id>e3476</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1002/dmrr.3476</pub-id><pub-id pub-id-type="pmid">34018307</pub-id><pub-id pub-id-type="pmcid">PMC8209812</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name></person-group>. <article-title>Predictive Value of HbA1c for in-Hospital Adverse Prognosis in COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>Prim Care Diabetes</source> (<year>2021</year>) <volume>15</volume>(<issue>6</issue>):<page-range>910&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.pcd.2021.07.013</pub-id><pub-id pub-id-type="pmcid">PMC8354788</pub-id><pub-id pub-id-type="pmid">34420899</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Peng</surname><given-names>A</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>7</issue>):<page-range>1399&#8211;407</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-0660</pub-id><pub-id pub-id-type="pmid">32409498</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>T</given-names></name><name name-style="western"><surname>Ruddiman</surname><given-names>K</given-names></name><name name-style="western"><surname>Lo</surname><given-names>KB</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>E</given-names></name><name name-style="western"><surname>DeJoy</surname><given-names>R</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Salacup</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>The Relationship Between Diabetes and Clinical Outcomes in COVID-19: A Single-Center Retrospective Analysis</article-title>. <source>Acta Diabetol</source> (<year>2021</year>) <volume>58</volume>(<issue>1</issue>):<page-range>33&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00592-020-01592-8</pub-id><pub-id pub-id-type="pmcid">PMC7429932</pub-id><pub-id pub-id-type="pmid">32804317</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pettrone</surname><given-names>K</given-names></name><name name-style="western"><surname>Burnett</surname><given-names>E</given-names></name><name name-style="western"><surname>Link-Gelles</surname><given-names>R</given-names></name><name name-style="western"><surname>Haight</surname><given-names>SC</given-names></name><name name-style="western"><surname>Schrodt</surname><given-names>C</given-names></name><name name-style="western"><surname>England</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March-April 2020</article-title>. <source>Emerg Infect Dis</source> (<year>2021</year>) <volume>27</volume>(<issue>4</issue>):<page-range>1164&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.3201/eid2704.204709</pub-id><pub-id pub-id-type="pmcid">PMC8007327</pub-id><pub-id pub-id-type="pmid">33754981</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rastad</surname><given-names>H</given-names></name><name name-style="western"><surname>Ejtahed</surname><given-names>HS</given-names></name><name name-style="western"><surname>Mahdavi-Ghorabi</surname><given-names>A</given-names></name><name name-style="western"><surname>Arzaghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Safari</surname><given-names>A</given-names></name><name name-style="western"><surname>Shahrestanaki</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Factors Associated With the Poor Outcomes in Diabetic Patients With COVID-19</article-title>. <source>J Diabetes Metab Disord</source> (<year>2020</year>) <volume>19</volume>(<issue>2</issue>):<page-range>1293&#8211;302</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s40200-020-00646-6</pub-id><pub-id pub-id-type="pmcid">PMC7546599</pub-id><pub-id pub-id-type="pmid">33072634</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wan</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China</article-title>. <source>Am J Med</source> (<year>2021</year>) <volume>134</volume>(<issue>1</issue>):<fpage>e6</fpage>&#8211;<lpage>e14</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.amjmed.2020.05.033</pub-id><pub-id pub-id-type="pmid">32653423</pub-id><pub-id pub-id-type="pmcid">PMC7350644</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tchang</surname><given-names>BG</given-names></name><name name-style="western"><surname>Lam</surname><given-names>T</given-names></name><name name-style="western"><surname>Steller</surname><given-names>I</given-names></name><name name-style="western"><surname>Touhamy</surname><given-names>S</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Askin</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Preadmission Predictors of Severe COVID-19 in Patients With Diabetes Mellitus</article-title>. <source>J Diabetes Complications</source> (<year>2021</year>) <volume>35</volume>(<issue>8</issue>):<elocation-id>107967</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2021.107967</pub-id><pub-id pub-id-type="pmid">34099384</pub-id><pub-id pub-id-type="pmcid">PMC8162023</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlesinger</surname><given-names>S</given-names></name><name name-style="western"><surname>Neuenschwander</surname><given-names>M</given-names></name><name name-style="western"><surname>Lang</surname><given-names>A</given-names></name><name name-style="western"><surname>Pafili</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuss</surname><given-names>O</given-names></name><name name-style="western"><surname>Herder</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Risk Phenotypes of Diabetes and Association With COVID-19 Severity and Death: A Living Systematic Review and Meta-Analysis</article-title>. <source>Diabetologia</source> (<year>2021</year>) <volume>64</volume>(<issue>7</issue>):<page-range>1480&#8211;91</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00125-021-05458-8</pub-id><pub-id pub-id-type="pmcid">PMC8079163</pub-id><pub-id pub-id-type="pmid">33907860</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riahi</surname><given-names>S</given-names></name><name name-style="western"><surname>Sombra</surname><given-names>LRS</given-names></name><name name-style="western"><surname>Lo</surname><given-names>KB</given-names></name><name name-style="western"><surname>Chacko</surname><given-names>SR</given-names></name><name name-style="western"><surname>Neto</surname><given-names>AGM</given-names></name><name name-style="western"><surname>Azmaiparashvili</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Insulin Use, Diabetes Control, and Outcomes in Patients With COVID-19</article-title>. <source>Endocr Res</source> (<year>2021</year>) <volume>46</volume>(<issue>2</issue>):<fpage>45</fpage>&#8211;<lpage>50</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1080/07435800.2020.1856865</pub-id><pub-id pub-id-type="pmid">33275067</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghany</surname><given-names>R</given-names></name><name name-style="western"><surname>Palacio</surname><given-names>A</given-names></name><name name-style="western"><surname>Dawkins</surname><given-names>E</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>McCarter</surname><given-names>D</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Metformin is Associated With Lower Hospitalizations, Mortality and Severe Coronavirus Infection Among Elderly Medicare Minority Patients in 8 States in USA</article-title>. <source>Diabetes Metab Syndr</source> (<year>2021</year>) <volume>15</volume>(<issue>2</issue>):<page-range>513&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2021.02.022</pub-id><pub-id pub-id-type="pmcid">PMC7891082</pub-id><pub-id pub-id-type="pmid">33662839</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>WX</given-names></name><name name-style="western"><surname>McCowen</surname><given-names>KC</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19</article-title>. <source>Endocr Pract</source> (<year>2020</year>) <volume>26</volume>(<issue>10</issue>):<page-range>1166&#8211;72</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.4158/EP-2020-0466</pub-id><pub-id pub-id-type="pmcid">PMC7834011</pub-id><pub-id pub-id-type="pmid">33471718</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>P</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>XL</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>JL</given-names></name><name name-style="western"><surname>Xue</surname><given-names>HY</given-names></name><etal/></person-group>. <article-title>Metformin Treatment Was Associated With Decreased Mortality in COVID-19 Patients With Diabetes in a Retrospective Analysis</article-title>. <source>Am J Trop Med Hyg</source> (<year>2020</year>) <volume>103</volume>(<issue>1</issue>):<fpage>69</fpage>&#8211;<lpage>72</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.4269/ajtmh.20-0375</pub-id><pub-id pub-id-type="pmid">32446312</pub-id><pub-id pub-id-type="pmcid">PMC7356425</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Xin</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Effects of Metformin, Insulin on COVID-19 Patients With Pre-Existed Type 2 Diabetes: A Multicentral Retrospective Study</article-title>. <source>Life Sci</source> (<year>2021</year>) <volume>275</volume>:<elocation-id>119371</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.lfs.2021.119371</pub-id><pub-id pub-id-type="pmid">33745895</pub-id><pub-id pub-id-type="pmcid">PMC7972834</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kow</surname><given-names>CS</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>SS</given-names></name></person-group>. <article-title>Mortality Risk With Preadmission Metformin Use in Patients With COVID-19 and Diabetes: A Meta-Analysis</article-title>. <source>J Med Virol</source> (<year>2021</year>) <volume>93</volume>(<issue>2</issue>):<page-range>695&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jmv.26498</pub-id><pub-id pub-id-type="pmid">32902868</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>TK</given-names></name><name name-style="western"><surname>Song</surname><given-names>IA</given-names></name></person-group>. <article-title>Metformin Use and Risk of COVID-19 Among Patients With Type II Diabetes Mellitus: An NHIS-COVID-19 Database Cohort Study</article-title>. <source>Acta Diabetol</source> (<year>2021</year>) <volume>58</volume>(<issue>6</issue>):<page-range>771&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00592-020-01666-7</pub-id><pub-id pub-id-type="pmcid">PMC7882044</pub-id><pub-id pub-id-type="pmid">33582839</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>T</given-names></name><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Qu</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>The Association Between Anti-Diabetic Agents and Clinical Outcomes of COVID-19 in Patients With Diabetes: A Systematic Review and Meta-Analysis</article-title>. <source>Arch Med Res</source> (<year>2021</year>) <elocation-id>S0188-4409(21)00167-3</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.arcmed.2021.08.002</pub-id><pub-id pub-id-type="pmcid">PMC8349690</pub-id><pub-id pub-id-type="pmid">34412904</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kan</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>F</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ye</surname><given-names>T</given-names></name><name name-style="western"><surname>Hou</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>708494</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fendo.2021.708494</pub-id><pub-id pub-id-type="pmid">34603199</pub-id><pub-id pub-id-type="pmcid">PMC8481667</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos-Rincon</surname><given-names>JM</given-names></name><name name-style="western"><surname>Perez-Belmonte</surname><given-names>LM</given-names></name><name name-style="western"><surname>Carrasco-Sanchez</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Jansen-Chaparro</surname><given-names>S</given-names></name><name name-style="western"><surname>De-Sousa-Baena</surname><given-names>M</given-names></name><name name-style="western"><surname>Bueno-Fonseca</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Cardiometabolic Therapy and Mortality in Very Old Patients With Diabetes Hospitalized Due to COVID-19</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> (<year>2021</year>) <volume>76</volume>(<issue>8</issue>):<page-range>e102&#8211;e9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1093/gerona/glab124</pub-id><pub-id pub-id-type="pmcid">PMC8135901</pub-id><pub-id pub-id-type="pmid">33945610</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirani</surname><given-names>M</given-names></name><name name-style="western"><surname>Favacchio</surname><given-names>G</given-names></name><name name-style="western"><surname>Carrone</surname><given-names>F</given-names></name><name name-style="western"><surname>Betella</surname><given-names>N</given-names></name><name name-style="western"><surname>Biamonte</surname><given-names>E</given-names></name><name name-style="western"><surname>Morenghi</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>12</issue>):<page-range>3042&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1340</pub-id><pub-id pub-id-type="pmid">33023989</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emral</surname><given-names>R</given-names></name><name name-style="western"><surname>Haymana</surname><given-names>C</given-names></name><name name-style="western"><surname>Demirci</surname><given-names>I</given-names></name><name name-style="western"><surname>Tasci</surname><given-names>I</given-names></name><name name-style="western"><surname>Sahin</surname><given-names>M</given-names></name><name name-style="western"><surname>Cakal</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Lower COVID-19 Mortality in Patients With Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results From a Turkish Nationwide Study</article-title>. <source>Diabetes Ther</source> (<year>2021</year>) <volume>12</volume>(<issue>11</issue>):<page-range>2857&#8211;70</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s13300-021-01133-8</pub-id><pub-id pub-id-type="pmcid">PMC8365288</pub-id><pub-id pub-id-type="pmid">34398433</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>R</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>M</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhogal</surname><given-names>RS</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>A</given-names></name><name name-style="western"><surname>Bhadada</surname><given-names>SK</given-names></name></person-group>. <article-title>Dipeptidyl Peptidase-4 Inhibitor Use and Mortality in COVID-19 Patients With Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis</article-title>. <source>Ther Adv Endocrinol Metab</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>2042018821996482</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1177/2042018821996482</pub-id><pub-id pub-id-type="pmid">33680425</pub-id><pub-id pub-id-type="pmcid">PMC7897812</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rastad</surname><given-names>H</given-names></name><name name-style="western"><surname>Karim</surname><given-names>H</given-names></name><name name-style="western"><surname>Ejtahed</surname><given-names>HS</given-names></name><name name-style="western"><surname>Tajbakhsh</surname><given-names>R</given-names></name><name name-style="western"><surname>Noorisepehr</surname><given-names>M</given-names></name><name name-style="western"><surname>Babaei</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Risk and Predictors of in-Hospital Mortality From COVID-19 in Patients With Diabetes and Cardiovascular Disease</article-title>. <source>Diabetol Metab Syndr</source> (<year>2020</year>) <volume>12</volume>:<fpage>57</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s13098-020-00565-9</pub-id><pub-id pub-id-type="pmid">32641974</pub-id><pub-id pub-id-type="pmcid">PMC7338100</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yue</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>G</given-names></name></person-group>. <article-title>Hyperglycemia Associated With Lymphopenia and Disease Severity of COVID-19 in Type 2 Diabetes Mellitus</article-title>. <source>J Diabetes Complications</source> (<year>2021</year>) <volume>35</volume>(<issue>2</issue>):<elocation-id>107809</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2020.107809</pub-id><pub-id pub-id-type="pmid">33288414</pub-id><pub-id pub-id-type="pmcid">PMC7690319</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhar</surname><given-names>SK</given-names></name><name name-style="western"><surname>Sachdeva</surname><given-names>K</given-names></name><name name-style="western"><surname>Das</surname><given-names>M</given-names></name></person-group>. <article-title>Inflammation and Hypercoagulopathy Are Predominant Risk Factors of Severity in COVID-19 Patients With Diabetes Mellitus: Summary of a Meta-Analysis</article-title>. <source>Diabetes Metab Syndr</source> (<year>2021</year>) <volume>15</volume>(<issue>2</issue>):<page-range>639&#8211;41</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2021.02.021</pub-id><pub-id pub-id-type="pmcid">PMC7903900</pub-id><pub-id pub-id-type="pmid">33676871</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dennis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mateen</surname><given-names>BA</given-names></name><name name-style="western"><surname>Sonabend</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Patel</surname><given-names>KA</given-names></name><name name-style="western"><surname>Hattersley</surname><given-names>AT</given-names></name><etal/></person-group>. <article-title>Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020</article-title>. <source>Diabetes Care</source> (<year>2021</year>) <volume>44</volume>(<issue>1</issue>):<page-range>50&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1444</pub-id><pub-id pub-id-type="pmcid">PMC7783930</pub-id><pub-id pub-id-type="pmid">33097559</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barron</surname><given-names>E</given-names></name><name name-style="western"><surname>Bakhai</surname><given-names>C</given-names></name><name name-style="western"><surname>Kar</surname><given-names>P</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>A</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>D</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Associations of Type 1 and Type 2 Diabetes With COVID-19-Related Mortality in England: A Whole-Population Study</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2020</year>) <volume>8</volume>(<issue>10</issue>):<page-range>813&#8211;22</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S2213-8587(20)30272-2</pub-id><pub-id pub-id-type="pmcid">PMC7426088</pub-id><pub-id pub-id-type="pmid">32798472</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes A</collab></person-group>. <article-title>Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>Suppl 1</issue>):<page-range>S14&#8211;31</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-S002</pub-id><pub-id pub-id-type="pmid">31862745</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCowen</surname><given-names>KC</given-names></name><name name-style="western"><surname>Malhotra</surname><given-names>A</given-names></name><name name-style="western"><surname>Bistrian</surname><given-names>BR</given-names></name></person-group>. <article-title>Stress-Induced Hyperglycemia</article-title>. <source>Crit Care Clin</source> (<year>2001</year>) <volume>17</volume>(<issue>1</issue>):<page-range>107&#8211;24</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/s0749-0704(05)70154-8</pub-id><pub-id pub-id-type="pmid">11219223</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Yi</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Fasting Blood Glucose Level is a Predictor of Mortality in Patients With COVID-19 Independent of Diabetes History</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>169</volume>:<elocation-id>108437</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108437</pub-id><pub-id pub-id-type="pmid">32920103</pub-id><pub-id pub-id-type="pmcid">PMC7482587</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kwak</surname><given-names>SG</given-names></name><name name-style="western"><surname>Park</surname><given-names>D</given-names></name><name name-style="western"><surname>Moon</surname><given-names>JS</given-names></name></person-group>. <article-title>Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients With Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study</article-title>. <source>Endocrinol Metab (Seoul)</source> (<year>2020</year>) <volume>35</volume>(<issue>3</issue>):<fpage>595</fpage>&#8211;<lpage>601</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.3803/EnM.2020.719</pub-id><pub-id pub-id-type="pmid">32842719</pub-id><pub-id pub-id-type="pmcid">PMC7520580</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Boppana</surname><given-names>A</given-names></name><name name-style="western"><surname>Traupman</surname><given-names>JA</given-names></name><name name-style="western"><surname>Unson</surname><given-names>E</given-names></name><name name-style="western"><surname>Maddock</surname><given-names>DA</given-names></name><name name-style="western"><surname>Chao</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Impaired Glucose Metabolism in Patients With Diabetes, Prediabetes, and Obesity is Associated With Severe COVID-19</article-title>. <source>J Med Virol</source> (<year>2021</year>) <volume>93</volume>(<issue>1</issue>):<page-range>409&#8211;15</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jmv.26227</pub-id><pub-id pub-id-type="pmcid">PMC7361926</pub-id><pub-id pub-id-type="pmid">32589756</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>The Associations Between Fasting Plasma Glucose Levels and Mortality of COVID-19 in Patients Without Diabetes</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>169</volume>:<elocation-id>108448</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108448</pub-id><pub-id pub-id-type="pmid">32946851</pub-id><pub-id pub-id-type="pmcid">PMC7492137</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Ma</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Song</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Fasting Blood Glucose at Admission is an Independent Predictor for 28-Day Mortality in Patients With COVID-19 Without Previous Diagnosis of Diabetes: A Multi-Centre Retrospective Study</article-title>. <source>Diabetologia</source> (<year>2020</year>) <volume>63</volume>(<issue>10</issue>):<page-range>2102&#8211;11</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00125-020-05209-1</pub-id><pub-id pub-id-type="pmcid">PMC7347402</pub-id><pub-id pub-id-type="pmid">32647915</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Association Between Longitudinal Change in Abnormal Fasting Blood Glucose Levels and Outcome of COVID-19 Patients Without Previous Diagnosis of Diabetes</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>640529</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fendo.2021.640529</pub-id><pub-id pub-id-type="pmid">33859617</pub-id><pub-id pub-id-type="pmcid">PMC8042381</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alahmad</surname><given-names>B</given-names></name><name name-style="western"><surname>Al-Shammari</surname><given-names>AA</given-names></name><name name-style="western"><surname>Bennakhi</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Mulla</surname><given-names>F</given-names></name><name name-style="western"><surname>Ali</surname><given-names>H</given-names></name></person-group>. <article-title>Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>12</issue>):<page-range>3113&#8211;6</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1941</pub-id><pub-id pub-id-type="pmcid">PMC7770269</pub-id><pub-id pub-id-type="pmid">33051331</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alshukry</surname><given-names>A</given-names></name><name name-style="western"><surname>Bu Abbas</surname><given-names>M</given-names></name><name name-style="western"><surname>Ali</surname><given-names>Y</given-names></name><name name-style="western"><surname>Alahmad</surname><given-names>B</given-names></name><name name-style="western"><surname>Al-Shammari</surname><given-names>AA</given-names></name><name name-style="western"><surname>Alhamar</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and Outcomes of COVID-19 Patients With Diabetes Mellitus in Kuwait</article-title>. <source>Heliyon</source> (<year>2021</year>) <volume>7</volume>(<issue>4</issue>):<elocation-id>e06706</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06706</pub-id><pub-id pub-id-type="pmid">33842709</pub-id><pub-id pub-id-type="pmcid">PMC8020058</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>SP</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Hyperglycemia is a Strong Predictor of Poor Prognosis in COVID-19</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>167</volume>:<elocation-id>108338</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108338</pub-id><pub-id pub-id-type="pmid">32712122</pub-id><pub-id pub-id-type="pmcid">PMC7377976</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>X</given-names></name><name name-style="western"><surname>Alwalid</surname><given-names>O</given-names></name><name name-style="western"><surname>Cui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Baseline Characteristics and Risk Factors for Short-Term Outcomes in 132 COVID-19 Patients With Diabetes in Wuhan China: A Retrospective Study</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>166</volume>:<elocation-id>108299</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108299</pub-id><pub-id pub-id-type="pmid">32623030</pub-id><pub-id pub-id-type="pmcid">PMC7332424</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iacobellis</surname><given-names>G</given-names></name><name name-style="western"><surname>Penaherrera</surname><given-names>CA</given-names></name><name name-style="western"><surname>Bermudez</surname><given-names>LE</given-names></name><name name-style="western"><surname>Bernal Mizrachi</surname><given-names>E</given-names></name></person-group>. <article-title>Admission Hyperglycemia and Radiological Findings of SARS-CoV2 in Patients With and Without Diabetes</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>164</volume>:<elocation-id>108185</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108185</pub-id><pub-id pub-id-type="pmid">32360710</pub-id><pub-id pub-id-type="pmcid">PMC7251996</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cui</surname><given-names>Z</given-names></name><name name-style="western"><surname>Pan</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Liang</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Glycemic Status Affects the Severity of Coronavirus Disease 2019 in Patients With Diabetes Mellitus: An Observational Study of CT Radiological Manifestations Using an Artificial Intelligence Algorithm</article-title>. <source>Acta Diabetol</source> (<year>2021</year>) <volume>58</volume>(<issue>5</issue>):<page-range>575&#8211;86</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00592-020-01654-x</pub-id><pub-id pub-id-type="pmcid">PMC7792916</pub-id><pub-id pub-id-type="pmid">33420614</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klonoff</surname><given-names>DC</given-names></name><name name-style="western"><surname>Messler</surname><given-names>JC</given-names></name><name name-style="western"><surname>Umpierrez</surname><given-names>GE</given-names></name><name name-style="western"><surname>Peng</surname><given-names>L</given-names></name><name name-style="western"><surname>Booth</surname><given-names>R</given-names></name><name name-style="western"><surname>Crowe</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis</article-title>. <source>Diabetes Care</source> (<year>2021</year>) <volume>44</volume>(<issue>2</issue>):<page-range>578&#8211;85</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1857</pub-id><pub-id pub-id-type="pmcid">PMC7818335</pub-id><pub-id pub-id-type="pmid">33323475</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bode</surname><given-names>B</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>V</given-names></name><name name-style="western"><surname>Messler</surname><given-names>J</given-names></name><name name-style="western"><surname>McFarland</surname><given-names>R</given-names></name><name name-style="western"><surname>Crowe</surname><given-names>J</given-names></name><name name-style="western"><surname>Booth</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States</article-title>. <source>J Diabetes Sci Technol</source> (<year>2020</year>) <volume>14</volume>(<issue>4</issue>):<page-range>813&#8211;21</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1177/1932296820924469</pub-id><pub-id pub-id-type="pmcid">PMC7673150</pub-id><pub-id pub-id-type="pmid">32389027</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charoenngam</surname><given-names>N</given-names></name><name name-style="western"><surname>Alexanian</surname><given-names>SM</given-names></name><name name-style="western"><surname>Apovian</surname><given-names>CM</given-names></name><name name-style="western"><surname>Holick</surname><given-names>MF</given-names></name></person-group>. <article-title>Association Between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients With and Without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients</article-title>. <source>Nutrients</source> (<year>2021</year>) <volume>13</volume>(<issue>7</issue>):<elocation-id>2199</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/nu13072199</pub-id><pub-id pub-id-type="pmid">34206813</pub-id><pub-id pub-id-type="pmcid">PMC8308462</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M</given-names></name><name name-style="western"><surname>Cao</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship With the Severity of Coronavirus Disease 2019</article-title>. <source>Mediators Inflamm</source> (<year>2021</year>) <volume>2021</volume>:<elocation-id>8812304</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1155/2021/8812304</pub-id><pub-id pub-id-type="pmid">33814982</pub-id><pub-id pub-id-type="pmcid">PMC7977979</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coppelli</surname><given-names>A</given-names></name><name name-style="western"><surname>Giannarelli</surname><given-names>R</given-names></name><name name-style="western"><surname>Aragona</surname><given-names>M</given-names></name><name name-style="western"><surname>Penno</surname><given-names>G</given-names></name><name name-style="western"><surname>Falcone</surname><given-names>M</given-names></name><name name-style="western"><surname>Tiseo</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study</article-title>. <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>10</issue>):<page-range>2345&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1380</pub-id><pub-id pub-id-type="pmid">32788285</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saand</surname><given-names>AR</given-names></name><name name-style="western"><surname>Flores</surname><given-names>M</given-names></name><name name-style="western"><surname>Kewan</surname><given-names>T</given-names></name><name name-style="western"><surname>Alqaisi</surname><given-names>S</given-names></name><name name-style="western"><surname>Alwakeel</surname><given-names>M</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Does Inpatient Hyperglycemia Predict a Worse Outcome in COVID-19 Intensive Care Unit Patients</article-title>? <source>J Diabetes</source> (<year>2021</year>) <volume>13</volume>(<issue>3</issue>):<page-range>253&#8211;60</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/1753-0407.13137</pub-id><pub-id pub-id-type="pmcid">PMC7753721</pub-id><pub-id pub-id-type="pmid">33216443</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Dai</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lei</surname><given-names>SQ</given-names></name><name name-style="western"><surname>Yan</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Minimized Glycemic Fluctuation Decreases the Risk of Severe Illness and Death in Patients With COVID-19</article-title>. <source>J Med Virol</source> (<year>2021</year>) <volume>93</volume>(<issue>7</issue>):<page-range>4060&#8211;2</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1002/jmv.26584</pub-id><pub-id pub-id-type="pmcid">PMC7675502</pub-id><pub-id pub-id-type="pmid">33026669</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Association of Early-Phase In-Hospital Glycemic Fluctuation With Mortality in Adult Patients With Coronavirus Disease 2019</article-title>. <source>Diabetes Care</source> (<year>2021</year>) <volume>44</volume>(<issue>4</issue>):<page-range>865&#8211;73</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-0780</pub-id><pub-id pub-id-type="pmid">33479161</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring</article-title>. <source>Diabetes Care</source> (<year>2021</year>) <volume>44</volume>(<issue>4</issue>):<page-range>976&#8211;82</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1448</pub-id><pub-id pub-id-type="pmcid">PMC7985431</pub-id><pub-id pub-id-type="pmid">33574126</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>B</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>M</given-names></name><name name-style="western"><surname>Gopalakrishnan</surname><given-names>M</given-names></name><name name-style="western"><surname>Garg</surname><given-names>MK</given-names></name><name name-style="western"><surname>Misra</surname><given-names>S</given-names></name></person-group>. <article-title>Effect of Plasma Glucose at Admission on COVID-19 Mortality: Experience From a Tertiary Hospital</article-title>. <source>Endocr Connect</source> (<year>2021</year>) <volume>10</volume>(<issue>6</issue>):<page-range>589&#8211;98</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1530/EC-21-0086</pub-id><pub-id pub-id-type="pmcid">PMC8240722</pub-id><pub-id pub-id-type="pmid">33971617</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Targher</surname><given-names>G</given-names></name><name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XB</given-names></name><name name-style="western"><surname>Yan</surname><given-names>HD</given-names></name><name name-style="western"><surname>Sun</surname><given-names>QF</given-names></name><name name-style="western"><surname>Pan</surname><given-names>KH</given-names></name><etal/></person-group>. <article-title>Patients With Diabetes Are at Higher Risk for Severe Illness From COVID-19</article-title>. <source>Diabetes Metab</source> (<year>2020</year>) <volume>46</volume>(<issue>4</issue>):<page-range>335&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabet.2020.05.001</pub-id><pub-id pub-id-type="pmcid">PMC7255326</pub-id><pub-id pub-id-type="pmid">32416321</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>MK</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name><name name-style="western"><surname>Moon</surname><given-names>JS</given-names></name><name name-style="western"><surname>Cho</surname><given-names>NH</given-names></name><name name-style="western"><surname>Han</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>The Clinical Characteristics and Outcomes of Patients With Moderate-To-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea</article-title>. <source>Diabetes Metab J</source> (<year>2020</year>) <volume>44</volume>(<issue>4</issue>):<page-range>602&#8211;13</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.4093/dmj.2020.0146</pub-id><pub-id pub-id-type="pmcid">PMC7453989</pub-id><pub-id pub-id-type="pmid">32794386</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>PB</given-names></name><name name-style="western"><surname>Kohn</surname><given-names>MA</given-names></name><name name-style="western"><surname>Koliwad</surname><given-names>SK</given-names></name><name name-style="western"><surname>Rushakoff</surname><given-names>RJ</given-names></name></person-group>. <article-title>Lack of Association Between Either Outpatient or Inpatient Glycemic Control and COVID-19 Illness Severity or Mortality in Patients With Diabetes</article-title>. <source>BMJ Open Diabetes Res Care</source> (<year>2021</year>) <volume>9</volume>(<issue>1</issue>):<elocation-id>e002203</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmjdrc-2021-002203</pub-id><pub-id pub-id-type="pmcid">PMC8169218</pub-id><pub-id pub-id-type="pmid">34059527</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group>. <article-title>Hyperglycemia at Admission is a Strong Predictor of Mortality and Severe/Critical Complications in COVID-19 Patients: A Meta-Analysis</article-title>. <source>Biosci Rep</source> (<year>2021</year>) <volume>41</volume>(<issue>2</issue>):<elocation-id>BSR20203584</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1042/BSR20203584</pub-id><pub-id pub-id-type="pmid">33480978</pub-id><pub-id pub-id-type="pmcid">PMC7876597</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarus</surname><given-names>G</given-names></name><name name-style="western"><surname>Audrey</surname><given-names>J</given-names></name><name name-style="western"><surname>Wangsaputra</surname><given-names>VK</given-names></name><name name-style="western"><surname>Tamara</surname><given-names>A</given-names></name><name name-style="western"><surname>Tahapary</surname><given-names>DL</given-names></name></person-group>. <article-title>High Admission Blood Glucose Independently Predicts Poor Prognosis in COVID-19 Patients: A Systematic Review and Dose-Response Meta-Analysis</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2021</year>) <volume>171</volume>:<elocation-id>108561</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108561</pub-id><pub-id pub-id-type="pmid">33310127</pub-id><pub-id pub-id-type="pmcid">PMC7725108</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sachdeva</surname><given-names>S</given-names></name><name name-style="western"><surname>Desai</surname><given-names>R</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>U</given-names></name><name name-style="western"><surname>Prakash</surname><given-names>A</given-names></name><name name-style="western"><surname>Jain</surname><given-names>A</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>A</given-names></name></person-group>. <article-title>Admission Hyperglycemia in Non-Diabetics Predicts Mortality and Disease Severity in COVID-19: A Pooled Analysis and Meta-Summary of Literature</article-title>. <source>SN Compr Clin Med</source> (<year>2020</year>) <volume>2</volume>(<issue>11</issue>):<page-range>2161&#8211;6</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s42399-020-00575-8</pub-id><pub-id pub-id-type="pmcid">PMC7550017</pub-id><pub-id pub-id-type="pmid">33073173</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fadini</surname><given-names>GP</given-names></name><name name-style="western"><surname>Morieri</surname><given-names>ML</given-names></name><name name-style="western"><surname>Boscari</surname><given-names>F</given-names></name><name name-style="western"><surname>Fioretto</surname><given-names>P</given-names></name><name name-style="western"><surname>Maran</surname><given-names>A</given-names></name><name name-style="western"><surname>Busetto</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Newly-Diagnosed Diabetes and Admission Hyperglycemia Predict COVID-19 Severity by Aggravating Respiratory Deterioration</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>168</volume>:<elocation-id>108374</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108374</pub-id><pub-id pub-id-type="pmid">32805345</pub-id><pub-id pub-id-type="pmcid">PMC7428425</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vargas-Vazquez</surname><given-names>A</given-names></name><name name-style="western"><surname>Bello-Chavolla</surname><given-names>OY</given-names></name><name name-style="western"><surname>Ortiz-Brizuela</surname><given-names>E</given-names></name><name name-style="western"><surname>Campos-Munoz</surname><given-names>A</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>R</given-names></name><name name-style="western"><surname>Villanueva-Reza</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Impact of Undiagnosed Type 2 Diabetes and Pre-Diabetes on Severity and Mortality for SARS-CoV-2 Infection</article-title>. <source>BMJ Open Diabetes Res Care</source> (<year>2021</year>) <volume>9</volume>(<issue>1</issue>):<elocation-id>e002026</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmjdrc-2020-002026</pub-id><pub-id pub-id-type="pmcid">PMC7887863</pub-id><pub-id pub-id-type="pmid">33593750</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Tian</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T</given-names></name><name name-style="western"><surname>Cui</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shi</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Newly Diagnosed Diabetes is Associated With a Higher Risk of Mortality Than Known Diabetes in Hospitalized Patients With COVID-19</article-title>. <source>Diabetes Obes Metab</source> (<year>2020</year>) <volume>22</volume>(<issue>10</issue>):<page-range>1897&#8211;906</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/dom.14099</pub-id><pub-id pub-id-type="pmcid">PMC7283710</pub-id><pub-id pub-id-type="pmid">32469464</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cariou</surname><given-names>B</given-names></name><name name-style="western"><surname>Pichelin</surname><given-names>M</given-names></name><name name-style="western"><surname>Goronflot</surname><given-names>T</given-names></name><name name-style="western"><surname>Gonfroy</surname><given-names>C</given-names></name><name name-style="western"><surname>Marre</surname><given-names>M</given-names></name><name name-style="western"><surname>Raffaitin-Cardin</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Phenotypic Characteristics and Prognosis of Newly Diagnosed Diabetes in Hospitalized Patients With COVID-19: Results From the CORONADO Study</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2021</year>) <volume>175</volume>:<elocation-id>108695</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2021.108695</pub-id><pub-id pub-id-type="pmid">33577905</pub-id><pub-id pub-id-type="pmcid">PMC7872857</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Diabetes, Even Newly Defined by HbA1c Testing, is Associated With an Increased Risk of in-Hospital Death in Adults With COVID-19</article-title>. <source>BMC Endocr Disord</source> (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>56</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s12902-021-00717-6</pub-id><pub-id pub-id-type="pmid">33771154</pub-id><pub-id pub-id-type="pmcid">PMC7995677</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><name name-style="western"><surname>Shojima</surname><given-names>N</given-names></name><name name-style="western"><surname>Noma</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamauchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kadowaki</surname><given-names>T</given-names></name></person-group>. <article-title>Glycemic Control, Mortality, and Hypoglycemia in Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials</article-title>. <source>Intensive Care Med</source> (<year>2017</year>) <volume>43</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>15</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00134-016-4523-0</pub-id><pub-id pub-id-type="pmid">27637719</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sardu</surname><given-names>C</given-names></name><name name-style="western"><surname>D'Onofrio</surname><given-names>N</given-names></name><name name-style="western"><surname>Balestrieri</surname><given-names>ML</given-names></name><name name-style="western"><surname>Barbieri</surname><given-names>M</given-names></name><name name-style="western"><surname>Rizzo</surname><given-names>MR</given-names></name><name name-style="western"><surname>Messina</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control</article-title>? <source>Diabetes Care</source> (<year>2020</year>) <volume>43</volume>(<issue>7</issue>):<page-range>1408&#8211;15</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-0723</pub-id><pub-id pub-id-type="pmcid">PMC7305003</pub-id><pub-id pub-id-type="pmid">32430456</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sardu</surname><given-names>C</given-names></name><name name-style="western"><surname>D'Onofrio</surname><given-names>N</given-names></name><name name-style="western"><surname>Balestrieri</surname><given-names>ML</given-names></name><name name-style="western"><surname>Barbieri</surname><given-names>M</given-names></name><name name-style="western"><surname>Rizzo</surname><given-names>MR</given-names></name><name name-style="western"><surname>Messina</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Hyperglycaemia on Admission to Hospital and COVID-19</article-title>. <source>Diabetologia</source> (<year>2020</year>) <volume>63</volume>(<issue>11</issue>):<page-range>2486&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s00125-020-05216-2</pub-id><pub-id pub-id-type="pmcid">PMC7335920</pub-id><pub-id pub-id-type="pmid">32632527</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misra</surname><given-names>S</given-names></name><name name-style="western"><surname>Barron</surname><given-names>E</given-names></name><name name-style="western"><surname>Vamos</surname><given-names>E</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>S</given-names></name><name name-style="western"><surname>Dhatariya</surname><given-names>K</given-names></name><name name-style="western"><surname>Kar</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Temporal Trends in Emergency Admissions for Diabetic Ketoacidosis in People With Diabetes in England Before and During the COVID-19 Pandemic: A Population-Based Study</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2021</year>) <volume>9</volume>(<issue>10</issue>):<page-range>671&#8211;80</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S2213-8587(21)00208-4</pub-id><pub-id pub-id-type="pmcid">PMC9765220</pub-id><pub-id pub-id-type="pmid">34481558</pub-id></mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ditkowsky</surname><given-names>J</given-names></name><name name-style="western"><surname>Lieber</surname><given-names>AC</given-names></name><name name-style="western"><surname>Leibner</surname><given-names>ES</given-names></name><name name-style="western"><surname>Genes</surname><given-names>N</given-names></name></person-group>. <article-title>SARS-CoV-2 Infection and Associated Rates of Diabetic Ketoacidosis in a New York City Emergency Department</article-title>. <source>West J Emerg Med</source> (<year>2021</year>) <volume>22</volume>(<issue>3</issue>):<fpage>599</fpage>&#8211;<lpage>602</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.5811/westjem.2021.2.49634</pub-id><pub-id pub-id-type="pmid">34125033</pub-id><pub-id pub-id-type="pmcid">PMC8203019</pub-id></mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallett</surname><given-names>L</given-names></name><name name-style="western"><surname>Kempegowda</surname><given-names>P</given-names></name><name name-style="western"><surname>Melson</surname><given-names>E</given-names></name><name name-style="western"><surname>Juszczak</surname><given-names>A</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Differences in Presentation, Severity and Management of DKA in Type 1 and Type 2 Diabetes During the COVID-19 Pandemic</article-title>. <source>Clin Med (Lond)</source> (<year>2021</year>) <volume>21</volume>(<issue>Suppl 2</issue>):<fpage>1</fpage>&#8211;<lpage>2</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.7861/clinmed.21-2-s1</pub-id><pub-id pub-id-type="pmid">34078672</pub-id></mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>A</given-names></name><name name-style="western"><surname>Deak</surname><given-names>A</given-names></name><name name-style="western"><surname>Allen</surname><given-names>S</given-names></name><name name-style="western"><surname>Silfani</surname><given-names>E</given-names></name><name name-style="western"><surname>Koppin</surname><given-names>C</given-names></name><name name-style="western"><surname>Zisman-Ilani</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Some Characteristics of Hyperglycaemic Crisis Differ Between Patients With and Without COVID-19 at a Safety-Net Hospital in a Cross-Sectional Study</article-title>. <source>Ann Med</source> (<year>2021</year>) <volume>53</volume>(<issue>1</issue>):<page-range>1642&#8211;5</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1080/07853890.2021.1975042</pub-id><pub-id pub-id-type="pmcid">PMC8439248</pub-id><pub-id pub-id-type="pmid">34511013</pub-id></mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alhumaid</surname><given-names>S</given-names></name><name name-style="western"><surname>Al Mutair</surname><given-names>A</given-names></name><name name-style="western"><surname>Al Alawi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rabaan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Alomari</surname><given-names>MA</given-names></name><name name-style="western"><surname>Al Salman</surname><given-names>SA</given-names></name><etal/></person-group>. <article-title>Diabetic Ketoacidosis in Patients With SARS-CoV-2: A Systematic Review and Meta-Analysis</article-title>. <source>Diabetol Metab Syndr</source> (<year>2021</year>) <volume>13</volume>(<issue>1</issue>):<fpage>120</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s13098-021-00740-6</pub-id><pub-id pub-id-type="pmid">34702335</pub-id><pub-id pub-id-type="pmcid">PMC8547563</pub-id></mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viswanathan</surname><given-names>V</given-names></name><name name-style="western"><surname>Puvvula</surname><given-names>A</given-names></name><name name-style="western"><surname>Jamthikar</surname><given-names>AD</given-names></name><name name-style="western"><surname>Saba</surname><given-names>L</given-names></name><name name-style="western"><surname>Johri</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kotsis</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Bidirectional Link Between Diabetes Mellitus and Coronavirus Disease 2019 Leading to Cardiovascular Disease: A Narrative Review</article-title>. <source>World J Diabetes</source> (<year>2021</year>) <volume>12</volume>(<issue>3</issue>):<page-range>215&#8211;37</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.4239/wjd.v12.i3.215</pub-id><pub-id pub-id-type="pmcid">PMC7958478</pub-id><pub-id pub-id-type="pmid">33758644</pub-id></mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathish</surname><given-names>T</given-names></name><name name-style="western"><surname>Kapoor</surname><given-names>N</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tapp</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Zimmet</surname><given-names>P</given-names></name></person-group>. <article-title>Proportion of Newly Diagnosed Diabetes in COVID-19 Patients: A Systematic Review and Meta-Analysis</article-title>. <source>Diabetes Obes Metab</source> (<year>2021</year>) <volume>23</volume>(<issue>3</issue>):<page-range>870&#8211;4</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/dom.14269</pub-id><pub-id pub-id-type="pmcid">PMC7753574</pub-id><pub-id pub-id-type="pmid">33245182</pub-id></mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanji</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sawada</surname><given-names>S</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>T</given-names></name><name name-style="western"><surname>Mita</surname><given-names>T</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Impact of COVID-19 Pandemic on Glycemic Control Among Outpatients With Type 2 Diabetes in Japan: A Hospital-Based Survey From a Country Without Lockdown</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2021</year>) <volume>176</volume>:<elocation-id>108840</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2021.108840</pub-id><pub-id pub-id-type="pmid">33933499</pub-id><pub-id pub-id-type="pmcid">PMC8084613</pub-id></mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verma</surname><given-names>A</given-names></name><name name-style="western"><surname>Rajput</surname><given-names>R</given-names></name><name name-style="western"><surname>Verma</surname><given-names>S</given-names></name><name name-style="western"><surname>Balania</surname><given-names>VKB</given-names></name><name name-style="western"><surname>Jangra</surname><given-names>B</given-names></name></person-group>. <article-title>Impact of Lockdown in COVID 19 on Glycemic Control in Patients With Type 1 Diabetes Mellitus</article-title>. <source>Diabetes Metab Syndr</source> (<year>2020</year>) <volume>14</volume>(<issue>5</issue>):<page-range>1213&#8211;6</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2020.07.016</pub-id><pub-id pub-id-type="pmcid">PMC7357511</pub-id><pub-id pub-id-type="pmid">32679527</pub-id></mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khare</surname><given-names>J</given-names></name><name name-style="western"><surname>Jindal</surname><given-names>S</given-names></name></person-group>. <article-title>Observational Study on Effect of Lock Down Due to COVID 19 on Glycemic Control in Patients With Diabetes: Experience From Central India</article-title>. <source>Diabetes Metab Syndr</source> (<year>2020</year>) <volume>14</volume>(<issue>6</issue>):<page-range>1571&#8211;4</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2020.08.012</pub-id><pub-id pub-id-type="pmcid">PMC7438221</pub-id><pub-id pub-id-type="pmid">32858474</pub-id></mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falcetta</surname><given-names>P</given-names></name><name name-style="western"><surname>Aragona</surname><given-names>M</given-names></name><name name-style="western"><surname>Ciccarone</surname><given-names>A</given-names></name><name name-style="western"><surname>Bertolotto</surname><given-names>A</given-names></name><name name-style="western"><surname>Campi</surname><given-names>F</given-names></name><name name-style="western"><surname>Coppelli</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Impact of COVID-19 Lockdown on Glucose Control of Elderly People With Type 2 Diabetes in Italy</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2021</year>) <volume>174</volume>:<elocation-id>108750</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2021.108750</pub-id><pub-id pub-id-type="pmid">33722703</pub-id><pub-id pub-id-type="pmcid">PMC9754212</pub-id></mixed-citation></ref><ref id="B191"><label>191</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'Onofrio</surname><given-names>L</given-names></name><name name-style="western"><surname>Pieralice</surname><given-names>S</given-names></name><name name-style="western"><surname>Maddaloni</surname><given-names>E</given-names></name><name name-style="western"><surname>Mignogna</surname><given-names>C</given-names></name><name name-style="western"><surname>Sterpetti</surname><given-names>S</given-names></name><name name-style="western"><surname>Coraggio</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Effects of the COVID-19 Lockdown on Glycaemic Control in Subjects With Type 2 Diabetes: The Glycalock Study</article-title>. <source>Diabetes Obes Metab</source> (<year>2021</year>) <volume>23</volume>(<issue>7</issue>):<page-range>1624&#8211;30</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/dom.14380</pub-id><pub-id pub-id-type="pmcid">PMC8251001</pub-id><pub-id pub-id-type="pmid">33764666</pub-id></mixed-citation></ref><ref id="B192"><label>192</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez</surname><given-names>E</given-names></name><name name-style="western"><surname>Cortazar</surname><given-names>A</given-names></name><name name-style="western"><surname>Bellido</surname><given-names>V</given-names></name></person-group>. <article-title>Impact of COVID-19 Lockdown on Glycemic Control in Patients With Type 1 Diabetes</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2020</year>) <volume>166</volume>:<elocation-id>108348</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108348</pub-id><pub-id pub-id-type="pmid">32711000</pub-id><pub-id pub-id-type="pmcid">PMC7375311</pub-id></mixed-citation></ref><ref id="B193"><label>193</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonora</surname><given-names>BM</given-names></name><name name-style="western"><surname>Morieri</surname><given-names>ML</given-names></name><name name-style="western"><surname>Avogaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Fadini</surname><given-names>GP</given-names></name></person-group>. <article-title>The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy</article-title>. <source>Diabetes Care</source> (<year>2021</year>) <volume>44</volume>(<issue>1</issue>):<page-range>e18&#8211;21</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/dc20-1872</pub-id><pub-id pub-id-type="pmid">33127611</pub-id></mixed-citation></ref><ref id="B194"><label>194</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudre</surname><given-names>CH</given-names></name><name name-style="western"><surname>Murray</surname><given-names>B</given-names></name><name name-style="western"><surname>Varsavsky</surname><given-names>T</given-names></name><name name-style="western"><surname>Graham</surname><given-names>MS</given-names></name><name name-style="western"><surname>Penfold</surname><given-names>RS</given-names></name><name name-style="western"><surname>Bowyer</surname><given-names>RC</given-names></name><etal/></person-group>. <article-title>Attributes and Predictors of Long-COVID: Analysis of COVID Cases and Their Symptoms Collected by the Covid Symptoms Study App</article-title>. <source>Nat Med</source> (<year>2020</year>) <volume>27</volume>(<issue>4</issue>):<page-range>626&#8211;31</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1101/2020.10.19.20214494</pub-id><pub-id pub-id-type="pmcid">PMC7611399</pub-id><pub-id pub-id-type="pmid">33692530</pub-id></mixed-citation></ref><ref id="B195"><label>195</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anaya</surname><given-names>JM</given-names></name><name name-style="western"><surname>Rojas</surname><given-names>M</given-names></name><name name-style="western"><surname>Salinas</surname><given-names>ML</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Roa</surname><given-names>G</given-names></name><name name-style="western"><surname>Lozano</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Post-COVID Syndrome. A Case Series and Comprehensive Review</article-title>. <source>Autoimmun Rev</source> (<year>2021</year>) <volume>20</volume>(<issue>11</issue>):<elocation-id>102947</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.autrev.2021.102947</pub-id><pub-id pub-id-type="pmid">34509649</pub-id><pub-id pub-id-type="pmcid">PMC8428988</pub-id></mixed-citation></ref><ref id="B196"><label>196</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Ren</surname><given-names>L</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>6-Month Consequences of COVID-19 in Patients Discharged From Hospital: A Cohort Study</article-title>. <source>Lancet</source> (<year>2021</year>) <volume>397</volume>(<issue>10270</issue>):<page-range>220&#8211;32</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S0140-6736(20)32656-8</pub-id><pub-id pub-id-type="pmcid">PMC7833295</pub-id><pub-id pub-id-type="pmid">33428867</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="expression-of-concern" ext-link-type="pmc" xlink:href="PMC9691145"/></mixed-citation></ref><ref id="B197"><label>197</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robey</surname><given-names>RC</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>K</given-names></name><name name-style="western"><surname>Hayton</surname><given-names>P</given-names></name><name name-style="western"><surname>Mudawi</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Greaves</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service</article-title>. <source>Adv Ther</source> (<year>2021</year>) <volume>38</volume>(<issue>8</issue>):<page-range>4505&#8211;19</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s12325-021-01833-4</pub-id><pub-id pub-id-type="pmcid">PMC8286847</pub-id><pub-id pub-id-type="pmid">34278556</pub-id></mixed-citation></ref><ref id="B198"><label>198</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akter</surname><given-names>F</given-names></name><name name-style="western"><surname>Mannan</surname><given-names>A</given-names></name><name name-style="western"><surname>Mehedi</surname><given-names>HMH</given-names></name><name name-style="western"><surname>Rob</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>S</given-names></name><name name-style="western"><surname>Salauddin</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Clinical Characteristics and Short Term Outcomes After Recovery From COVID-19 in Patients With and Without Diabetes in Bangladesh</article-title>. <source>Diabetes Metab Syndr</source> (<year>2020</year>) <volume>14</volume>(<issue>6</issue>):<page-range>2031&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2020.10.016</pub-id><pub-id pub-id-type="pmcid">PMC7575434</pub-id><pub-id pub-id-type="pmid">33113469</pub-id></mixed-citation></ref><ref id="B199"><label>199</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomar</surname><given-names>BS</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M</given-names></name><name name-style="western"><surname>Nathiya</surname><given-names>D</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>E</given-names></name><name name-style="western"><surname>Bareth</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Prevalence of Symptoms in Patients Discharged From COVID Care Facility of NIMS Hospital: Is RT PCR Negativity Truly Reflecting Recovery? A Single-Centre Observational Study</article-title>. <source>Int J Gen Med</source> (<year>2021</year>) <volume>14</volume>:<page-range>1069&#8211;78</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2147/IJGM.S295499</pub-id><pub-id pub-id-type="pmcid">PMC8006813</pub-id><pub-id pub-id-type="pmid">33790636</pub-id></mixed-citation></ref><ref id="B200"><label>200</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez-de-Las-Penas</surname><given-names>C</given-names></name><name name-style="western"><surname>Guijarro</surname><given-names>C</given-names></name><name name-style="western"><surname>Torres-Macho</surname><given-names>J</given-names></name><name name-style="western"><surname>Velasco-Arribas</surname><given-names>M</given-names></name><name name-style="western"><surname>Susana</surname><given-names>PC</given-names></name><name name-style="western"><surname>Hernandez-Barrera</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Diabetes and the Risk of Long-Term Post-COVID Symptoms</article-title>. <source>Diabetes</source> (<year>2021</year>) <volume>70</volume>(<issue>12</issue>):<page-range>2917&#8211;21</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2337/db21-0329</pub-id><pub-id pub-id-type="pmid">34580087</pub-id></mixed-citation></ref><ref id="B201"><label>201</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogoina</surname><given-names>D</given-names></name><name name-style="western"><surname>James</surname><given-names>HI</given-names></name><name name-style="western"><surname>Ogoinja</surname><given-names>SZ</given-names></name></person-group>. <article-title>Post-Discharge Symptoms Among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study</article-title>. <source>Am J Trop Med Hyg</source> (<year>2021</year>) <volume>105</volume>(<issue>3</issue>):<page-range>731&#8211;6</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.4269/ajtmh.21-0509</pub-id><pub-id pub-id-type="pmcid">PMC8592373</pub-id><pub-id pub-id-type="pmid">34270448</pub-id></mixed-citation></ref><ref id="B202"><label>202</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kingery</surname><given-names>JR</given-names></name><name name-style="western"><surname>Bf Martin</surname><given-names>P</given-names></name><name name-style="western"><surname>Baer</surname><given-names>BR</given-names></name><name name-style="western"><surname>Pinheiro</surname><given-names>LC</given-names></name><name name-style="western"><surname>Rajan</surname><given-names>M</given-names></name><name name-style="western"><surname>Clermont</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection</article-title>. <source>J Gen Intern Med</source> (<year>2021</year>) <volume>36</volume>(<issue>8</issue>):<page-range>2378&#8211;85</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s11606-021-06924-0</pub-id><pub-id pub-id-type="pmcid">PMC8183585</pub-id><pub-id pub-id-type="pmid">34100231</pub-id></mixed-citation></ref><ref id="B203"><label>203</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavery</surname><given-names>AM</given-names></name><name name-style="western"><surname>Preston</surname><given-names>LE</given-names></name><name name-style="western"><surname>Ko</surname><given-names>JY</given-names></name><name name-style="western"><surname>Chevinsky</surname><given-names>JR</given-names></name><name name-style="western"><surname>DeSisto</surname><given-names>CL</given-names></name><name name-style="western"><surname>Pennington</surname><given-names>AF</given-names></name><etal/></person-group>. <article-title>Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission - United States, March-August 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source> (<year>2020</year>) <volume>69</volume>(<issue>45</issue>):<page-range>1695&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.15585/mmwr.mm6945e2</pub-id><pub-id pub-id-type="pmcid">PMC7660660</pub-id><pub-id pub-id-type="pmid">33180754</pub-id></mixed-citation></ref><ref id="B204"><label>204</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeon</surname><given-names>WH</given-names></name><name name-style="western"><surname>Seon</surname><given-names>JY</given-names></name><name name-style="western"><surname>Park</surname><given-names>SY</given-names></name><name name-style="western"><surname>Oh</surname><given-names>IH</given-names></name></person-group>. <article-title>Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data</article-title>. <source>Int J Environ Res Public Health</source> (<year>2020</year>) <volume>17</volume>(<issue>16</issue>):<elocation-id>5844</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/ijerph17165844</pub-id><pub-id pub-id-type="pmid">32806775</pub-id><pub-id pub-id-type="pmcid">PMC7460295</pub-id></mixed-citation></ref><ref id="B205"><label>205</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atalla</surname><given-names>E</given-names></name><name name-style="western"><surname>Kalligeros</surname><given-names>M</given-names></name><name name-style="western"><surname>Giampaolo</surname><given-names>G</given-names></name><name name-style="western"><surname>Mylona</surname><given-names>EK</given-names></name><name name-style="western"><surname>Shehadeh</surname><given-names>F</given-names></name><name name-style="western"><surname>Mylonakis</surname><given-names>E</given-names></name></person-group>. <article-title>Readmissions Among Patients With COVID-19</article-title>. <source>Int J Clin Pract</source> (<year>2021</year>) <volume>75</volume>(<issue>3</issue>):<elocation-id>e13700</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1111/ijcp.13700</pub-id><pub-id pub-id-type="pmid">32894801</pub-id></mixed-citation></ref><ref id="B206"><label>206</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowles</surname><given-names>KH</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>M</given-names></name><name name-style="western"><surname>Barron</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>E</given-names></name><name name-style="western"><surname>O'Connor</surname><given-names>M</given-names></name><name name-style="western"><surname>Mikkelsen</surname><given-names>M</given-names></name></person-group>. <article-title>Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients</article-title>. <source>Ann Intern Med</source> (<year>2021</year>) <volume>174</volume>(<issue>3</issue>):<page-range>316&#8211;25</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.7326/M20-5206</pub-id><pub-id pub-id-type="pmcid">PMC7707212</pub-id><pub-id pub-id-type="pmid">33226861</pub-id></mixed-citation></ref><ref id="B207"><label>207</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Lorenzo</surname><given-names>R</given-names></name><name name-style="western"><surname>Conte</surname><given-names>C</given-names></name><name name-style="western"><surname>Lanzani</surname><given-names>C</given-names></name><name name-style="western"><surname>Benedetti</surname><given-names>F</given-names></name><name name-style="western"><surname>Roveri</surname><given-names>L</given-names></name><name name-style="western"><surname>Mazza</surname><given-names>MG</given-names></name><etal/></person-group>. <article-title>Residual Clinical Damage After COVID-19: A Retrospective and Prospective Observational Cohort Study</article-title>. <source>PloS One</source> (<year>2020</year>) <volume>15</volume>(<issue>10</issue>):<elocation-id>e0239570</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0239570</pub-id><pub-id pub-id-type="pmid">33052920</pub-id><pub-id pub-id-type="pmcid">PMC7556454</pub-id></mixed-citation></ref><ref id="B208"><label>208</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murillo-Zamora</surname><given-names>E</given-names></name><name name-style="western"><surname>Mendoza-Cano</surname><given-names>O</given-names></name><name name-style="western"><surname>Delgado-Enciso</surname><given-names>I</given-names></name><name name-style="western"><surname>Hernandez-Suarez</surname><given-names>CM</given-names></name></person-group>. <article-title>Predictors of Severe Symptomatic Laboratory-Confirmed SARS-CoV-2 Reinfection</article-title>. <source>Public Health</source> (<year>2021</year>) <volume>193</volume>:<page-range>113&#8211;5</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.puhe.2021.01.021</pub-id><pub-id pub-id-type="pmcid">PMC7879028</pub-id><pub-id pub-id-type="pmid">33774512</pub-id></mixed-citation></ref><ref id="B209"><label>209</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Somani</surname><given-names>SS</given-names></name><name name-style="western"><surname>Richter</surname><given-names>F</given-names></name><name name-style="western"><surname>Fuster</surname><given-names>V</given-names></name><name name-style="western"><surname>De Freitas</surname><given-names>JK</given-names></name><name name-style="western"><surname>Naik</surname><given-names>N</given-names></name><name name-style="western"><surname>Sigel</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Characterization of Patients Who Return to Hospital Following Discharge From Hospitalization for COVID-19</article-title>. <source>J Gen Intern Med</source> (<year>2020</year>) <volume>35</volume>(<issue>10</issue>):<page-range>2838&#8211;44</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s11606-020-06120-6</pub-id><pub-id pub-id-type="pmcid">PMC7437962</pub-id><pub-id pub-id-type="pmid">32815060</pub-id></mixed-citation></ref><ref id="B210"><label>210</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fouad</surname><given-names>YA</given-names></name><name name-style="western"><surname>Abdelaziz</surname><given-names>TT</given-names></name><name name-style="western"><surname>Askoura</surname><given-names>A</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>MI</given-names></name><name name-style="western"><surname>Mahmoud</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ashour</surname><given-names>DM</given-names></name><etal/></person-group>. <article-title>Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic</article-title>. <source>Front Med (Lausanne)</source> (<year>2021</year>) <volume>8</volume>:<elocation-id>645270</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fmed.2021.645270</pub-id><pub-id pub-id-type="pmid">34124087</pub-id><pub-id pub-id-type="pmcid">PMC8192710</pub-id></mixed-citation></ref><ref id="B211"><label>211</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lionakis</surname><given-names>MS</given-names></name><name name-style="western"><surname>Kontoyiannis</surname><given-names>DP</given-names></name></person-group>. <article-title>Glucocorticoids and Invasive Fungal Infections</article-title>. <source>Lancet</source> (<year>2003</year>) <volume>362</volume>(<issue>9398</issue>):<page-range>1828&#8211;38</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/S0140-6736(03)14904-5</pub-id><pub-id pub-id-type="pmid">14654323</pub-id></mixed-citation></ref><ref id="B212"><label>212</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perricone</surname><given-names>C</given-names></name><name name-style="western"><surname>Bartoloni</surname><given-names>E</given-names></name><name name-style="western"><surname>Bursi</surname><given-names>R</given-names></name><name name-style="western"><surname>Cafaro</surname><given-names>G</given-names></name><name name-style="western"><surname>Guidelli</surname><given-names>GM</given-names></name><name name-style="western"><surname>Shoenfeld</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>COVID-19 as Part of the Hyperferritinemic Syndromes: The Role of Iron Depletion Therapy</article-title>. <source>Immunol Res</source> (<year>2020</year>) <volume>68</volume>(<issue>4</issue>):<page-range>213&#8211;24</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s12026-020-09145-5</pub-id><pub-id pub-id-type="pmcid">PMC7366458</pub-id><pub-id pub-id-type="pmid">32681497</pub-id></mixed-citation></ref><ref id="B213"><label>213</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>W</given-names></name><name name-style="western"><surname>Keighley</surname><given-names>C</given-names></name><name name-style="western"><surname>Wolfe</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WL</given-names></name><name name-style="western"><surname>Slavin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Kong</surname><given-names>DCM</given-names></name><etal/></person-group>. <article-title>The Epidemiology and Clinical Manifestations of Mucormycosis: A Systematic Review and Meta-Analysis of Case Reports</article-title>. <source>Clin Microbiol Infect</source> (<year>2019</year>) <volume>25</volume>(<issue>1</issue>):<fpage>26</fpage>&#8211;<lpage>34</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.cmi.2018.07.011</pub-id><pub-id pub-id-type="pmid">30036666</pub-id></mixed-citation></ref><ref id="B214"><label>214</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>M</given-names></name><name name-style="western"><surname>Honavar</surname><given-names>SG</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>R</given-names></name><name name-style="western"><surname>Sengupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Rao</surname><given-names>R</given-names></name><name name-style="western"><surname>Kim</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Epidemiology, Clinical Profile, Management, and Outcome of COVID-19-Associated Rhino-Orbital-Cerebral Mucormycosis in 2826 Patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1</article-title>. <source>Indian J Ophthalmol</source> (<year>2021</year>) <volume>69</volume>(<issue>7</issue>):<page-range>1670&#8211;92</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.4103/ijo.IJO_1565_21</pub-id><pub-id pub-id-type="pmcid">PMC8374756</pub-id><pub-id pub-id-type="pmid">34156034</pub-id></mixed-citation></ref><ref id="B215"><label>215</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>R</given-names></name><name name-style="western"><surname>Singh</surname><given-names>B</given-names></name><name name-style="western"><surname>Bhadada</surname><given-names>SK</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhogal</surname><given-names>RS</given-names></name><name name-style="western"><surname>Hage</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>COVID-19-Associated Mucormycosis: An Updated Systematic Review of Literature</article-title>. <source>Mycoses</source> (<year>2021</year>) <volume>64</volume>(<issue>12</issue>):<page-range>1452&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/myc.13338</pub-id><pub-id pub-id-type="pmcid">PMC8447126</pub-id><pub-id pub-id-type="pmid">34133798</pub-id></mixed-citation></ref><ref id="B216"><label>216</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>SR</given-names></name><name name-style="western"><surname>Misra</surname><given-names>A</given-names></name></person-group>. <article-title>Mucormycosis in COVID-19: A Systematic Review of Cases Reported Worldwide and in India</article-title>. <source>Diabetes Metab Syndr</source> (<year>2021</year>) <volume>15</volume>(<issue>4</issue>):<fpage>102146</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.dsx.2021.05.019</pub-id><pub-id pub-id-type="pmid">34192610</pub-id><pub-id pub-id-type="pmcid">PMC8137376</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>